% alzhub.org library filter % Source: https://alzhub.org/research?atag=efficacy % 500 entries, in the order the page lists them. Built from alzhub.org's own records. % 0 entries have no readable author in the source record and carry no author field. @article{oki2024-39229900, author = {Oki, Y. and Osaki, T. and Kumagai, R. and Murata, S. and Encho, H. and Ono, R. and Yasuda, H. and Kowa, H.}, title = {{An 18-month multimodal intervention trial for preventing dementia: J-MINT PRIME Tamba}}, journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association}, year = {2024}, doi = {10.1002/alz.14170}, pmid = {39229900}, url = {https://doi.org/10.1002/alz.14170} } @article{yunusa2019-30901041, author = {Yunusa, I. and Alsumali, A. and Garba, A. E. and Regestein, Q. R. and Eguale, T.}, title = {{Assessment of Reported Comparative Effectiveness and Safety of Atypical Antipsychotics in the Treatment of Behavioral and Psychological Symptoms of Dementia: A Network Meta-analysis}}, journal = {JAMA network open}, year = {2019}, doi = {10.1001/jamanetworkopen.2019.0828}, pmid = {30901041}, url = {https://doi.org/10.1001/jamanetworkopen.2019.0828} } @article{salloway2014-24450891, author = {Salloway, S. and Sperling, R. and Fox, N. C. and Blennow, K. and Klunk, W. and Raskind, M. and Sabbagh, M. and Honig, L. S. and others}, title = {{Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease}}, journal = {The New England journal of medicine}, year = {2014}, doi = {10.1056/nejmoa1304839}, pmid = {24450891}, url = {https://doi.org/10.1056/nejmoa1304839} } @article{zimmer2025-40063015, author = {Zimmer, J. A. and Ardayfio, P. and Wang, H. and Khanna, R. and Evans, C. D. and Lu, M. and Sparks, J. and Andersen, S. and Lauzon, S. and Nery, E. S. M. and others}, title = {{Amyloid-Related Imaging Abnormalities With Donanemab in Early Symptomatic Alzheimer Disease: Secondary Analysis of the TRAILBLAZER-ALZ and ALZ 2 Randomized Clinical Trials}}, journal = {JAMA Neurology}, year = {2025}, doi = {10.1001/jamaneurol.2025.0065}, pmid = {40063015}, url = {https://doi.org/10.1001/jamaneurol.2025.0065} } @article{egan2019-30970186, author = {Egan, M. F. and Kost, J. and Voss, T. and Mukai, Y. and Aisen, P. S. and Cummings, J. L. and Tariot, P. N. and Vellas, B. and others}, title = {{Randomized Trial of Verubecestat for Prodromal Alzheimer's Disease}}, journal = {The New England journal of medicine}, year = {2019}, doi = {10.1056/nejmoa1812840}, pmid = {30970186}, url = {https://doi.org/10.1056/nejmoa1812840} } @article{birks2006-16437430, author = {Birks, J. and Harvey, R. J.}, title = {{Donepezil for dementia due to Alzheimer's disease}}, journal = {The Cochrane database of systematic reviews}, year = {2006}, doi = {10.1002/14651858.cd001190.pub2}, pmid = {16437430}, url = {https://doi.org/10.1002/14651858.cd001190.pub2} } @article{buddhaeberlein2022-35542991, author = {Budd Haeberlein, S. and Aisen, P. S. and Barkhof, F. and Chalkias, S. and Chen, T. and Cohen, S. and Dent, G. and Hansson, O. and others}, title = {{Two Randomized Phase 3 Studies of Aducanumab in Early Alzheimer's Disease}}, journal = {The journal of prevention of Alzheimer's disease}, year = {2022}, doi = {10.14283/jpad.2022.30}, pmid = {35542991}, url = {https://doi.org/10.14283/jpad.2022.30} } @article{pontecorvo2022-36251300, author = {Pontecorvo, M. J. and Lu, M. and Burnham, S. C. and Schade, A. E. and Dage, J. L. and Shcherbinin, S. and Collins, E. C. and Sims, JR. and others}, title = {{Association of Donanemab Treatment With Exploratory Plasma Biomarkers in Early Symptomatic Alzheimer Disease: A Secondary Analysis of the TRAILBLAZER-ALZ Randomized Clinical Trial}}, journal = {JAMA neurology}, year = {2022}, doi = {10.1001/jamaneurol.2022.3392}, pmid = {36251300}, url = {https://doi.org/10.1001/jamaneurol.2022.3392} } @article{schneider2005-16234500, author = {Schneider, L. S. and Dagerman, K. S. and Insel, P.}, title = {{Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials}}, journal = {JAMA}, year = {2005}, doi = {10.1001/jama.294.15.1934}, pmid = {16234500}, url = {https://doi.org/10.1001/jama.294.15.1934} } @article{gilman2005-15883316, author = {Gilman, S. and Koller, M. and Black, R. S. and Jenkins, L. and Griffith, S. G. and Fox, N. C. and Eisner, L. and Kirby, L. and others}, title = {{Clinical effects of Abeta immunization (AN1792) in patients with AD in an interrupted trial}}, journal = {Neurology}, year = {2005}, doi = {10.1212/01.wnl.0000159740.16984.3c}, pmid = {15883316}, url = {https://doi.org/10.1212/01.wnl.0000159740.16984.3c} } @article{dekosky2008-19017911, author = {DeKosky, S. T. and Williamson, J. D. and Fitzpatrick, A. L. and Kronmal, R. A. and Ives, D. G. and Saxton, J. A. and Lopez, O. L. and Burke, G. and others}, title = {{Ginkgo biloba for prevention of dementia: a randomized controlled trial}}, journal = {JAMA}, year = {2008}, doi = {10.1001/jama.2008.683}, pmid = {19017911}, url = {https://doi.org/10.1001/jama.2008.683} } @article{porsteinsson2014-24549548, author = {Porsteinsson, A. P. and Drye, L. T. and Pollock, B. G. and Devanand, D. P. and Frangakis, C. and Ismail, Z. and Marano, C. and Meinert, C. L. and others}, title = {{Effect of citalopram on agitation in Alzheimer disease: the CitAD randomized clinical trial}}, journal = {JAMA}, year = {2014}, doi = {10.1001/jama.2014.93}, pmid = {24549548}, url = {https://doi.org/10.1001/jama.2014.93} } @article{egan2018-29719179, author = {Egan, M. F. and Kost, J. and Tariot, P. N. and Aisen, P. S. and Cummings, J. L. and Vellas, B. and Sur, C. and Mukai, Y. and others}, title = {{Randomized Trial of Verubecestat for Mild-to-Moderate Alzheimer's Disease}}, journal = {The New England journal of medicine}, year = {2018}, doi = {10.1056/nejmoa1706441}, pmid = {29719179}, url = {https://doi.org/10.1056/nejmoa1706441} } @article{honig2018-29365294, author = {Honig, L. S. and Vellas, B. and Woodward, M. and Boada, M. and Bullock, R. and Borrie, M. and Hager, K. and Andreasen, N. and others}, title = {{Trial of Solanezumab for Mild Dementia Due to Alzheimer's Disease}}, journal = {The New England journal of medicine}, year = {2018}, doi = {10.1056/nejmoa1705971}, pmid = {29365294}, url = {https://doi.org/10.1056/nejmoa1705971} } @article{florian2023-36730056, author = {Florian, H. and Wang, D. and Arnold, S. E. and Boada, M. and Guo, Q. and Jin, Z. and Zheng, H. and Fisseha, N. and others}, title = {{Tilavonemab in early Alzheimer's disease: results from a phase 2, randomized, double-blind study}}, journal = {Brain : a journal of neurology}, year = {2023}, doi = {10.1093/brain/awad024}, pmid = {36730056}, url = {https://doi.org/10.1093/brain/awad024} } @article{thunborg2024-38812047, author = {Thunborg, C. and Wang, R. and Rosenberg, A. and Sindi, S. and Andersen, P. and Andrieu, S. and Broersen, L. M. and Coley, N. and others}, title = {{Integrating a multimodal lifestyle intervention with medical food in prodromal Alzheimer's disease: the MIND-ADmini randomized controlled trial}}, journal = {Alzheimer's research \& therapy}, year = {2024}, doi = {10.1186/s13195-024-01468-x}, pmid = {38812047}, url = {https://doi.org/10.1186/s13195-024-01468-x} } @article{cummings2026-c800c391, author = {Cummings, J. L. and Atri, A. and Scheltens, P. and others}, title = {{Efficacy and safety of oral semaglutide 14 mg (flexible dose) in early-stage symptomatic Alzheimer's disease (EVOKE and EVOKE+): two phase 3, randomised, placebo-controlled trials}}, journal = {The Lancet}, year = {2026}, doi = {10.1016/s0140-6736(26)00459-9}, pmid = {41865758}, url = {https://doi.org/10.1016/s0140-6736(26)00459-9} } @article{tariot2004-14734594, author = {Tariot, P. N. and Farlow, M. R. and Grossberg, G. T. and Graham, S. M. and McDonald, S. and Gergel, I. and {Memantine Study Group}}, title = {{Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial}}, journal = {JAMA}, year = {2004}, doi = {10.1001/jama.291.3.317}, pmid = {14734594}, url = {https://doi.org/10.1001/jama.291.3.317} } @article{turner2015-26362286, author = {Turner, R. S. and Thomas, R. G. and Craft, S. and van Dyck, C. H. and Mintzer, J. and Reynolds, B. A. and Brewer, J. B. and Rissman, R. A. and others}, title = {{A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease}}, journal = {Neurology}, year = {2015}, doi = {10.1212/wnl.0000000000002035}, pmid = {26362286}, url = {https://doi.org/10.1212/wnl.0000000000002035} } @article{ostrowitzki2022-36121669, author = {Ostrowitzki, S. and Bittner, T. and Sink, K. M. and Mackey, H. and Rabe, C. and Honig, L. S. and Cassetta, E. and Woodward, M. and others}, title = {{Evaluating the Safety and Efficacy of Crenezumab vs Placebo in Adults With Early Alzheimer Disease: Two Phase 3 Randomized Placebo-Controlled Trials}}, journal = {JAMA neurology}, year = {2022}, doi = {10.1001/jamaneurol.2022.2909}, pmid = {36121669}, url = {https://doi.org/10.1001/jamaneurol.2022.2909} } @article{bateman2023-37966285, author = {Bateman, R. J. and Smith, J. and Donohue, M. C. and Delmar, P. and Abbas, R. and Salloway, S. and Wojtowicz, J. and Blennow, K. and others}, title = {{Two Phase 3 Trials of Gantenerumab in Early Alzheimer's Disease}}, journal = {The New England journal of medicine}, year = {2023}, doi = {10.1056/nejmoa2304430}, pmid = {37966285}, url = {https://doi.org/10.1056/nejmoa2304430} } @article{swanson2021-33865446, author = {Swanson, C. J. and Zhang, Y. and Dhadda, S. and Wang, J. and Kaplow, J. and Lai, R. Y. K. and Lannfelt, L. and Bradley, H. and others}, title = {{A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer's disease with lecanemab, an anti-Aβ protofibril antibody}}, journal = {Alzheimer's research \& therapy}, year = {2021}, doi = {10.1186/s13195-021-00813-8}, pmid = {33865446}, url = {https://doi.org/10.1186/s13195-021-00813-8} } @article{cummings2025-39780249, author = {Cummings, J. L. and Atri, A. and Feldman, H. H. and Hansson, O. and Sano, M. and Knop, F. K. and Johannsen, P. and León, T. and others}, title = {{evoke and evoke+: design of two large-scale, double-blind, placebo-controlled, phase 3 studies evaluating efficacy, safety, and tolerability of semaglutide in early-stage symptomatic Alzheimer's disease}}, journal = {Alzheimer's research \& therapy}, year = {2025}, doi = {10.1186/s13195-024-01666-7}, pmid = {39780249}, url = {https://doi.org/10.1186/s13195-024-01666-7} } @article{quinn2010-21045096, author = {Quinn, J. F. and Raman, R. and Thomas, R. G. and Yurko-Mauro, K. and Nelson, E. B. and Van Dyck, C. and Galvin, J. E. and Emond, J. and others}, title = {{Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial}}, journal = {JAMA}, year = {2010}, doi = {10.1001/jama.2010.1510}, pmid = {21045096}, url = {https://doi.org/10.1001/jama.2010.1510} } @article{green2009-20009055, author = {Green, R. C. and Schneider, L. S. and Amato, D. A. and Beelen, A. P. and Wilcock, G. and Swabb, E. A. and Zavitz, K. H. and {Tarenflurbil Phase 3 Study Group}}, title = {{Effect of tarenflurbil on cognitive decline and activities of daily living in patients with mild Alzheimer disease: a randomized controlled trial}}, journal = {JAMA}, year = {2009}, doi = {10.1001/jama.2009.1866}, pmid = {20009055}, url = {https://doi.org/10.1001/jama.2009.1866} } @article{mcshane2019-30891742, author = {McShane, R. and Westby, M. J. and Roberts, E. and Minakaran, N. and Schneider, L. and Farrimond, L. E. and Maayan, N. and Ware, J. and others}, title = {{Memantine for dementia}}, journal = {The Cochrane database of systematic reviews}, year = {2019}, doi = {10.1002/14651858.cd003154.pub6}, pmid = {30891742}, url = {https://doi.org/10.1002/14651858.cd003154.pub6} } @article{vandyck2023-36449413, author = {van Dyck, C. H. and Swanson, C. J. and Aisen, P. and Bateman, R. J. and Chen, C. and Gee, M. and Kanekiyo, M. and Li, D. and others}, title = {{Lecanemab in Early Alzheimer's Disease}}, journal = {The New England journal of medicine}, year = {2023}, doi = {10.1056/nejmoa2212948}, pmid = {36449413}, url = {https://doi.org/10.1056/nejmoa2212948} } @article{dysken2014-24381967, author = {Dysken, M. W. and Sano, M. and Asthana, S. and Vertrees, J. E. and Pallaki, M. and Llorente, M. and Love, S. and Schellenberg, G. D. and others}, title = {{Effect of vitamin E and memantine on functional decline in Alzheimer disease: the TEAM-AD VA cooperative randomized trial}}, journal = {JAMA}, year = {2014}, doi = {10.1001/jama.2013.282834}, pmid = {24381967}, url = {https://doi.org/10.1001/jama.2013.282834} } @article{howard2020-31738372, author = {Howard, R. and Zubko, O. and Bradley, R. and Harper, E. and Pank, L. and O'Brien, J. and Fox, C. and Tabet, N. and others}, title = {{Minocycline at 2 Different Dosages vs Placebo for Patients With Mild Alzheimer Disease: A Randomized Clinical Trial}}, journal = {JAMA neurology}, year = {2020}, doi = {10.1001/jamaneurol.2019.3762}, pmid = {31738372}, url = {https://doi.org/10.1001/jamaneurol.2019.3762} } @article{forette1998-9802273, author = {Forette, F. and Seux, M. L. and Staessen, J. A. and Thijs, L. and Birkenhäger, W. H. and Babarskiene, M. R. and Babeanu, S. and Bossini, A. and others}, title = {{Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial}}, journal = {Lancet (London, England)}, year = {1998}, doi = {10.1016/s0140-6736(98)03086-4}, pmid = {9802273}, url = {https://doi.org/10.1016/s0140-6736(98)03086-4} } @article{mintun2021-33720637, author = {Mintun, M. A. and Lo, A. C. and Duggan Evans, C. and Wessels, A. M. and Ardayfio, P. A. and Andersen, S. W. and Shcherbinin, S. and Sparks, J. and others}, title = {{Donanemab in Early Alzheimer's Disease}}, journal = {The New England journal of medicine}, year = {2021}, doi = {10.1056/nejmoa2100708}, pmid = {33720637}, url = {https://doi.org/10.1056/nejmoa2100708} } @article{birks2018-29923184, author = {Birks, J. S. and Harvey, R. J.}, title = {{Donepezil for dementia due to Alzheimer's disease}}, journal = {The Cochrane database of systematic reviews}, year = {2018}, doi = {10.1002/14651858.cd001190.pub3}, pmid = {29923184}, url = {https://doi.org/10.1002/14651858.cd001190.pub3} } @article{maher2011-21954480, author = {Maher, A. R. and Maglione, M. and Bagley, S. and Suttorp, M. and Hu, J. H. and Ewing, B. and Wang, Z. and Timmer, M. and others}, title = {{Efficacy and comparative effectiveness of atypical antipsychotic medications for off-label uses in adults: a systematic review and meta-analysis}}, journal = {JAMA}, year = {2011}, doi = {10.1001/jama.2011.1360}, pmid = {21954480}, url = {https://doi.org/10.1001/jama.2011.1360} } @article{edison2025-41326666, author = {Edison, P. and Femminella, G. D. and Ritchie, C. and Nowell, J. and Holmes, C. and Walker, Z. and Ridha, B. and Raza, S. and Livingston, N. R. and Frangou, E. and others}, title = {{Liraglutide in mild to moderate Alzheimer's disease: a phase 2b clinical trial}}, journal = {Nature Medicine}, year = {2025}, doi = {10.1038/s41591-025-04106-7}, pmid = {41326666}, url = {https://doi.org/10.1038/s41591-025-04106-7} } @article{lamb2018-29769247, author = {Lamb, S. E. and Sheehan, B. and Atherton, N. and Nichols, V. and Collins, H. and Mistry, D. and others}, title = {{Dementia And Physical Activity (DAPA) trial of moderate to high intensity exercise training for people with dementia: randomised controlled trial}}, journal = {BMJ}, year = {2018}, doi = {10.1136/bmj.k1675}, pmid = {29769247}, url = {https://doi.org/10.1136/bmj.k1675} } @article{honig2024-38730496, author = {Honig, L. S. and Sabbagh, M. N. and van Dyck, C. H. and Sperling, R. A. and Hersch, S. and Matta, A. and Giorgi, L. and Gee, M. and others}, title = {{Updated safety results from phase 3 lecanemab study in early Alzheimer's disease}}, journal = {Alzheimer's research \& therapy}, year = {2024}, doi = {10.1186/s13195-024-01441-8}, pmid = {38730496}, url = {https://doi.org/10.1186/s13195-024-01441-8} } @article{aisen2008-18854539, author = {Aisen, P. S. and Schneider, L. S. and Sano, M. and Diaz-Arrastia, R. and van Dyck, C. H. and Weiner, M. F. and Bottiglieri, T. and Jin, S. and others}, title = {{High-dose B vitamin supplementation and cognitive decline in Alzheimer disease: a randomized controlled trial}}, journal = {JAMA}, year = {2008}, doi = {10.1001/jama.300.15.1774}, pmid = {18854539}, url = {https://doi.org/10.1001/jama.300.15.1774} } @article{wessels2020-31764959, author = {Wessels, A. M. and Tariot, P. N. and Zimmer, J. A. and Selzler, K. J. and Bragg, S. M. and Andersen, S. W. and Landry, J. and Krull, J. H. and others}, title = {{Efficacy and Safety of Lanabecestat for Treatment of Early and Mild Alzheimer Disease: The AMARANTH and DAYBREAK-ALZ Randomized Clinical Trials}}, journal = {JAMA neurology}, year = {2020}, doi = {10.1001/jamaneurol.2019.3988}, pmid = {31764959}, url = {https://doi.org/10.1001/jamaneurol.2019.3988} } @article{teng2022-35696185, author = {Teng, E. and Manser, P. T. and Pickthorn, K. and Brunstein, F. and Blendstrup, M. and Sanabria Bohorquez, S. and Wildsmith, K. R. and Toth, B. and others}, title = {{Safety and Efficacy of Semorinemab in Individuals With Prodromal to Mild Alzheimer Disease: A Randomized Clinical Trial}}, journal = {JAMA neurology}, year = {2022}, doi = {10.1001/jamaneurol.2022.1375}, pmid = {35696185}, url = {https://doi.org/10.1001/jamaneurol.2022.1375} } @article{ryan2020-32213642, author = {Ryan, J. and Storey, E. and Murray, A. M. and Woods, R. L. and Wolfe, R. and Reid, C. M. and Nelson, M. R. and Chong, T. T. J. and others}, title = {{Randomized placebo-controlled trial of the effects of aspirin on dementia and cognitive decline}}, journal = {Neurology}, year = {2020}, doi = {10.1212/wnl.0000000000009277}, pmid = {32213642}, url = {https://doi.org/10.1212/wnl.0000000000009277} } @article{atri2018-29318278, author = {Atri, A. and Frölich, L. and Ballard, C. and Tariot, P. N. and Molinuevo, J. L. and Boneva, N. and Windfeld, K. and Raket, L. L. and others}, title = {{Effect of Idalopirdine as Adjunct to Cholinesterase Inhibitors on Change in Cognition in Patients With Alzheimer Disease: Three Randomized Clinical Trials}}, journal = {JAMA}, year = {2018}, doi = {10.1001/jama.2017.20373}, pmid = {29318278}, url = {https://doi.org/10.1001/jama.2017.20373} } @article{ayton2025-39495531, author = {Ayton, S. and Barton, D. and Brew, B. and Brodtmann, A. and Clarnette, R. and Desmond, P. and Devos, D. and Ellis, K. A. and others}, title = {{Deferiprone in Alzheimer Disease: A Randomized Clinical Trial}}, journal = {JAMA neurology}, year = {2025}, doi = {10.1001/jamaneurol.2024.3733}, pmid = {39495531}, url = {https://doi.org/10.1001/jamaneurol.2024.3733} } @article{emre2004-15590953, author = {Emre, M. and Aarsland, D. and Albanese, A. and Byrne, E. J. and Deuschl, G. and De Deyn, P. P. and Durif, F. and Kulisevsky, J. and others}, title = {{Rivastigmine for dementia associated with Parkinson's disease}}, journal = {The New England journal of medicine}, year = {2004}, doi = {10.1056/nejmoa041470}, pmid = {15590953}, url = {https://doi.org/10.1056/nejmoa041470} } @article{ostrowitzki2017-29221491, author = {Ostrowitzki, S. and Lasser, R. A. and Dorflinger, E. and Scheltens, P. and Barkhof, F. and Nikolcheva, T. and Ashford, E. and Retout, S. and others}, title = {{A phase III randomized trial of gantenerumab in prodromal Alzheimer's disease}}, journal = {Alzheimer's research \& therapy}, year = {2017}, doi = {10.1186/s13195-017-0318-y}, pmid = {29221491}, url = {https://doi.org/10.1186/s13195-017-0318-y} } @article{birks2003-12917900, author = {Birks, J. S. and Harvey, R.}, title = {{Donepezil for dementia due to Alzheimer's disease}}, journal = {The Cochrane database of systematic reviews}, year = {2003}, doi = {10.1002/14651858.cd001190}, pmid = {12917900}, url = {https://doi.org/10.1002/14651858.cd001190} } @article{birks2000-11034705, author = {Birks, J. and Grimley Evans, J. and Iakovidou, V. and Tsolaki, M.}, title = {{Rivastigmine for Alzheimer's disease}}, journal = {The Cochrane database of systematic reviews}, year = {2000}, doi = {10.1002/14651858.cd001191}, pmid = {11034705}, url = {https://doi.org/10.1002/14651858.cd001191} } @article{henderson2016-26795874, author = {Henderson, E. J. and Lord, SR. and Brodie, M. A. and Gaunt, D. M. and Lawrence, A. D. and Close, J. C. and Whone, A. L. and others}, title = {{Rivastigmine for gait stability in patients with Parkinson's disease (ReSPonD): a randomised, double-blind, placebo-controlled, phase 2 trial}}, journal = {The Lancet. Neurology}, year = {2016}, doi = {10.1016/s1474-4422(15)00389-0}, pmid = {26795874}, url = {https://doi.org/10.1016/s1474-4422(15)00389-0} } @article{arellanes2020-32690472, author = {Arellanes, I. C. and Choe, N. and Solomon, V. and He, X. and Kavin, B. and Martinez, A. E. and Kono, N. and Buennagel, D. P. and others}, title = {{Brain delivery of supplemental docosahexaenoic acid (DHA): A randomized placebo-controlled clinical trial}}, journal = {EBioMedicine}, year = {2020}, doi = {10.1016/j.ebiom.2020.102883}, pmid = {32690472}, url = {https://doi.org/10.1016/j.ebiom.2020.102883} } @article{craft2020-32568367, author = {Craft, S. and Raman, R. and Chow, T. W. and Rafii, M. S. and Sun, C. K. and Rissman, R. A. and Donohue, M. C. and Brewer, J. B. and others}, title = {{Safety, Efficacy, and Feasibility of Intranasal Insulin for the Treatment of Mild Cognitive Impairment and Alzheimer Disease Dementia: A Randomized Clinical Trial}}, journal = {JAMA neurology}, year = {2020}, doi = {10.1001/jamaneurol.2020.1840}, pmid = {32568367}, url = {https://doi.org/10.1001/jamaneurol.2020.1840} } @article{salloway2025-39556389, author = {Salloway, S. and Wojtowicz, J. and Voyle, N. and Lane, C. A. and Klein, G. and Lyons, M. and Rossomanno, S. and Mazzo, F. and others}, title = {{Amyloid-Related Imaging Abnormalities (ARIA) in Clinical Trials of Gantenerumab in Early Alzheimer Disease}}, journal = {JAMA neurology}, year = {2025}, doi = {10.1001/jamaneurol.2024.3937}, pmid = {39556389}, url = {https://doi.org/10.1001/jamaneurol.2024.3937} } @article{tzourio2003-12742805, author = {Tzourio, C. and Anderson, C. and Chapman, N. and Woodward, M. and Neal, B. and MacMahon, S. and Chalmers, J. and {PROGRESS Collaborative Group}}, title = {{Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease}}, journal = {Archives of internal medicine}, year = {2003}, doi = {10.1001/archinte.163.9.1069}, pmid = {12742805}, url = {https://doi.org/10.1001/archinte.163.9.1069} } @article{rogers1998-9443470, author = {Rogers, S. L. and Farlow, M. R. and Doody, R. S. and Mohs, R. and Friedhoff, L. T.}, title = {{A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Donepezil Study Group}}, journal = {Neurology}, year = {1998}, doi = {10.1212/wnl.50.1.136}, pmid = {9443470}, url = {https://doi.org/10.1212/wnl.50.1.136} } @article{sabbagh2020-31879235, author = {Sabbagh, M. and Sadowsky, C. and Tousi, B. and Agronin, M. E. and Alva, G. and Armon, C. and Bernick, C. and Keegan, A. P. and others}, title = {{Effects of a combined transcranial magnetic stimulation (TMS) and cognitive training intervention in patients with Alzheimer's disease}}, journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association}, year = {2020}, doi = {10.1016/j.jalz.2019.08.197}, pmid = {31879235}, url = {https://doi.org/10.1016/j.jalz.2019.08.197} } @article{battle2021-33704781, author = {Battle, C. E. and Abdul-Rahim, A. H. and Shenkin, S. D. and Hewitt, J. and Quinn, T. J.}, title = {{Cholinesterase inhibitors for vascular dementia and other vascular cognitive impairments: a network meta-analysis}}, journal = {The Cochrane database of systematic reviews}, year = {2021}, doi = {10.1002/14651858.cd013306.pub2}, pmid = {33704781}, url = {https://doi.org/10.1002/14651858.cd013306.pub2} } @article{alaama2011-20845391, author = {Al-Aama, T. and Brymer, C. and Gutmanis, I. and Woolmore-Goodwin, S. M. and Esbaugh, J. and Dasgupta, M.}, title = {{Melatonin decreases delirium in elderly patients: a randomized, placebo-controlled trial}}, journal = {International journal of geriatric psychiatry}, year = {2011}, doi = {10.1002/gps.2582}, pmid = {20845391}, url = {https://doi.org/10.1002/gps.2582} } @article{black2003-12970516, author = {Black, S. and Román, G. C. and Geldmacher, D. S. and Salloway, S. and Hecker, J. and Burns, A. and Perdomo, C. and Kumar, D. and others}, title = {{Efficacy and tolerability of donepezil in vascular dementia: positive results of a 24-week, multicenter, international, randomized, placebo-controlled clinical trial}}, journal = {Stroke}, year = {2003}, doi = {10.1161/01.str.0000091396.95360.e1}, pmid = {12970516}, url = {https://doi.org/10.1161/01.str.0000091396.95360.e1} } @article{wang2025-40172303, author = {Wang, H. and Serap Monkul Nery, E. and Ardayfio, P. and Khanna, R. and Otero Svaldi, D. and Gueorguieva, I. and Shcherbinin, S. and Andersen, S. W. and Hauck, P. M. and Engle, S. E. and others}, title = {{Modified titration of donanemab reduces ARIA risk and maintains amyloid reduction}}, journal = {Alzheimer's \& Dementia}, year = {2025}, doi = {10.1002/alz.70062}, pmid = {40172303}, url = {https://doi.org/10.1002/alz.70062} } @article{nonino2026-41985900, author = {Nonino, F. and Minozzi, S. and Sambati, L. and Del Giovane, C. and Baldin, E. and Bassi, M. C. and others}, title = {{Amyloid-beta-targeting monoclonal antibodies for people with mild cognitive impairment or mild dementia due to Alzheimer's disease (Cochrane review)}}, journal = {Cochrane Database of Systematic Reviews}, year = {2026}, doi = {10.1002/14651858.CD016297}, pmid = {41985900}, url = {https://doi.org/10.1002/14651858.CD016297} } @article{lu2025-41082199, author = {Lu, M. and Kim, M. J. and Collins, E. C. and Shcherbinin, S. and Ellinwood, A. K. and Yokoi, Y. and Brooks, D. A. and Hansson, O. and others}, title = {{Posttreatment Amyloid Levels and Clinical Outcomes Following Donanemab for Early Symptomatic Alzheimer Disease: A Secondary Analysis of the TRAILBLAZER-ALZ 2 Randomized Clinical Trial}}, journal = {JAMA neurology}, year = {2025}, doi = {10.1001/jamaneurol.2025.3869}, pmid = {41082199}, url = {https://doi.org/10.1001/jamaneurol.2025.3869} } @article{fox2005-15883317, author = {Fox, N. C. and Black, R. S. and Gilman, S. and Rossor, M. N. and Griffith, S. G. and Jenkins, L. and Koller, M.}, title = {{Effects of Abeta immunization (AN1792) on MRI measures of cerebral volume in Alzheimer disease}}, journal = {Neurology}, year = {2005}, doi = {10.1212/01.wnl.0000159743.08996.99}, pmid = {15883317}, url = {https://doi.org/10.1212/01.wnl.0000159743.08996.99} } @article{feldman2010-20200346, author = {Feldman, H. H. and Doody, R. S. and Kivipelto, M. and Sparks, D. L. and Waters, D. D. and Jones, R. W. and Schwam, E. and Schindler, R. and others}, title = {{Randomized controlled trial of atorvastatin in mild to moderate Alzheimer disease: LEADe}}, journal = {Neurology}, year = {2010}, doi = {10.1212/wnl.0b013e3181d6476a}, pmid = {20200346}, url = {https://doi.org/10.1212/wnl.0b013e3181d6476a} } @article{lebars1997-9343463, author = {Le Bars, P. L. and Katz, M. M. and Berman, N. and Itil, T. M. and Freedman, A. M. and Schatzberg, A. F.}, title = {{A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group}}, journal = {JAMA}, year = {1997}, doi = {10.1001/jama.278.16.1327}, pmid = {9343463}, url = {https://doi.org/10.1001/jama.278.16.1327} } @article{shanks2024-38760589, author = {Shanks, H. R. C. and Chen, K. and Reiman, E. M. and Blennow, K. and Cummings, J. L. and Massa, S. M. and Longo, F. M. and Börjesson-Hanson, A. and others}, title = {{p75 neurotrophin receptor modulation in mild to moderate Alzheimer disease: a randomized, placebo-controlled phase 2a trial}}, journal = {Nature medicine}, year = {2024}, doi = {10.1038/s41591-024-02977-w}, pmid = {38760589}, url = {https://doi.org/10.1038/s41591-024-02977-w} } @article{adesuyan2024-38324745, author = {Adesuyan, M. and Jani, Y. H. and Alsugeir, D. and Howard, R. and Ju, C. and Wei, L. and Brauer, R.}, title = {{Phosphodiesterase Type 5 Inhibitors in Men With Erectile Dysfunction and the Risk of Alzheimer Disease: A Cohort Study}}, journal = {Neurology}, year = {2024}, doi = {10.1212/wnl.0000000000209131}, pmid = {38324745}, url = {https://doi.org/10.1212/wnl.0000000000209131} } @article{dubois2023-36849969, author = {Dubois, B. and López-Arrieta, J. and Lipschitz, S. and Doskas, T. and Spiru, L. and Moroz, S. and Venger, O. and Vermersch, P. and others}, title = {{Masitinib for mild-to-moderate Alzheimer's disease: results from a randomized, placebo-controlled, phase 3, clinical trial}}, journal = {Alzheimer's research \& therapy}, year = {2023}, doi = {10.1186/s13195-023-01169-x}, pmid = {36849969}, url = {https://doi.org/10.1186/s13195-023-01169-x} } @article{morris2017-28187125, author = {Morris, J. K. and Vidoni, E. D. and Johnson, D. K. and Van Sciver, A. and Mahnken, J. D. and Honea, R. A. and Wilkins, H. M. and Brooks, W. M. and others}, title = {{Aerobic exercise for Alzheimer's disease: A randomized controlled pilot trial}}, journal = {PloS one}, year = {2017}, doi = {10.1371/journal.pone.0170547}, pmid = {28187125}, url = {https://doi.org/10.1371/journal.pone.0170547} } @article{sampson2007-17006875, author = {Sampson, E. L. and Raven, P. R. and Ndhlovu, P. N. and Vallance, A. and Garlick, N. and Watts, J. and Blanchard, M. R. and Bruce, A. and others}, title = {{A randomized, double-blind, placebo-controlled trial of donepezil hydrochloride (Aricept) for reducing the incidence of postoperative delirium after elective total hip replacement}}, journal = {International journal of geriatric psychiatry}, year = {2007}, doi = {10.1002/gps.1679}, pmid = {17006875}, url = {https://doi.org/10.1002/gps.1679} } @article{forette2002-12374512, author = {Forette, F. and Seux, M. L. and Staessen, J. A. and Thijs, L. and Babarskiene, M. R. and Babeanu, S. and Bossini, A. and Fagard, R. and others}, title = {{The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) study}}, journal = {Archives of internal medicine}, year = {2002}, doi = {10.1001/archinte.162.18.2046}, pmid = {12374512}, url = {https://doi.org/10.1001/archinte.162.18.2046} } @article{teri2003-14559955, author = {Teri, L. and Gibbons, L. E. and McCurry, S. M. and Logsdon, R. G. and Buchner, D. M. and Barlow, W. E. and Kukull, W. A. and LaCroix, A. Z. and others}, title = {{Exercise plus behavioral management in patients with Alzheimer disease: a randomized controlled trial}}, journal = {JAMA}, year = {2003}, doi = {10.1001/jama.290.15.2015}, pmid = {14559955}, url = {https://doi.org/10.1001/jama.290.15.2015} } @article{sano2011-21795660, author = {Sano, M. and Bell, K. L. and Galasko, D. and Galvin, J. E. and Thomas, R. G. and van Dyck, C. H. and Aisen, P. S.}, title = {{A randomized, double-blind, placebo-controlled trial of simvastatin to treat Alzheimer disease}}, journal = {Neurology}, year = {2011}, doi = {10.1212/wnl.0b013e318228bf11}, pmid = {21795660}, url = {https://doi.org/10.1212/wnl.0b013e318228bf11} } @article{cummings2015-26393847, author = {Cummings, J. L. and Lyketsos, C. G. and Peskind, E. R. and Porsteinsson, A. P. and Mintzer, J. E. and Scharre, D. W. and De La Gandara, J. E. and Agronin, M. and others}, title = {{Effect of Dextromethorphan-Quinidine on Agitation in Patients With Alzheimer Disease Dementia: A Randomized Clinical Trial}}, journal = {JAMA}, year = {2015}, doi = {10.1001/jama.2015.10214}, pmid = {26393847}, url = {https://doi.org/10.1001/jama.2015.10214} } @article{mckeith2000-11145488, author = {McKeith, I. and Del Ser, T. and Spano, P. and Emre, M. and Wesnes, K. and Anand, R. and Cicin-Sain, A. and Ferrara, R. and others}, title = {{Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study}}, journal = {Lancet (London, England)}, year = {2000}, doi = {10.1016/s0140-6736(00)03399-7}, pmid = {11145488}, url = {https://doi.org/10.1016/s0140-6736(00)03399-7} } @article{monteroodasso2018-29661156, author = {Montero-Odasso, M. and Almeida, Q. J. and Burhan, A. M. and Camicioli, R. and Doyon, J. and Fraser, S. and Li, K. and Liu-Ambrose, T. and others}, title = {{SYNERGIC TRIAL (SYNchronizing Exercises, Remedies in Gait and Cognition) a multi-Centre randomized controlled double blind trial to improve gait and cognition in mild cognitive impairment}}, journal = {BMC geriatrics}, year = {2018}, doi = {10.1186/s12877-018-0782-7}, pmid = {29661156}, url = {https://doi.org/10.1186/s12877-018-0782-7} } @article{reade2016-26975647, author = {Reade, M. C. and Eastwood, G. M. and Bellomo, R. and Bailey, M. and Bersten, A. and Cheung, B. and Davies, A. and Delaney, A. and others}, title = {{Effect of Dexmedetomidine Added to Standard Care on Ventilator-Free Time in Patients With Agitated Delirium: A Randomized Clinical Trial}}, journal = {JAMA}, year = {2016}, doi = {10.1001/jama.2016.2707}, pmid = {26975647}, url = {https://doi.org/10.1001/jama.2016.2707} } @article{vandyck2023-22dd8fce, author = {van Dyck, C. H. and Swanson, C. J. and Aisen, P. and Bateman, R. J. and Chen, C. and Gee, M. and Kanekiyo, M. and Li, D. and Reyderman, L. and Cohen, S. and Froelich, L. and Katayama, S. and Sabbagh, M. and Vellas, B. and Watson, D. and Dhadda, S. and Irizarry, M. and Kramer, L. D. and Iwatsubo, T.}, title = {{Lecanemab in Early Alzheimer's Disease}}, journal = {New England Journal of Medicine}, year = {2023}, pmid = {36449413} } @article{sims2023-9857475c, author = {Sims, JR. and Zimmer, J. A. and Evans, C. D. and Lu, M. and Ardayfio, P. and Sparks, J. and Wessels, A. M. and Shcherbinin, S. and Wang, H. and Monkul Nery, E. S. and Collins, E. C. and Solomon, P. and Salloway, S. and Apostolova, L. G. and Hansson, O. and Ritchie, C. and Brooks, D. A. and Mintun, M. and Skovronsky, D. M. and {TRAILBLAZER-ALZ 2 Investigators}}, title = {{Donanemab in Early Symptomatic Alzheimer Disease: The TRAILBLAZER-ALZ 2 Randomized Clinical Trial}}, journal = {JAMA}, year = {2023}, pmid = {37459141} } @article{rajji2025-40133524, author = {Rajji, T. K. and Baksh, S. N. and Shade, D. M. and Ismail, Z. and Burhan, A. M. and Okhravi, H. R. and Padala, P. R. and Rosenberg, P. B. and Schneider, L. S. and Porsteinsson, A. P. and others}, title = {{Escitalopram for agitation in Alzheimer's dementia: a randomized controlled phase 3 trial}}, journal = {Nature Medicine}, year = {2025}, doi = {10.1038/s41591-025-03569-y}, pmid = {40133524}, url = {https://doi.org/10.1038/s41591-025-03569-y} } @article{ebell2024-38253509, author = {Ebell, M. H. and Barry, H. C. and Baduni, K. and Grasso, G.}, title = {{Clinically Important Benefits and Harms of Monoclonal Antibodies Targeting Amyloid for the Treatment of Alzheimer Disease: A Systematic Review and Meta-Analysis}}, journal = {Annals of Family Medicine}, year = {2024}, doi = {10.1370/afm.3050}, pmid = {38253509}, url = {https://doi.org/10.1370/afm.3050} } @article{wagemann2024-38683602, author = {Wagemann, O. and Liu, H. and Wang, G. and Shi, X. and Bittner, T. and Scelsi, M. A. and Farlow, M. R. and Clifford, D. B. and others}, title = {{Downstream Biomarker Effects of Gantenerumab or Solanezumab in Dominantly Inherited Alzheimer Disease: The DIAN-TU-001 Randomized Clinical Trial}}, journal = {JAMA neurology}, year = {2024}, doi = {10.1001/jamaneurol.2024.0991}, pmid = {38683602}, url = {https://doi.org/10.1001/jamaneurol.2024.0991} } @article{salloway2009-19923550, author = {Salloway, S. and Sperling, R. and Gilman, S. and Fox, N. C. and Blennow, K. and Raskind, M. and Sabbagh, M. and Honig, L. S. and others}, title = {{A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease}}, journal = {Neurology}, year = {2009}, doi = {10.1212/wnl.0b013e3181c67808}, pmid = {19923550}, url = {https://doi.org/10.1212/wnl.0b013e3181c67808} } @article{coric2012-22892585, author = {Coric, V. and van Dyck, C. H. and Salloway, S. and Andreasen, N. and Brody, M. and Richter, R. W. and Soininen, H. and Thein, S. and others}, title = {{Safety and tolerability of the γ-secretase inhibitor avagacestat in a phase 2 study of mild to moderate Alzheimer disease}}, journal = {Archives of neurology}, year = {2012}, doi = {10.1001/archneurol.2012.2194}, pmid = {22892585}, url = {https://doi.org/10.1001/archneurol.2012.2194} } @article{sims2023-37459141, author = {Sims, JR. and Zimmer, J. A. and Evans, C. D. and Lu, M. and Ardayfio, P. and Sparks, J. and Wessels, A. M. and Shcherbinin, S. and others}, title = {{Donanemab in Early Symptomatic Alzheimer Disease: The TRAILBLAZER-ALZ 2 Randomized Clinical Trial}}, journal = {JAMA}, year = {2023}, doi = {10.1001/jama.2023.13239}, pmid = {37459141}, url = {https://doi.org/10.1001/jama.2023.13239} } @article{craft2012-21911655, author = {Craft, S. and Baker, L. D. and Montine, T. J. and Minoshima, S. and Watson, G. S. and Claxton, A. and Arbuckle, M. and Callaghan, M. and others}, title = {{Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial}}, journal = {Archives of neurology}, year = {2012}, doi = {10.1001/archneurol.2011.233}, pmid = {21911655}, url = {https://doi.org/10.1001/archneurol.2011.233} } @article{bodick1997-9109749, author = {Bodick, N. C. and Offen, W. W. and Levey, A. I. and Cutler, N. R. and Gauthier, S. G. and Satlin, A. and Shannon, H. E. and Tollefson, G. D. and others}, title = {{Effects of xanomeline, a selective muscarinic receptor agonist, on cognitive function and behavioral symptoms in Alzheimer disease}}, journal = {Archives of neurology}, year = {1997}, doi = {10.1001/archneur.1997.00550160091022}, pmid = {9109749}, url = {https://doi.org/10.1001/archneur.1997.00550160091022} } @article{vossel2021-34570177, author = {Vossel, K. and Ranasinghe, K. G. and Beagle, A. J. and La, A. and Ah Pook, K. and Castro, M. and Mizuiri, D. and Honma, S. M. and others}, title = {{Effect of Levetiracetam on Cognition in Patients With Alzheimer Disease With and Without Epileptiform Activity: A Randomized Clinical Trial}}, journal = {JAMA neurology}, year = {2021}, doi = {10.1001/jamaneurol.2021.3310}, pmid = {34570177}, url = {https://doi.org/10.1001/jamaneurol.2021.3310} } @article{salloway2004-15326237, author = {Salloway, S. and Ferris, S. and Kluger, A. and Goldman, R. and Griesing, T. and Kumar, D. and Richardson, S. and {Donepezil 401 Study Group}}, title = {{Efficacy of donepezil in mild cognitive impairment: a randomized placebo-controlled trial}}, journal = {Neurology}, year = {2004}, doi = {10.1212/01.wnl.0000134664.80320.92}, pmid = {15326237}, url = {https://doi.org/10.1212/01.wnl.0000134664.80320.92} } @article{aisen2011-22291741, author = {Aisen, P. S. and Gauthier, S. and Ferris, S. H. and Saumier, D. and Haine, D. and Garceau, D. and Duong, A. and Suhy, J. and others}, title = {{Tramiprosate in mild-to-moderate Alzheimer's disease - a randomized, double-blind, placebo-controlled, multi-centre study (the Alphase Study)}}, journal = {Archives of medical science : AMS}, year = {2011}, doi = {10.5114/aoms.2011.20612}, pmid = {22291741}, url = {https://doi.org/10.5114/aoms.2011.20612} } @article{cummings2018-29695589, author = {Cummings, J. L. and Cohen, S. and van Dyck, C. H. and Brody, M. and Curtis, C. and Cho, W. and Ward, M. and Friesenhahn, M. and others}, title = {{ABBY: A phase 2 randomized trial of crenezumab in mild to moderate Alzheimer disease}}, journal = {Neurology}, year = {2018}, doi = {10.1212/wnl.0000000000005550}, pmid = {29695589}, url = {https://doi.org/10.1212/wnl.0000000000005550} } @article{coric2015-26414022, author = {Coric, V. and Salloway, S. and van Dyck, C. H. and Dubois, B. and Andreasen, N. and Brody, M. and Curtis, C. and Soininen, H. and others}, title = {{Targeting Prodromal Alzheimer Disease With Avagacestat: A Randomized Clinical Trial}}, journal = {JAMA neurology}, year = {2015}, doi = {10.1001/jamaneurol.2015.0607}, pmid = {26414022}, url = {https://doi.org/10.1001/jamaneurol.2015.0607} } @article{meyer2019-30952794, author = {Meyer, P. F. and Tremblay-Mercier, J. and Leoutsakos, J. and Madjar, C. and Lafaille-Magnan, M. E. and Savard, M. and Rosa-Neto, P. and Poirier, J. and others}, title = {{INTREPAD: A randomized trial of naproxen to slow progress of presymptomatic Alzheimer disease}}, journal = {Neurology}, year = {2019}, doi = {10.1212/wnl.0000000000007232}, pmid = {30952794}, url = {https://doi.org/10.1212/wnl.0000000000007232} } @article{monteiro2023-37643887, author = {Monteiro, C. and Toth, B. and Brunstein, F. and Bobbala, A. and Datta, S. and Ceniceros, R. and Sanabria Bohorquez, S. M. and Anania, V. G. and others}, title = {{Randomized Phase II Study of the Safety and Efficacy of Semorinemab in Participants With Mild-to-Moderate Alzheimer Disease: Lauriet}}, journal = {Neurology}, year = {2023}, doi = {10.1212/wnl.0000000000207663}, pmid = {37643887}, url = {https://doi.org/10.1212/wnl.0000000000207663} } @article{raskind2000-10881250, author = {Raskind, M. A. and Peskind, E. R. and Wessel, T. and Yuan, W.}, title = {{Galantamine in AD: A 6-month randomized, placebo-controlled trial with a 6-month extension. The Galantamine USA-1 Study Group}}, journal = {Neurology}, year = {2000}, doi = {10.1212/wnl.54.12.2261}, pmid = {10881250}, url = {https://doi.org/10.1212/wnl.54.12.2261} } @article{feldman2001-11524468, author = {Feldman, H. and Gauthier, S. and Hecker, J. and Vellas, B. and Subbiah, P. and Whalen, E. and {Donepezil MSAD Study Investigators Group}}, title = {{A 24-week, randomized, double-blind study of donepezil in moderate to severe Alzheimer's disease}}, journal = {Neurology}, year = {2001}, doi = {10.1212/wnl.57.4.613}, pmid = {11524468}, url = {https://doi.org/10.1212/wnl.57.4.613} } @article{henderson2000-10668686, author = {Henderson, V. W. and Paganini-Hill, A. and Miller, B. L. and Elble, R. J. and Reyes, P. F. and Shoupe, D. and McCleary, C. A. and Klein, R. A. and others}, title = {{Estrogen for Alzheimer's disease in women: randomized, double-blind, placebo-controlled trial}}, journal = {Neurology}, year = {2000}, doi = {10.1212/wnl.54.2.295}, pmid = {10668686}, url = {https://doi.org/10.1212/wnl.54.2.295} } @article{xiao2021-33731209, author = {Xiao, S. and Chan, P. and Wang, T. and Hong, Z. and Wang, S. and Kuang, W. and He, J. and Pan, X. and others}, title = {{A 36-week multicenter, randomized, double-blind, placebo-controlled, parallel-group, phase 3 clinical trial of sodium oligomannate for mild-to-moderate Alzheimer's dementia}}, journal = {Alzheimer's research \& therapy}, year = {2021}, doi = {10.1186/s13195-021-00795-7}, pmid = {33731209}, url = {https://doi.org/10.1186/s13195-021-00795-7} } @article{kryscio2017-28319243, author = {Kryscio, R. J. and Abner, E. L. and Caban-Holt, A. and Lovell, M. and Goodman, P. and Darke, A. K. and Yee, M. and Crowley, J. and others}, title = {{Association of Antioxidant Supplement Use and Dementia in the Prevention of Alzheimer's Disease by Vitamin E and Selenium Trial (PREADViSE)}}, journal = {JAMA neurology}, year = {2017}, doi = {10.1001/jamaneurol.2016.5778}, pmid = {28319243}, url = {https://doi.org/10.1001/jamaneurol.2016.5778} } @article{douaud2013-23690582, author = {Douaud, G. and Refsum, H. and de Jager, C. A. and Jacoby, R. and Nichols, T. E. and Smith, S. M. and Smith, A. D.}, title = {{Preventing Alzheimer's disease-related gray matter atrophy by B-vitamin treatment}}, journal = {Proceedings of the National Academy of Sciences of the United States of America}, year = {2013}, doi = {10.1073/pnas.1301816110}, pmid = {23690582}, url = {https://doi.org/10.1073/pnas.1301816110} } @article{rolinski2012-22419314, author = {Rolinski, M. and Fox, C. and Maidment, I. and McShane, R.}, title = {{Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease}}, journal = {The Cochrane database of systematic reviews}, year = {2012}, doi = {10.1002/14651858.cd006504.pub2}, pmid = {22419314}, url = {https://doi.org/10.1002/14651858.cd006504.pub2} } @article{lawlor2018-30248105, author = {Lawlor, B. and Segurado, R. and Kennelly, S. and Olde Rikkert, M. G. M. and Howard, R. and Pasquier, F. and Börjesson-Hanson, A. and Tsolaki, M. and others}, title = {{Nilvadipine in mild to moderate Alzheimer disease: A randomised controlled trial}}, journal = {PLoS medicine}, year = {2018}, doi = {10.1371/journal.pmed.1002660}, pmid = {30248105}, url = {https://doi.org/10.1371/journal.pmed.1002660} } @article{prins2021-34044875, author = {Prins, N. D. and Harrison, J. E. and Chu, H. M. and Blackburn, K. and Alam, J. J. and Scheltens, P. and {REVERSE-SD Study Investigators}}, title = {{A phase 2 double-blind placebo-controlled 24-week treatment clinical study of the p38 alpha kinase inhibitor neflamapimod in mild Alzheimer's disease}}, journal = {Alzheimer's research \& therapy}, year = {2021}, doi = {10.1186/s13195-021-00843-2}, pmid = {34044875}, url = {https://doi.org/10.1186/s13195-021-00843-2} } @article{wang2020-31760522, author = {Wang, X. and Mao, Z. and Ling, Z. and Yu, X.}, title = {{Repetitive transcranial magnetic stimulation for cognitive impairment in Alzheimer's disease: a meta-analysis of randomized controlled trials}}, journal = {Journal of neurology}, year = {2020}, doi = {10.1007/s00415-019-09644-y}, pmid = {31760522}, url = {https://doi.org/10.1007/s00415-019-09644-y} } @article{schneider2006-16505124, author = {Schneider, L. S. and Dagerman, K. and Insel, P. S.}, title = {{Efficacy and adverse effects of atypical antipsychotics for dementia: meta-analysis of randomized, placebo-controlled trials}}, journal = {The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry}, year = {2006}, doi = {10.1097/01.jgp.0000200589.01396.6d}, pmid = {16505124}, url = {https://doi.org/10.1097/01.jgp.0000200589.01396.6d} } @article{zhong2007-17316169, author = {Zhong, K. X. and Tariot, P. N. and Mintzer, J. and Minkwitz, M. C. and Devine, N. A.}, title = {{Quetiapine to treat agitation in dementia: a randomized, double-blind, placebo-controlled study}}, journal = {Current Alzheimer research}, year = {2007}, doi = {10.2174/156720507779939805}, pmid = {17316169}, url = {https://doi.org/10.2174/156720507779939805} } @article{mittelman1996-8940320, author = {Mittelman, M. S. and Ferris, S. H. and Shulman, E. and Steinberg, G. and Levin, B.}, title = {{A family intervention to delay nursing home placement of patients with Alzheimer disease. A randomized controlled trial}}, journal = {JAMA}, year = {1996}, doi = {10.1001/jama.1996.03540210033030}, pmid = {8940320}, url = {https://doi.org/10.1001/jama.1996.03540210033030} } @article{breitner2011-21784351, author = {Breitner, J. C. and Baker, L. D. and Montine, T. J. and Meinert, C. L. and Lyketsos, C. G. and Ashe, K. H. and Brandt, J. and Craft, S. and others}, title = {{Extended results of the Alzheimer's disease anti-inflammatory prevention trial}}, journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association}, year = {2011}, doi = {10.1016/j.jalz.2010.12.014}, pmid = {21784351}, url = {https://doi.org/10.1016/j.jalz.2010.12.014} } @article{pitkala2013-23589097, author = {Pitkälä, K. H. and Pöysti, M. M. and Laakkonen, M. L. and Tilvis, R. S. and Savikko, N. and Kautiainen, H. and Strandberg, T. E.}, title = {{Effects of the Finnish Alzheimer disease exercise trial (FINALEX): a randomized controlled trial}}, journal = {JAMA internal medicine}, year = {2013}, doi = {10.1001/jamainternmed.2013.359}, pmid = {23589097}, url = {https://doi.org/10.1001/jamainternmed.2013.359} } @article{peskind2006-16861375, author = {Peskind, E. R. and Potkin, S. G. and Pomara, N. and Ott, B. R. and Graham, S. M. and Olin, J. T. and McDonald, S.}, title = {{Memantine treatment in mild to moderate Alzheimer disease: a 24-week randomized, controlled trial}}, journal = {The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry}, year = {2006}, doi = {10.1097/01.jgp.0000224350.82719.83}, pmid = {16861375}, url = {https://doi.org/10.1097/01.jgp.0000224350.82719.83} } @article{chew2015-26305649, author = {Chew, E. Y. and Clemons, T. E. and Agrón, E. and Launer, L. J. and Grodstein, F. and Bernstein, P. S.}, title = {{Effect of Omega-3 Fatty Acids, Lutein/Zeaxanthin, or Other Nutrient Supplementation on Cognitive Function: The AREDS2 Randomized Clinical Trial}}, journal = {JAMA}, year = {2015}, doi = {10.1001/jama.2015.9677}, pmid = {26305649}, url = {https://doi.org/10.1001/jama.2015.9677} } @article{sperling2021-33464300, author = {Sperling, R. and Henley, D. and Aisen, P. S. and Raman, R. and Donohue, M. C. and Ernstrom, K. and Rafii, M. S. and Streffer, J. and others}, title = {{Findings of Efficacy, Safety, and Biomarker Outcomes of Atabecestat in Preclinical Alzheimer Disease: A Truncated Randomized Phase 2b/3 Clinical Trial}}, journal = {JAMA neurology}, year = {2021}, doi = {10.1001/jamaneurol.2020.4857}, pmid = {33464300}, url = {https://doi.org/10.1001/jamaneurol.2020.4857} } @article{mintzer2021-34570180, author = {Mintzer, J. and Lanctôt, K. L. and Scherer, R. W. and Rosenberg, P. B. and Herrmann, N. and van Dyck, C. H. and Padala, P. R. and Brawman-Mintzer, O. and others}, title = {{Effect of Methylphenidate on Apathy in Patients With Alzheimer Disease: The ADMET 2 Randomized Clinical Trial}}, journal = {JAMA neurology}, year = {2021}, doi = {10.1001/jamaneurol.2021.3356}, pmid = {34570180}, url = {https://doi.org/10.1001/jamaneurol.2021.3356} } @article{truong2022-36096687, author = {Truong, C. and Recto, C. and Lafont, C. and Canoui-Poitrine, F. and Belmin, J. B. and Lafuente-Lafuente, C.}, title = {{Effect of Cholinesterase Inhibitors on Mortality in Patients With Dementia: A Systematic Review of Randomized and Nonrandomized Trials}}, journal = {Neurology}, year = {2022}, doi = {10.1212/wnl.0000000000201161}, pmid = {36096687}, url = {https://doi.org/10.1212/wnl.0000000000201161} } @article{erkinjuntti2002-11965273, author = {Erkinjuntti, T. and Kurz, A. and Gauthier, S. and Bullock, R. and Lilienfeld, S. and Damaraju, C. V.}, title = {{Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomised trial}}, journal = {Lancet (London, England)}, year = {2002}, doi = {10.1016/s0140-6736(02)08267-3}, pmid = {11965273}, url = {https://doi.org/10.1016/s0140-6736(02)08267-3} } @article{feldman2007-17509485, author = {Feldman, H. H. and Ferris, S. and Winblad, B. and Sfikas, N. and Mancione, L. and He, Y. and Tekin, S. and Burns, A. and others}, title = {{Effect of rivastigmine on delay to diagnosis of Alzheimer's disease from mild cognitive impairment: the InDDEx study}}, journal = {The Lancet. Neurology}, year = {2007}, doi = {10.1016/s1474-4422(07)70109-6}, pmid = {17509485}, url = {https://doi.org/10.1016/s1474-4422(07)70109-6} } @article{anderson2011-20980201, author = {Anderson, C. and Teo, K. and Gao, P. and Arima, H. and Dans, A. and Unger, T. and Commerford, P. and Dyal, L. and others}, title = {{Renin-angiotensin system blockade and cognitive function in patients at high risk of cardiovascular disease: analysis of data from the ONTARGET and TRANSCEND studies}}, journal = {The Lancet. Neurology}, year = {2011}, doi = {10.1016/s1474-4422(10)70250-7}, pmid = {20980201}, url = {https://doi.org/10.1016/s1474-4422(10)70250-7} } @article{birks2015-25858345, author = {Birks, J. S. and Grimley Evans, J.}, title = {{Rivastigmine for Alzheimer's disease}}, journal = {The Cochrane database of systematic reviews}, year = {2015}, doi = {10.1002/14651858.cd001191.pub3}, pmid = {25858345}, url = {https://doi.org/10.1002/14651858.cd001191.pub3} } @article{devanand2026-41405855, author = {Devanand, D P and Wisniewski, Thomas and Razlighi, Qolamreza and Qian, Min and Wei, Renjie and Andrews, Howard F and Acosta, Edward P and Bell, Karen L and others}, title = {{Valacyclovir Treatment of Early Symptomatic Alzheimer Disease: The VALAD Randomized Clinical Trial}}, journal = {JAMA}, year = {2026}, doi = {10.1001/jama.2025.21738}, pmid = {41405855}, url = {https://doi.org/10.1001/jama.2025.21738} } @article{fleisher2024-38386949, author = {Fleisher, A. S. and Munsie, L. M. and Perahia, D. G. S. and Andersen, S. W. and Higgins, I. A. and Hauck, P. M. and Lo, A. C. and Sims, JR. and others}, title = {{Assessment of Efficacy and Safety of Zagotenemab: Results From PERISCOPE-ALZ, a Phase 2 Study in Early Symptomatic Alzheimer Disease}}, journal = {Neurology}, year = {2024}, doi = {10.1212/wnl.0000000000208061}, pmid = {38386949}, url = {https://doi.org/10.1212/wnl.0000000000208061} } @article{fleisher2011-21917762, author = {Fleisher, A. S. and Truran, D. and Mai, J. T. and Langbaum, J. B. and Aisen, P. S. and Cummings, J. L. and Jack, C. R. and Weiner, M. W. and others}, title = {{Chronic divalproex sodium use and brain atrophy in Alzheimer disease}}, journal = {Neurology}, year = {2011}, doi = {10.1212/wnl.0b013e318230a16c}, pmid = {21917762}, url = {https://doi.org/10.1212/wnl.0b013e318230a16c} } @article{ritchie2003-14676042, author = {Ritchie, C. W. and Bush, A. I. and Mackinnon, A. and Macfarlane, S. and Mastwyk, M. and MacGregor, L. and Kiers, L. and Cherny, R. and others}, title = {{Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting Abeta amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial}}, journal = {Archives of neurology}, year = {2003}, doi = {10.1001/archneur.60.12.1685}, pmid = {14676042}, url = {https://doi.org/10.1001/archneur.60.12.1685} } @article{rogers1998-9588436, author = {Rogers, S. L. and Doody, R. S. and Mohs, R. C. and Friedhoff, L. T.}, title = {{Donepezil improves cognition and global function in Alzheimer disease: a 15-week, double-blind, placebo-controlled study. Donepezil Study Group}}, journal = {Archives of internal medicine}, year = {1998}, doi = {10.1001/archinte.158.9.1021}, pmid = {9588436}, url = {https://doi.org/10.1001/archinte.158.9.1021} } @article{ostrowitzki2012-21987394, author = {Ostrowitzki, S. and Deptula, D. and Thurfjell, L. and Barkhof, F. and Bohrmann, B. and Brooks, D. J. and Klunk, W. E. and Ashford, E. and others}, title = {{Mechanism of amyloid removal in patients with Alzheimer disease treated with gantenerumab}}, journal = {Archives of neurology}, year = {2012}, doi = {10.1001/archneurol.2011.1538}, pmid = {21987394}, url = {https://doi.org/10.1001/archneurol.2011.1538} } @article{butchart2015-25934853, author = {Butchart, J. and Brook, L. and Hopkins, V. and Teeling, J. and Püntener, U. and Culliford, D. and Sharples, R. and Sharif, S. and others}, title = {{Etanercept in Alzheimer disease: A randomized, placebo-controlled, double-blind, phase 2 trial}}, journal = {Neurology}, year = {2015}, doi = {10.1212/wnl.0000000000001617}, pmid = {25934853}, url = {https://doi.org/10.1212/wnl.0000000000001617} } @article{black2007-17664405, author = {Black, S. E. and Doody, R. and Li, H. and McRae, T. and Jambor, K. M. and Xu, Y. and Sun, Y. and Perdomo, C. A. and others}, title = {{Donepezil preserves cognition and global function in patients with severe Alzheimer disease}}, journal = {Neurology}, year = {2007}, doi = {10.1212/01.wnl.0000266627.96040.5a}, pmid = {17664405}, url = {https://doi.org/10.1212/01.wnl.0000266627.96040.5a} } @article{sha2019-30383097, author = {Sha, S. J. and Deutsch, G. K. and Tian, L. and Richardson, K. and Coburn, M. and Gaudioso, J. L. and Marcal, T. and Solomon, E. and others}, title = {{Safety, Tolerability, and Feasibility of Young Plasma Infusion in the Plasma for Alzheimer Symptom Amelioration Study: A Randomized Clinical Trial}}, journal = {JAMA neurology}, year = {2019}, doi = {10.1001/jamaneurol.2018.3288}, pmid = {30383097}, url = {https://doi.org/10.1001/jamaneurol.2018.3288} } @article{mori2012-22829268, author = {Mori, E. and Ikeda, M. and Kosaka, K. and {Donepezil-DLB Study Investigators}}, title = {{Donepezil for dementia with Lewy bodies: a randomized, placebo-controlled trial}}, journal = {Annals of neurology}, year = {2012}, doi = {10.1002/ana.23557}, pmid = {22829268}, url = {https://doi.org/10.1002/ana.23557} } @article{russ2012-22972133, author = {Russ, T. C. and Morling, JR.}, title = {{Cholinesterase inhibitors for mild cognitive impairment}}, journal = {The Cochrane database of systematic reviews}, year = {2012}, doi = {10.1002/14651858.cd009132.pub2}, pmid = {22972133}, url = {https://doi.org/10.1002/14651858.cd009132.pub2} } @article{birks2006-16437532, author = {Birks, J.}, title = {{Cholinesterase inhibitors for Alzheimer's disease}}, journal = {The Cochrane database of systematic reviews}, year = {2006}, doi = {10.1002/14651858.cd005593}, pmid = {16437532}, url = {https://doi.org/10.1002/14651858.cd005593} } @article{loy2006-16437436, author = {Loy, C. and Schneider, L.}, title = {{Galantamine for Alzheimer's disease and mild cognitive impairment}}, journal = {The Cochrane database of systematic reviews}, year = {2006}, doi = {10.1002/14651858.cd001747.pub3}, pmid = {16437436}, url = {https://doi.org/10.1002/14651858.cd001747.pub3} } @article{cummings2026-41865758, author = {Cummings, Jeffrey L and Atri, Alireza and Sano, Mary and Zetterberg, Henrik and Scheltens, Philip and Knop, Filip K and Johannsen, Peter and Wichmann, Christian Ahmad and others}, title = {{Efficacy and safety of oral semaglutide 14 mg (flexible dose) in early-stage symptomatic Alzheimer's disease (evoke and evoke+): two phase 3, randomised, placebo-controlled trials}}, journal = {The Lancet}, year = {2026}, doi = {10.1016/s0140-6736(26)00459-9}, pmid = {41865758}, url = {https://doi.org/10.1016/s0140-6736(26)00459-9} } @article{bagattini2020-33002645, author = {Bagattini, C. and Zanni, M. and Barocco, F. and Caffarra, P. and Brignani, D. and Miniussi, C. and Defanti, C. A.}, title = {{Enhancing cognitive training effects in Alzheimer's disease: rTMS as an add-on treatment}}, journal = {Brain stimulation}, year = {2020}, doi = {10.1016/j.brs.2020.09.010}, pmid = {33002645}, url = {https://doi.org/10.1016/j.brs.2020.09.010} } @article{bergamaschi2013-23784727, author = {Bergamaschi, S. and Arcara, G. and Calza, A. and Villani, D. and Orgeta, V. and Mondini, S.}, title = {{One-year repeated cycles of cognitive training (CT) for Alzheimer's disease}}, journal = {Aging clinical and experimental research}, year = {2013}, doi = {10.1007/s40520-013-0065-2}, pmid = {23784727}, url = {https://doi.org/10.1007/s40520-013-0065-2} } @article{krishnan2003-14594748, author = {Krishnan, K. R. and Charles, H. C. and Doraiswamy, P. M. and Mintzer, J. and Weisler, R. and Yu, X. and Perdomo, C. and Ieni, JR. and others}, title = {{Randomized, placebo-controlled trial of the effects of donepezil on neuronal markers and hippocampal volumes in Alzheimer's disease}}, journal = {The American journal of psychiatry}, year = {2003}, doi = {10.1176/appi.ajp.160.11.2003}, pmid = {14594748}, url = {https://doi.org/10.1176/appi.ajp.160.11.2003} } @article{ballard2006-16437455, author = {Ballard, C. and Waite, J.}, title = {{The effectiveness of atypical antipsychotics for the treatment of aggression and psychosis in Alzheimer's disease}}, journal = {The Cochrane database of systematic reviews}, year = {2006}, doi = {10.1002/14651858.cd003476.pub2}, pmid = {16437455}, url = {https://doi.org/10.1002/14651858.cd003476.pub2} } @article{paczynski2025-40354064, author = {Paczynski, M. and Hofmann, A. and Posey, Z. and Gregersen, M. and Rudman, M. and Ellington, D. and Aldinger, M. and Musiek, E. S. and Holtzman, D. M. and Bateman, R. J. and others}, title = {{Lecanemab Treatment in a Specialty Memory Clinic}}, journal = {JAMA Neurology}, year = {2025}, doi = {10.1001/jamaneurol.2025.1232}, pmid = {40354064}, url = {https://doi.org/10.1001/jamaneurol.2025.1232} } @article{freundlevi2006-17030655, author = {Freund-Levi, Y. and Eriksdotter-Jönhagen, M. and Cederholm, T. and Basun, H. and Faxén-Irving, G. and Garlind, A. and Vedin, I. and Vessby, B. and others}, title = {{Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial}}, journal = {Archives of neurology}, year = {2006}, doi = {10.1001/archneur.63.10.1402}, pmid = {17030655}, url = {https://doi.org/10.1001/archneur.63.10.1402} } @article{study2007-17460158, author = {{ADAPT Research Group} and Lyketsos, C. G. and Breitner, J. C. and Green, R. C. and Martin, B. K. and Meinert, C. and Piantadosi, S. and Sabbagh, M.}, title = {{Naproxen and celecoxib do not prevent AD in early results from a randomized controlled trial}}, journal = {Neurology}, year = {2007}, doi = {10.1212/01.wnl.0000260269.93245.d2}, pmid = {17460158}, url = {https://doi.org/10.1212/01.wnl.0000260269.93245.d2} } @article{shinto2014-24077434, author = {Shinto, L. and Quinn, J. and Montine, T. and Dodge, H. H. and Woodward, W. and Baldauf-Wagner, S. and Waichunas, D. and Bumgarner, L. and others}, title = {{A randomized placebo-controlled pilot trial of omega-3 fatty acids and alpha lipoic acid in Alzheimer's disease}}, journal = {Journal of Alzheimer's disease : JAD}, year = {2014}, doi = {10.3233/jad-130722}, pmid = {24077434}, url = {https://doi.org/10.3233/jad-130722} } @article{siemers2006-16505324, author = {Siemers, E. R. and Quinn, J. F. and Kaye, J. and Farlow, M. R. and Porsteinsson, A. and Tariot, P. and Zoulnouni, P. and Galvin, J. E. and others}, title = {{Effects of a gamma-secretase inhibitor in a randomized study of patients with Alzheimer disease}}, journal = {Neurology}, year = {2006}, doi = {10.1212/01.wnl.0000198762.41312.e1}, pmid = {16505324}, url = {https://doi.org/10.1212/01.wnl.0000198762.41312.e1} } @article{rosenberg2010-20087081, author = {Rosenberg, P. B. and Drye, L. T. and Martin, B. K. and Frangakis, C. and Mintzer, J. E. and Weintraub, D. and Porsteinsson, A. P. and Schneider, L. S. and others}, title = {{Sertraline for the treatment of depression in Alzheimer disease}}, journal = {The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry}, year = {2010}, doi = {10.1097/jgp.0b013e3181c796eb}, pmid = {20087081}, url = {https://doi.org/10.1097/jgp.0b013e3181c796eb} } @article{tariot2011-21810649, author = {Tariot, P. N. and Schneider, L. S. and Cummings, J. and Thomas, R. G. and Raman, R. and Jakimovich, L. J. and Loy, R. and Bartocci, B. and others}, title = {{Chronic divalproex sodium to attenuate agitation and clinical progression of Alzheimer disease}}, journal = {Archives of general psychiatry}, year = {2011}, doi = {10.1001/archgenpsychiatry.2011.72}, pmid = {21810649}, url = {https://doi.org/10.1001/archgenpsychiatry.2011.72} } @article{jung2024-38709534, author = {Jung, Y. H. and Jang, H. and Park, S. and Kim, H. J. and Seo, S. W. and Kim, G. B. and Shon, Y. M. and Kim, S. and others}, title = {{Effectiveness of Personalized Hippocampal Network-Targeted Stimulation in Alzheimer Disease: A Randomized Clinical Trial}}, journal = {JAMA network open}, year = {2024}, doi = {10.1001/jamanetworkopen.2024.9220}, pmid = {38709534}, url = {https://doi.org/10.1001/jamanetworkopen.2024.9220} } @article{maier2020-32463470, author = {Maier, F. and Spottke, A. and Bach, J. P. and Bartels, C. and Buerger, K. and Dodel, R. and Fellgiebel, A. and Fliessbach, K. and others}, title = {{Bupropion for the Treatment of Apathy in Alzheimer Disease: A Randomized Clinical Trial}}, journal = {JAMA network open}, year = {2020}, doi = {10.1001/jamanetworkopen.2020.6027}, pmid = {32463470}, url = {https://doi.org/10.1001/jamanetworkopen.2020.6027} } @article{marjoribanks2017-28093732, author = {Marjoribanks, J. and Farquhar, C. and Roberts, H. and Lethaby, A. and Lee, J.}, title = {{Long-term hormone therapy for perimenopausal and postmenopausal women}}, journal = {The Cochrane database of systematic reviews}, year = {2017}, doi = {10.1002/14651858.cd004143.pub5}, pmid = {28093732}, url = {https://doi.org/10.1002/14651858.cd004143.pub5} } @article{curtis2015-25622185, author = {Curtis, C. and Gamez, J. E. and Singh, U. and Sadowsky, C. H. and Villena, T. and Sabbagh, M. N. and Beach, T. G. and Duara, R. and others}, title = {{Phase 3 trial of flutemetamol labeled with radioactive fluorine 18 imaging and neuritic plaque density}}, journal = {JAMA neurology}, year = {2015}, doi = {10.1001/jamaneurol.2014.4144}, pmid = {25622185}, url = {https://doi.org/10.1001/jamaneurol.2014.4144} } @article{vandenberghe2010-20687209, author = {Vandenberghe, R. and Van Laere, K. and Ivanoiu, A. and Salmon, E. and Bastin, C. and Triau, E. and Hasselbalch, S. and Law, I. and others}, title = {{18F-flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: a phase 2 trial}}, journal = {Annals of neurology}, year = {2010}, doi = {10.1002/ana.22068}, pmid = {20687209}, url = {https://doi.org/10.1002/ana.22068} } @article{emre2010-20729148, author = {Emre, M. and Tsolaki, M. and Bonuccelli, U. and Destée, A. and Tolosa, E. and Kutzelnigg, A. and Ceballos-Baumann, A. and Zdravkovic, S. and others}, title = {{Memantine for patients with Parkinson's disease dementia or dementia with Lewy bodies: a randomised, double-blind, placebo-controlled trial}}, journal = {The Lancet. Neurology}, year = {2010}, doi = {10.1016/s1474-4422(10)70194-0}, pmid = {20729148}, url = {https://doi.org/10.1016/s1474-4422(10)70194-0} } @article{morris1998-9595967, author = {Morris, J. C. and Cyrus, P. A. and Orazem, J. and Mas, J. and Bieber, F. and Ruzicka, B. B. and Gulanski, B.}, title = {{Metrifonate benefits cognitive, behavioral, and global function in patients with Alzheimer's disease}}, journal = {Neurology}, year = {1998}, doi = {10.1212/wnl.50.5.1222}, pmid = {9595967}, url = {https://doi.org/10.1212/wnl.50.5.1222} } @article{holmes2008-18640458, author = {Holmes, C. and Boche, D. and Wilkinson, D. and Yadegarfar, G. and Hopkins, V. and Bayer, A. and Jones, R. W. and Bullock, R. and others}, title = {{Long-term effects of Abeta42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial}}, journal = {Lancet (London, England)}, year = {2008}, doi = {10.1016/s0140-6736(08)61075-2}, pmid = {18640458}, url = {https://doi.org/10.1016/s0140-6736(08)61075-2} } @article{blackman2021-33289311, author = {Blackman, J. and Swirski, M. and Clynes, J. and Harding, S. and Leng, Y. and Coulthard, E.}, title = {{Pharmacological and non-pharmacological interventions to enhance sleep in mild cognitive impairment and mild Alzheimer's disease: A systematic review}}, journal = {Journal of sleep research}, year = {2021}, doi = {10.1111/jsr.13229}, pmid = {33289311}, url = {https://doi.org/10.1111/jsr.13229} } @article{lozano2016-27567810, author = {Lozano, A. M. and Fosdick, L. and Chakravarty, M. M. and Leoutsakos, J. M. and Munro, C. and Oh, E. and Drake, K. E. and Lyman, C. H. and others}, title = {{A Phase II Study of Fornix Deep Brain Stimulation in Mild Alzheimer's Disease}}, journal = {Journal of Alzheimer's disease : JAD}, year = {2016}, doi = {10.3233/jad-160017}, pmid = {27567810}, url = {https://doi.org/10.3233/jad-160017} } @article{dichgans2008-18296124, author = {Dichgans, M. and Markus, H. S. and Salloway, S. and Verkkoniemi, A. and Moline, M. and Wang, Q. and Posner, H. and Chabriat, H. S.}, title = {{Donepezil in patients with subcortical vascular cognitive impairment: a randomised double-blind trial in CADASIL}}, journal = {The Lancet. Neurology}, year = {2008}, doi = {10.1016/s1474-4422(08)70046-2}, pmid = {18296124}, url = {https://doi.org/10.1016/s1474-4422(08)70046-2} } @article{sevigny2024-38745011, author = {Sevigny, J. and Uspenskaya, O. and Heckman, L. D. and Wong, L. C. and Hatch, D. A. and Tewari, A. and Vandenberghe, R. and Irwin, D. J. and others}, title = {{Progranulin AAV gene therapy for frontotemporal dementia: translational studies and phase 1/2 trial interim results}}, journal = {Nature medicine}, year = {2024}, doi = {10.1038/s41591-024-02973-0}, pmid = {38745011}, url = {https://doi.org/10.1038/s41591-024-02973-0} } @article{sugimoto2021-34585222, author = {Sugimoto, T. and Sakurai, T. and Akatsu, H. and Doi, T. and Fujiwara, Y. and Hirakawa, A. and Kinoshita, F. and Kuzuya, M. and others}, title = {{The Japan-Multimodal Intervention Trial for Prevention of Dementia (J-MINT): The Study Protocol for an 18-Month, Multicenter, Randomized, Controlled Trial}}, journal = {The journal of prevention of Alzheimer's disease}, year = {2021}, doi = {10.14283/jpad.2021.29}, pmid = {34585222}, url = {https://doi.org/10.14283/jpad.2021.29} } @article{wieland2026-41641880, author = {Wieland, Lisa S and Ludeman, Emilie and Chi, Yuan and Feinberg, Termeh M and Chen, I-Hui and Chen, Kee-Hsin and Zhu, Yanan and Wolverson, Emma and others}, title = {{Ginkgo biloba for cognitive impairment and dementia}}, journal = {The Cochrane database of systematic reviews}, year = {2026}, doi = {10.1002/14651858.CD013661.pub2}, pmid = {41641880}, url = {https://doi.org/10.1002/14651858.CD013661.pub2} } @article{cantoni2025-41359335, author = {Cantoni, V. and Casula, E. P. and Tarantino, B. and Cupidi, C. and Huber, N. and Altomare, D. and Premi, E. and Zummo, E. and others}, title = {{Home-Based Gamma Transcranial Alternating Current Stimulation in Patients With Alzheimer Disease: A Randomized Clinical Trial}}, journal = {JAMA network open}, year = {2025}, doi = {10.1001/jamanetworkopen.2025.46556}, pmid = {41359335}, url = {https://doi.org/10.1001/jamanetworkopen.2025.46556} } @article{ooms2014-24887018, author = {Ooms, S. and Overeem, S. and Besse, K. and Rikkert, M. O. and Verbeek, M. and Claassen, J. A.}, title = {{Effect of 1 night of total sleep deprivation on cerebrospinal fluid β-amyloid 42 in healthy middle-aged men: a randomized clinical trial}}, journal = {JAMA neurology}, year = {2014}, doi = {10.1001/jamaneurol.2014.1173}, pmid = {24887018}, url = {https://doi.org/10.1001/jamaneurol.2014.1173} } @article{geldmacher2011-20837824, author = {Geldmacher, D. S. and Fritsch, T. and McClendon, M. J. and Landreth, G.}, title = {{A randomized pilot clinical trial of the safety of pioglitazone in treatment of patients with Alzheimer disease}}, journal = {Archives of neurology}, year = {2011}, doi = {10.1001/archneurol.2010.229}, pmid = {20837824}, url = {https://doi.org/10.1001/archneurol.2010.229} } @article{kurlan2007-17452579, author = {Kurlan, R. and Cummings, J. and Raman, R. and Thal, L. and {Alzheimer's Disease Cooperative Study Group}}, title = {{Quetiapine for agitation or psychosis in patients with dementia and parkinsonism}}, journal = {Neurology}, year = {2007}, doi = {10.1212/01.wnl.0000260060.60870.89}, pmid = {17452579}, url = {https://doi.org/10.1212/01.wnl.0000260060.60870.89} } @article{shinto2024-39088212, author = {Shinto, L. H. and Murchison, C. F. and Silbert, L. C. and Dodge, H. H. and Lahna, D. and Rooney, W. and Kaye, J. and Quinn, J. F. and others}, title = {{ω-3 PUFA for Secondary Prevention of White Matter Lesions and Neuronal Integrity Breakdown in Older Adults: A Randomized Clinical Trial}}, journal = {JAMA network open}, year = {2024}, doi = {10.1001/jamanetworkopen.2024.26872}, pmid = {39088212}, url = {https://doi.org/10.1001/jamanetworkopen.2024.26872} } @article{djaiani2016-26575144, author = {Djaiani, G. and Silverton, N. and Fedorko, L. and Carroll, J. and Styra, R. and Rao, V. and Katznelson, R.}, title = {{Dexmedetomidine versus Propofol Sedation Reduces Delirium after Cardiac Surgery: A Randomized Controlled Trial}}, journal = {Anesthesiology}, year = {2016}, doi = {10.1097/aln.0000000000000951}, pmid = {26575144}, url = {https://doi.org/10.1097/aln.0000000000000951} } @article{phillips2021-33622392, author = {Phillips, M. C. L. and Deprez, L. M. and Mortimer, G. M. N. and Murtagh, D. K. J. and McCoy, S. and Mylchreest, R. and Gilbertson, L. J. and Clark, K. M. and others}, title = {{Randomized crossover trial of a modified ketogenic diet in Alzheimer's disease}}, journal = {Alzheimer's research \& therapy}, year = {2021}, doi = {10.1186/s13195-021-00783-x}, pmid = {33622392}, url = {https://doi.org/10.1186/s13195-021-00783-x} } @article{oken1998-9823823, author = {Oken, B. S. and Storzbach, D. M. and Kaye, J. A.}, title = {{The efficacy of Ginkgo biloba on cognitive function in Alzheimer disease}}, journal = {Archives of neurology}, year = {1998}, doi = {10.1001/archneur.55.11.1409}, pmid = {9823823}, url = {https://doi.org/10.1001/archneur.55.11.1409} } @article{geldmacher2003-12834513, author = {Geldmacher, D. S. and Provenzano, G. and McRae, T. and Mastey, V. and Ieni, JR.}, title = {{Donepezil is associated with delayed nursing home placement in patients with Alzheimer's disease}}, journal = {Journal of the American Geriatrics Society}, year = {2003}, doi = {10.1046/j.1365-2389.2003.51306.x}, pmid = {12834513}, url = {https://doi.org/10.1046/j.1365-2389.2003.51306.x} } @article{berk2020-32492080, author = {Berk, M. and Woods, R. L. and Nelson, M. R. and Shah, R. C. and Reid, C. M. and Storey, E. and Fitzgerald, S. and Lockery, J. E. and others}, title = {{Effect of Aspirin vs Placebo on the Prevention of Depression in Older People: A Randomized Clinical Trial}}, journal = {JAMA psychiatry}, year = {2020}, doi = {10.1001/jamapsychiatry.2020.1214}, pmid = {32492080}, url = {https://doi.org/10.1001/jamapsychiatry.2020.1214} } @article{dedeyn1999-10496251, author = {De Deyn, P. P. and Rabheru, K. and Rasmussen, A. and Bocksberger, J. P. and Dautzenberg, P. L. and Eriksson, S. and Lawlor, B. A.}, title = {{A randomized trial of risperidone, placebo, and haloperidol for behavioral symptoms of dementia}}, journal = {Neurology}, year = {1999}, doi = {10.1212/wnl.53.5.946}, pmid = {10496251}, url = {https://doi.org/10.1212/wnl.53.5.946} } @article{crappermclachlan1991-1674295, author = {Crapper McLachlan, D. R. and Dalton, A. J. and Kruck, T. P. and Bell, M. Y. and Smith, W. L. and Kalow, W. and Andrews, D. F.}, title = {{Intramuscular desferrioxamine in patients with Alzheimer's disease}}, journal = {Lancet (London, England)}, year = {1991}, doi = {10.1016/0140-6736(91)92978-b}, pmid = {1674295}, url = {https://doi.org/10.1016/0140-6736(91)92978-b} } @article{reynolds2011-21199965, author = {Reynolds, C. F. and Butters, M. A. and Lopez, O. and Pollock, B. G. and Dew, M. A. and Mulsant, B. H. and Lenze, E. J. and Holm, M. and others}, title = {{Maintenance treatment of depression in old age: a randomized, double-blind, placebo-controlled evaluation of the efficacy and safety of donepezil combined with antidepressant pharmacotherapy}}, journal = {Archives of general psychiatry}, year = {2011}, doi = {10.1001/archgenpsychiatry.2010.184}, pmid = {21199965}, url = {https://doi.org/10.1001/archgenpsychiatry.2010.184} } @article{dubois2012-22915447, author = {Dubois, B. and Tolosa, E. and Katzenschlager, R. and Emre, M. and Lees, A. J. and Schumann, G. and Pourcher, E. and Gray, J. and others}, title = {{Donepezil in Parkinson's disease dementia: a randomized, double-blind efficacy and safety study}}, journal = {Movement disorders : official journal of the Movement Disorder Society}, year = {2012}, doi = {10.1002/mds.25098}, pmid = {22915447}, url = {https://doi.org/10.1002/mds.25098} } @article{sato2011-19923038, author = {Sato, T. and Hanyu, H. and Hirao, K. and Kanetaka, H. and Sakurai, H. and Iwamoto, T.}, title = {{Efficacy of PPAR-γ agonist pioglitazone in mild Alzheimer disease}}, journal = {Neurobiology of aging}, year = {2011}, doi = {10.1016/j.neurobiolaging.2009.10.009}, pmid = {19923038}, url = {https://doi.org/10.1016/j.neurobiolaging.2009.10.009} } @article{study2008-18474729, author = {{ADAPT Research Group} and Martin, B. K. and Szekely, C. and Brandt, J. and Piantadosi, S. and Breitner, J. C. and Craft, S. and Evans, D. and others}, title = {{Cognitive function over time in the Alzheimer's Disease Anti-inflammatory Prevention Trial (ADAPT): results of a randomized, controlled trial of naproxen and celecoxib}}, journal = {Archives of neurology}, year = {2008}, doi = {10.1001/archneur.2008.65.7.nct70006}, pmid = {18474729}, url = {https://doi.org/10.1001/archneur.2008.65.7.nct70006} } @article{fleisher2008-18695053, author = {Fleisher, A. S. and Raman, R. and Siemers, E. R. and Becerra, L. and Clark, C. M. and Dean, R. A. and Farlow, M. R. and Galvin, J. E. and others}, title = {{Phase 2 safety trial targeting amyloid beta production with a gamma-secretase inhibitor in Alzheimer disease}}, journal = {Archives of neurology}, year = {2008}, doi = {10.1001/archneur.65.8.1031}, pmid = {18695053}, url = {https://doi.org/10.1001/archneur.65.8.1031} } @article{salloway2011-21917766, author = {Salloway, S. and Sperling, R. and Keren, R. and Porsteinsson, A. P. and van Dyck, C. H. and Tariot, P. N. and Gilman, S. and Arnold, D. and others}, title = {{A phase 2 randomized trial of ELND005, scyllo-inositol, in mild to moderate Alzheimer disease}}, journal = {Neurology}, year = {2011}, doi = {10.1212/wnl.0b013e3182309fa5}, pmid = {21917766}, url = {https://doi.org/10.1212/wnl.0b013e3182309fa5} } @article{galasko2014-24696507, author = {Galasko, D. and Bell, J. and Mancuso, J. Y. and Kupiec, J. W. and Sabbagh, M. N. and van Dyck, C. and Thomas, R. G. and Aisen, P. S. and others}, title = {{Clinical trial of an inhibitor of RAGE-Aβ interactions in Alzheimer disease}}, journal = {Neurology}, year = {2014}, doi = {10.1212/wnl.0000000000000364}, pmid = {24696507}, url = {https://doi.org/10.1212/wnl.0000000000000364} } @article{rafii2011-21502597, author = {Rafii, M. S. and Walsh, S. and Little, J. T. and Behan, K. and Reynolds, B. and Ward, C. and Jin, S. and Thomas, R. and others}, title = {{A phase II trial of huperzine A in mild to moderate Alzheimer disease}}, journal = {Neurology}, year = {2011}, doi = {10.1212/wnl.0b013e318216eb7b}, pmid = {21502597}, url = {https://doi.org/10.1212/wnl.0b013e318216eb7b} } @article{williamson2007-17599421, author = {Williamson, J. D. and Miller, M. E. and Bryan, R. N. and Lazar, R. M. and Coker, L. H. and Johnson, J. and Cukierman, T. and Horowitz, K. R. and others}, title = {{The Action to Control Cardiovascular Risk in Diabetes Memory in Diabetes Study (ACCORD-MIND): rationale, design, and methods}}, journal = {The American journal of cardiology}, year = {2007}, doi = {10.1016/j.amjcard.2007.03.029}, pmid = {17599421}, url = {https://doi.org/10.1016/j.amjcard.2007.03.029} } @article{sevigny2008-19015485, author = {Sevigny, J. J. and Ryan, J. M. and van Dyck, C. H. and Peng, Y. and Lines, C. R. and Nessly, M. L. and {MK-677 Protocol 30 Study Group}}, title = {{Growth hormone secretagogue MK-677: no clinical effect on AD progression in a randomized trial}}, journal = {Neurology}, year = {2008}, doi = {10.1212/01.wnl.0000335163.88054.e7}, pmid = {19015485}, url = {https://doi.org/10.1212/01.wnl.0000335163.88054.e7} } @article{schneider2019-31492718, author = {Schneider, L. S. and Geffen, Y. and Rabinowitz, J. and Thomas, R. G. and Schmidt, R. and Ropele, S. and Weinstock, M. and {Ladostigil Study Group}}, title = {{Low-dose ladostigil for mild cognitive impairment: A phase 2 placebo-controlled clinical trial}}, journal = {Neurology}, year = {2019}, doi = {10.1212/wnl.0000000000008239}, pmid = {31492718}, url = {https://doi.org/10.1212/wnl.0000000000008239} } @article{rolland2019-31426362, author = {Rolland, Y. and Barreto, P. S. and Maltais, M. and Guyonnet, S. and Cantet, C. and Andrieu, S. and Vellas, B.}, title = {{Effect of Long-Term Omega 3 Polyunsaturated Fatty Acid Supplementation with or without Multidomain Lifestyle Intervention on Muscle Strength in Older Adults: Secondary Analysis of the Multidomain Alzheimer Preventive Trial (MAPT)}}, journal = {Nutrients}, year = {2019}, doi = {10.3390/nu11081931}, pmid = {31426362}, url = {https://doi.org/10.3390/nu11081931} } @article{watt2020-32546202, author = {Watt, J. A. and Goodarzi, Z. and Veroniki, A. A. and Nincic, V. and Khan, P. A. and Ghassemi, M. and Thompson, Y. and Lai, Y. and others}, title = {{Safety of pharmacologic interventions for neuropsychiatric symptoms in dementia: a systematic review and network meta-analysis}}, journal = {BMC geriatrics}, year = {2020}, doi = {10.1186/s12877-020-01607-7}, pmid = {32546202}, url = {https://doi.org/10.1186/s12877-020-01607-7} } @article{higgins2003-12917896, author = {Higgins, J. P. and Flicker, L.}, title = {{Lecithin for dementia and cognitive impairment}}, journal = {The Cochrane database of systematic reviews}, year = {2003}, doi = {10.1002/14651858.cd001015}, pmid = {12917896}, url = {https://doi.org/10.1002/14651858.cd001015} } @article{marcum2023-36598787, author = {Marcum, Z. A. and Gabriel, N. and Bress, A. P. and Hernandez, I.}, title = {{Association of New Use of Antihypertensives That Stimulate vs Inhibit Type 2 and 4 Angiotensin II Receptors With Dementia Among Medicare Beneficiaries}}, journal = {JAMA network open}, year = {2023}, doi = {10.1001/jamanetworkopen.2022.49370}, pmid = {36598787}, url = {https://doi.org/10.1001/jamanetworkopen.2022.49370} } @article{saito2023-38048134, author = {Saito, S. and Suzuki, K. and Ohtani, R. and Maki, T. and Kowa, H. and Tachibana, H. and Washida, K. and Kawabata, N. and others}, title = {{Efficacy and Safety of Cilostazol in Mild Cognitive Impairment: A Randomized Clinical Trial}}, journal = {JAMA network open}, year = {2023}, doi = {10.1001/jamanetworkopen.2023.44938}, pmid = {38048134}, url = {https://doi.org/10.1001/jamanetworkopen.2023.44938} } @article{billiotidegage2014-25208536, author = {Billioti de Gage, S. and Moride, Y. and Ducruet, T. and Kurth, T. and Verdoux, H. and Tournier, M. and Pariente, A. and Bégaud, B.}, title = {{Benzodiazepine use and risk of Alzheimer's disease: case-control study}}, journal = {BMJ (Clinical research ed.)}, year = {2014}, doi = {10.1136/bmj.g5205}, pmid = {25208536}, url = {https://doi.org/10.1136/bmj.g5205} } @article{koenig2017-28538088, author = {Koenig, A. M. and Mechanic-Hamilton, D. and Xie, S. X. and Combs, M. F. and Cappola, A. R. and Xie, L. and Detre, J. A. and Wolk, D. A. and others}, title = {{Effects of the Insulin Sensitizer Metformin in Alzheimer Disease: Pilot Data From a Randomized Placebo-controlled Crossover Study}}, journal = {Alzheimer disease and associated disorders}, year = {2017}, doi = {10.1097/wad.0000000000000202}, pmid = {28538088}, url = {https://doi.org/10.1097/wad.0000000000000202} } @article{reines2004-14718699, author = {Reines, S. A. and Block, G. A. and Morris, J. C. and Liu, G. and Nessly, M. L. and Lines, C. R. and Norman, B. A. and Baranak, C. C. and others}, title = {{Rofecoxib: no effect on Alzheimer's disease in a 1-year, randomized, blinded, controlled study}}, journal = {Neurology}, year = {2004}, doi = {10.1212/wnl.62.1.66}, pmid = {14718699}, url = {https://doi.org/10.1212/wnl.62.1.66} } @article{mervin2018-29325922, author = {Mervin, M. C. and Moyle, W. and Jones, C. and Murfield, J. and Draper, B. and Beattie, E. and Shum, D. H. K. and O'Dwyer, S. and others}, title = {{The Cost-Effectiveness of Using PARO, a Therapeutic Robotic Seal, to Reduce Agitation and Medication Use in Dementia: Findings from a Cluster-Randomized Controlled Trial}}, journal = {Journal of the American Medical Directors Association}, year = {2018}, doi = {10.1016/j.jamda.2017.10.008}, pmid = {29325922}, url = {https://doi.org/10.1016/j.jamda.2017.10.008} } @article{petersen2005-15829527, author = {Petersen, R. C. and Thomas, R. G. and Grundman, M. and Bennett, D. and Doody, R. and Ferris, S. and Galasko, D. and Jin, S. and others}, title = {{Vitamin E and donepezil for the treatment of mild cognitive impairment}}, journal = {The New England journal of medicine}, year = {2005}, doi = {10.1056/nejmoa050151}, pmid = {15829527}, url = {https://doi.org/10.1056/nejmoa050151} } @article{auchus2007-17664404, author = {Auchus, A. P. and Brashear, H. R. and Salloway, S. and Korczyn, A. D. and De Deyn, P. P. and Gassmann-Mayer, C. and {GAL-INT-26 Study Group}}, title = {{Galantamine treatment of vascular dementia: a randomized trial}}, journal = {Neurology}, year = {2007}, doi = {10.1212/01.wnl.0000266625.31615.f6}, pmid = {17664404}, url = {https://doi.org/10.1212/01.wnl.0000266625.31615.f6} } @article{boada2020-32715623, author = {Boada, M. and López, O. L. and Olazarán, J. and Núñez, L. and Pfeffer, M. and Paricio, M. and Lorites, J. and Piñol-Ripoll, G. and others}, title = {{A randomized, controlled clinical trial of plasma exchange with albumin replacement for Alzheimer's disease: Primary results of the AMBAR Study}}, journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association}, year = {2020}, doi = {10.1002/alz.12137}, pmid = {32715623}, url = {https://doi.org/10.1002/alz.12137} } @article{ko2022-36399339, author = {Ko, Darae and Lin, Kueiyu Joshua and Bessette, Lily Gui and Lee, Su Been and Walkey, Allan J. and Cheng, Susan C. and Kim, Erin and Glynn, Robert J. and others}, title = {{Trends in Use of Oral Anticoagulants in Older Adults With Newly Diagnosed Atrial Fibrillation, 2010-2020}}, journal = {JAMA Network Open}, year = {2022}, doi = {10.1001/jamanetworkopen.2022.42964}, pmid = {36399339}, url = {https://doi.org/10.1001/jamanetworkopen.2022.42964} } @article{amieva2016-26572551, author = {Amieva, H. and Robert, P. H. and Grandoulier, A. S. and Meillon, C. and De Rotrou, J. and Andrieu, S. and Berr, C. and Desgranges, B. and others}, title = {{Group and individual cognitive therapies in Alzheimer's disease: the ETNA3 randomized trial}}, journal = {International psychogeriatrics}, year = {2016}, doi = {10.1017/s1041610215001830}, pmid = {26572551}, url = {https://doi.org/10.1017/s1041610215001830} } @article{wang2024-228e687c, author = {Wang, W. and Wang, Q. Q. and Qi, X. and Gurney, M. and Perry, G. and Volkow, N. D. and Davis, P. B. and Kaelber, D. C. and Xu, R.}, title = {{Associations of semaglutide with first-time diagnosis of Alzheimer's disease in patients with type 2 diabetes: Target trial emulation using nationwide real-world data in the US}}, journal = {Alzheimer's \& Dementia}, year = {2024} } @article{liu2018-29429971, author = {Liu, E. and Wang, D. and Sperling, R. and Salloway, S. and Fox, N. C. and Blennow, K. and Scheltens, P. and Schmidt, M. E. and others}, title = {{Biomarker pattern of ARIA-E participants in phase 3 randomized clinical trials with bapineuzumab}}, journal = {Neurology}, year = {2018}, doi = {10.1212/wnl.0000000000005060}, pmid = {29429971}, url = {https://doi.org/10.1212/wnl.0000000000005060} } @article{shao2012-23100399, author = {Shao, H. and Breitner, J. C. and Whitmer, R. A. and Wang, J. and Hayden, K. and Wengreen, H. and Corcoran, C. and Tschanz, J. and others}, title = {{Hormone therapy and Alzheimer disease dementia: new findings from the Cache County Study}}, journal = {Neurology}, year = {2012}, doi = {10.1212/wnl.0b013e318271f823}, pmid = {23100399}, url = {https://doi.org/10.1212/wnl.0b013e318271f823} } @article{doody2009-19176895, author = {Doody, R. S. and Ferris, S. H. and Salloway, S. and Sun, Y. and Goldman, R. and Watkins, W. E. and Xu, Y. and Murthy, A. K.}, title = {{Donepezil treatment of patients with MCI: a 48-week randomized, placebo-controlled trial}}, journal = {Neurology}, year = {2009}, doi = {10.1212/01.wnl.0000344650.95823.03}, pmid = {19176895}, url = {https://doi.org/10.1212/01.wnl.0000344650.95823.03} } @article{lin2021-33881530, author = {Lin, C. H. and Chen, P. K. and Wang, S. H. and Lane, H. Y.}, title = {{Effect of Sodium Benzoate on Cognitive Function Among Patients With Behavioral and Psychological Symptoms of Dementia: Secondary Analysis of a Randomized Clinical Trial}}, journal = {JAMA network open}, year = {2021}, doi = {10.1001/jamanetworkopen.2021.6156}, pmid = {33881530}, url = {https://doi.org/10.1001/jamanetworkopen.2021.6156} } @article{thal1996-8960716, author = {Thal, L. J. and Schwartz, G. and Sano, M. and Weiner, M. and Knopman, D. and Harrell, L. and Bodenheimer, S. and Rossor, M. and others}, title = {{A multicenter double-blind study of controlled-release physostigmine for the treatment of symptoms secondary to Alzheimer's disease. Physostigmine Study Group}}, journal = {Neurology}, year = {1996}, doi = {10.1212/wnl.47.6.1389}, pmid = {8960716}, url = {https://doi.org/10.1212/wnl.47.6.1389} } @article{feustel2020-31792092, author = {Feustel, A. C. and MacPherson, A. and Fergusson, D. A. and Kieburtz, K. and Kimmelman, J.}, title = {{Risks and benefits of unapproved disease-modifying treatments for neurodegenerative disease}}, journal = {Neurology}, year = {2020}, doi = {10.1212/wnl.0000000000008699}, pmid = {31792092}, url = {https://doi.org/10.1212/wnl.0000000000008699} } @article{anstey2020-32969833, author = {Anstey, K. J. and Cherbuin, N. and Kim, S. and McMaster, M. and D'Este, C. and Lautenschlager, N. and Rebok, G. and McRae, I. and others}, title = {{An Internet-Based Intervention Augmented With a Diet and Physical Activity Consultation to Decrease the Risk of Dementia in At-Risk Adults in a Primary Care Setting: Pragmatic Randomized Controlled Trial}}, journal = {Journal of medical Internet research}, year = {2020}, doi = {10.2196/19431}, pmid = {32969833}, url = {https://doi.org/10.2196/19431} } @article{grill2025-39671543, author = {Grill, J. D. and Tam, S. and Thai, G. and Vides, B. and Pierce, A. L. and Green, K. and Gillen, D. L. and Teng, E. and others}, title = {{Phase 2A Proof-of-Concept Double-Blind, Randomized, Placebo-Controlled Trial of Nicotinamide in Early Alzheimer Disease}}, journal = {Neurology}, year = {2025}, doi = {10.1212/wnl.0000000000210152}, pmid = {39671543}, url = {https://doi.org/10.1212/wnl.0000000000210152} } @article{tzeng2018-29488144, author = {Tzeng, N. S. and Chung, C. H. and Lin, F. H. and Chiang, C. P. and Yeh, C. B. and Huang, S. Y. and Lu, R. B. and Chang, H. A. and others}, title = {{Anti-herpetic Medications and Reduced Risk of Dementia in Patients with Herpes Simplex Virus Infections-a Nationwide, Population-Based Cohort Study in Taiwan}}, journal = {Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics}, year = {2018}, doi = {10.1007/s13311-018-0611-x}, pmid = {29488144}, url = {https://doi.org/10.1007/s13311-018-0611-x} } @article{rouch2015-25700645, author = {Rouch, L. and Cestac, P. and Hanon, O. and Cool, C. and Helmer, C. and Bouhanick, B. and Chamontin, B. and Dartigues, J. F. and others}, title = {{Antihypertensive drugs, prevention of cognitive decline and dementia: a systematic review of observational studies, randomized controlled trials and meta-analyses, with discussion of potential mechanisms}}, journal = {CNS drugs}, year = {2015}, doi = {10.1007/s40263-015-0230-6}, pmid = {25700645}, url = {https://doi.org/10.1007/s40263-015-0230-6} } @article{raina2008-18316756, author = {Raina, P. and Santaguida, P. and Ismaila, A. and Patterson, C. and Cowan, D. and Levine, M. and Booker, L. and Oremus, M.}, title = {{Effectiveness of cholinesterase inhibitors and memantine for treating dementia: evidence review for a clinical practice guideline}}, journal = {Annals of internal medicine}, year = {2008}, doi = {10.7326/0003-4819-148-5-200803040-00009}, pmid = {18316756}, url = {https://doi.org/10.7326/0003-4819-148-5-200803040-00009} } @article{brodaty2003-12633121, author = {Brodaty, H. and Ames, D. and Snowdon, J. and Woodward, M. and Kirwan, J. and Clarnette, R. and Lee, E. and Lyons, B. and others}, title = {{A randomized placebo-controlled trial of risperidone for the treatment of aggression, agitation, and psychosis of dementia}}, journal = {The Journal of clinical psychiatry}, year = {2003}, doi = {10.4088/jcp.v64n0205}, pmid = {12633121}, url = {https://doi.org/10.4088/jcp.v64n0205} } @article{katz1999-10084637, author = {Katz, I. R. and Jeste, D. V. and Mintzer, J. E. and Clyde, C. and Napolitano, J. and Brecher, M.}, title = {{Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: a randomized, double-blind trial. Risperidone Study Group}}, journal = {The Journal of clinical psychiatry}, year = {1999}, doi = {10.4088/jcp.v60n0207}, pmid = {10084637}, url = {https://doi.org/10.4088/jcp.v60n0207} } @article{wilcock2008-18450517, author = {Wilcock, G. K. and Black, S. E. and Hendrix, S. B. and Zavitz, K. H. and Swabb, E. A. and Laughlin, M. A. and {Tarenflurbil Phase II Study investigators}}, title = {{Efficacy and safety of tarenflurbil in mild to moderate Alzheimer's disease: a randomised phase II trial}}, journal = {The Lancet. Neurology}, year = {2008}, doi = {10.1016/s1474-4422(08)70090-5}, pmid = {18450517}, url = {https://doi.org/10.1016/s1474-4422(08)70090-5} } @article{gauthier2009-19536424, author = {Gauthier, S. and Aisen, P. S. and Ferris, S. H. and Saumier, D. and Duong, A. and Haine, D. and Garceau, D. and Suhy, J. and others}, title = {{Effect of tramiprosate in patients with mild-to-moderate Alzheimer's disease: exploratory analyses of the MRI sub-group of the Alphase study}}, journal = {The journal of nutrition, health \& aging}, year = {2009}, doi = {10.1007/s12603-009-0106-x}, pmid = {19536424}, url = {https://doi.org/10.1007/s12603-009-0106-x} } @article{liu2025-40507855, author = {Liu, X. and Baxley, S. and Hebron, M. and Turner, R. S. and Moussa, C.}, title = {{Resveratrol Attenuates CSF Markers of Neurodegeneration and Neuroinflammation in Individuals with Alzheimer's Disease}}, journal = {International journal of molecular sciences}, year = {2025}, doi = {10.3390/ijms26115044}, pmid = {40507855}, url = {https://doi.org/10.3390/ijms26115044} } @article{pasqualetti2009-19448381, author = {Pasqualetti, P. and Bonomini, C. and Dal Forno, G. and Paulon, L. and Sinforiani, E. and Marra, C. and Zanetti, O. and Rossini, P. M.}, title = {{A randomized controlled study on effects of ibuprofen on cognitive progression of Alzheimer's disease}}, journal = {Aging clinical and experimental research}, year = {2009}, doi = {10.1007/bf03325217}, pmid = {19448381}, url = {https://doi.org/10.1007/bf03325217} } @article{mulnard2000-10697060, author = {Mulnard, R. A. and Cotman, C. W. and Kawas, C. and van Dyck, C. H. and Sano, M. and Doody, R. and Koss, E. and Pfeiffer, E. and others}, title = {{Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer's Disease Cooperative Study}}, journal = {JAMA}, year = {2000}, doi = {10.1001/jama.283.8.1007}, pmid = {10697060}, url = {https://doi.org/10.1001/jama.283.8.1007} } @article{schneider2011-21482915, author = {Schneider, L. S. and Dagerman, K. S. and Higgins, J. P. and McShane, R.}, title = {{Lack of evidence for the efficacy of memantine in mild Alzheimer disease}}, journal = {Archives of neurology}, year = {2011}, doi = {10.1001/archneurol.2011.69}, pmid = {21482915}, url = {https://doi.org/10.1001/archneurol.2011.69} } @article{sabbagh2011-21192237, author = {Sabbagh, M. N. and Agro, A. and Bell, J. and Aisen, P. S. and Schweizer, E. and Galasko, D.}, title = {{PF-04494700, an oral inhibitor of receptor for advanced glycation end products (RAGE), in Alzheimer disease}}, journal = {Alzheimer disease and associated disorders}, year = {2011}, doi = {10.1097/wad.0b013e318204b550}, pmid = {21192237}, url = {https://doi.org/10.1097/wad.0b013e318204b550} } @article{vandyck2007-17545739, author = {van Dyck, C. H. and Tariot, P. N. and Meyers, B. and Malca Resnick, E. and {Memantine MEM-MD-01 Study Group}}, title = {{A 24-week randomized, controlled trial of memantine in patients with moderate-to-severe Alzheimer disease}}, journal = {Alzheimer disease and associated disorders}, year = {2007}, doi = {10.1097/wad.0b013e318065c495}, pmid = {17545739}, url = {https://doi.org/10.1097/wad.0b013e318065c495} } @article{gehrman2009-19155748, author = {Gehrman, P. R. and Connor, D. J. and Martin, J. L. and Shochat, T. and Corey-Bloom, J. and Ancoli-Israel, S.}, title = {{Melatonin fails to improve sleep or agitation in double-blind randomized placebo-controlled trial of institutionalized patients with Alzheimer disease}}, journal = {The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry}, year = {2009}, doi = {10.1097/jgp.0b013e318187de18}, pmid = {19155748}, url = {https://doi.org/10.1097/jgp.0b013e318187de18} } @article{giudici2020-33036701, author = {Giudici, K. V. and de Souto Barreto, P. and Beard, J. and Cantet, C. and Araujo de Carvalho, I. and Rolland, Y. and Vellas, B. and {MAPT DSA group}}, title = {{Effect of long-term omega-3 supplementation and a lifestyle multidomain intervention on intrinsic capacity among community-dwelling older adults: Secondary analysis of a randomized, placebo-controlled trial (MAPT study)}}, journal = {Maturitas}, year = {2020}, doi = {10.1016/j.maturitas.2020.06.012}, pmid = {33036701}, url = {https://doi.org/10.1016/j.maturitas.2020.06.012} } @article{henderson2015-26537053, author = {Henderson, V. W. and Ala, T. and Sainani, K. L. and Bernstein, A. L. and Stephenson, B. S. and Rosen, A. C. and Farlow, M. R.}, title = {{Raloxifene for women with Alzheimer disease: A randomized controlled pilot trial}}, journal = {Neurology}, year = {2015}, doi = {10.1212/wnl.0000000000002171}, pmid = {26537053}, url = {https://doi.org/10.1212/wnl.0000000000002171} } @article{li2017-28821686, author = {Li, G. and Mayer, C. L. and Morelli, D. and Millard, S. P. and Raskind, W. H. and Petrie, E. C. and Cherrier, M. and Fagan, A. M. and others}, title = {{Effect of simvastatin on CSF Alzheimer disease biomarkers in cognitively normal adults}}, journal = {Neurology}, year = {2017}, doi = {10.1212/wnl.0000000000004392}, pmid = {28821686}, url = {https://doi.org/10.1212/wnl.0000000000004392} } @article{villardita1992-1603291, author = {Villardita, C. and Grioli, S. and Lomeo, C. and Cattaneo, C. and Parini, J.}, title = {{Clinical studies with oxiracetam in patients with dementia of Alzheimer type and multi-infarct dementia of mild to moderate degree}}, journal = {Neuropsychobiology}, year = {1992}, doi = {10.1159/000118805}, pmid = {1603291}, url = {https://doi.org/10.1159/000118805} } @article{berry2023-37040116, author = {Berry, D. A. and Dhadda, S. and Kanekiyo, M. and Li, D. and Swanson, C. J. and Irizarry, M. and Kramer, L. D. and Berry, S. M.}, title = {{Lecanemab for Patients With Early Alzheimer Disease: Bayesian Analysis of a Phase 2b Dose-Finding Randomized Clinical Trial}}, journal = {JAMA network open}, year = {2023}, doi = {10.1001/jamanetworkopen.2023.7230}, pmid = {37040116}, url = {https://doi.org/10.1001/jamanetworkopen.2023.7230} } @article{wetmore2024-39748836, author = {Wetmore, J. B. and Rodriguez, S. and Diaz Caro, D. and Cabán, M. and Uhlmann, W. and Goldman, J. and Leu, C. S. and Godinez, J. D. and others}, title = {{Designing and implementing the IDEAL Study: A randomized clinical trial of APOE genotype disclosure for late-onset Alzheimer's disease in an urban Latino population}}, journal = {Alzheimer's \& dementia (New York, N. Y.)}, year = {2024}, doi = {10.1002/trc2.70016}, pmid = {39748836}, url = {https://doi.org/10.1002/trc2.70016} } @article{mohs2001-11502917, author = {Mohs, R. C. and Doody, R. S. and Morris, J. C. and Ieni, JR. and Rogers, S. L. and Perdomo, C. A. and Pratt, R. D. and {"312" Study Group}}, title = {{A 1-year, placebo-controlled preservation of function survival study of donepezil in AD patients}}, journal = {Neurology}, year = {2001}, doi = {10.1212/wnl.57.3.481}, pmid = {11502917}, url = {https://doi.org/10.1212/wnl.57.3.481} } @article{mccurry2005-15877554, author = {McCurry, S. M. and Gibbons, L. E. and Logsdon, R. G. and Vitiello, M. V. and Teri, L.}, title = {{Nighttime insomnia treatment and education for Alzheimer's disease: a randomized, controlled trial}}, journal = {Journal of the American Geriatrics Society}, year = {2005}, doi = {10.1111/j.1532-5415.2005.53252.x}, pmid = {15877554}, url = {https://doi.org/10.1111/j.1532-5415.2005.53252.x} } @article{ancoliisrael2008-18795985, author = {Ancoli-Israel, S. and Palmer, B. W. and Cooke, JR. and Corey-Bloom, J. and Fiorentino, L. and Natarajan, L. and Liu, L. and Ayalon, L. and others}, title = {{Cognitive effects of treating obstructive sleep apnea in Alzheimer's disease: a randomized controlled study}}, journal = {Journal of the American Geriatrics Society}, year = {2008}, doi = {10.1111/j.1532-5415.2008.01934.x}, pmid = {18795985}, url = {https://doi.org/10.1111/j.1532-5415.2008.01934.x} } @article{lu2009-19528519, author = {Lu, P. H. and Edland, S. D. and Teng, E. and Tingus, K. and Petersen, R. C. and Cummings, J. L. and {Alzheimer's Disease Cooperative Study Group}}, title = {{Donepezil delays progression to AD in MCI subjects with depressive symptoms}}, journal = {Neurology}, year = {2009}, doi = {10.1212/wnl.0b013e3181aa52d3}, pmid = {19528519}, url = {https://doi.org/10.1212/wnl.0b013e3181aa52d3} } @article{boon2025-41109234, author = {Boon, B. D. C. and Piura, Y. D. and Moloney, C. M. and Chalk, J. L. and Lincoln, S. J. and Rutledge, M. H. and Rothberg, D. M. and Kouri, N. and others}, title = {{Neuropathological changes and amyloid-related imaging abnormalities in Alzheimer's disease treated with aducanumab versus untreated: a retrospective case-control study}}, journal = {The Lancet. Neurology}, year = {2025}, doi = {10.1016/s1474-4422(25)00313-8}, pmid = {41109234}, url = {https://doi.org/10.1016/s1474-4422(25)00313-8} } @article{rosenberg2013-24021498, author = {Rosenberg, P. B. and Lanctôt, K. L. and Drye, L. T. and Herrmann, N. and Scherer, R. W. and Bachman, D. L. and Mintzer, J. E. and {ADMET Investigators}}, title = {{Safety and efficacy of methylphenidate for apathy in Alzheimer's disease: a randomized, placebo-controlled trial}}, journal = {The Journal of clinical psychiatry}, year = {2013}, doi = {10.4088/jcp.12m08099}, pmid = {24021498}, url = {https://doi.org/10.4088/jcp.12m08099} } @article{simko2022-36215904, author = {Šimko, P. and Kent, J. A. and Rektorova, I.}, title = {{Is non-invasive brain stimulation effective for cognitive enhancement in Alzheimer's disease? An updated meta-analysis}}, journal = {Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology}, year = {2022}, doi = {10.1016/j.clinph.2022.09.010}, pmid = {36215904}, url = {https://doi.org/10.1016/j.clinph.2022.09.010} } @article{street2000-11015815, author = {Street, J. S. and Clark, W. S. and Gannon, K. S. and Cummings, J. L. and Bymaster, F. P. and Tamura, R. N. and Mitan, S. J. and Kadam, D. L. and others}, title = {{Olanzapine treatment of psychotic and behavioral symptoms in patients with Alzheimer disease in nursing care facilities: a double-blind, randomized, placebo-controlled trial. The HGEU Study Group}}, journal = {Archives of general psychiatry}, year = {2000}, doi = {10.1001/archpsyc.57.10.968}, pmid = {11015815}, url = {https://doi.org/10.1001/archpsyc.57.10.968} } @article{sparks2005-15883262, author = {Sparks, D. L. and Sabbagh, M. N. and Connor, D. J. and Lopez, J. and Launer, L. J. and Browne, P. and Wasser, D. and Johnson-Traver, S. and others}, title = {{Atorvastatin for the treatment of mild to moderate Alzheimer disease: preliminary results}}, journal = {Archives of neurology}, year = {2005}, doi = {10.1001/archneur.62.5.753}, pmid = {15883262}, url = {https://doi.org/10.1001/archneur.62.5.753} } @article{clare2010-20808145, author = {Clare, L. and Linden, D. E. and Woods, R. T. and Whitaker, R. and Evans, S. J. and Parkinson, C. H. and van Paasschen, J. and Nelis, S. M. and others}, title = {{Goal-oriented cognitive rehabilitation for people with early-stage Alzheimer disease: a single-blind randomized controlled trial of clinical efficacy}}, journal = {The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry}, year = {2010}, doi = {10.1097/jgp.0b013e3181d5792a}, pmid = {20808145}, url = {https://doi.org/10.1097/jgp.0b013e3181d5792a} } @article{porsteinsson2008-18288936, author = {Porsteinsson, A. P. and Grossberg, G. T. and Mintzer, J. and Olin, J. T. and {Memantine MEM-MD-12 Study Group}}, title = {{Memantine treatment in patients with mild to moderate Alzheimer's disease already receiving a cholinesterase inhibitor: a randomized, double-blind, placebo-controlled trial}}, journal = {Current Alzheimer research}, year = {2008}, doi = {10.2174/156720508783884576}, pmid = {18288936}, url = {https://doi.org/10.2174/156720508783884576} } @article{vandyck2019-31329216, author = {van Dyck, C. H. and Nygaard, H. B. and Chen, K. and Donohue, M. C. and Raman, R. and Rissman, R. A. and Brewer, J. B. and Koeppe, R. A. and others}, title = {{Effect of AZD0530 on Cerebral Metabolic Decline in Alzheimer Disease: A Randomized Clinical Trial}}, journal = {JAMA neurology}, year = {2019}, doi = {10.1001/jamaneurol.2019.2050}, pmid = {31329216}, url = {https://doi.org/10.1001/jamaneurol.2019.2050} } @article{raskind2004-14967774, author = {Raskind, M. A. and Peskind, E. R. and Truyen, L. and Kershaw, P. and Damaraju, C. V.}, title = {{The cognitive benefits of galantamine are sustained for at least 36 months: a long-term extension trial}}, journal = {Archives of neurology}, year = {2004}, doi = {10.1001/archneur.61.2.252}, pmid = {14967774}, url = {https://doi.org/10.1001/archneur.61.2.252} } @article{vandongen2003-12767414, author = {van Dongen, M. and van Rossum, E. and Kessels, A. and Sielhorst, H. and Knipschild, P.}, title = {{Ginkgo for elderly people with dementia and age-associated memory impairment: a randomized clinical trial}}, journal = {Journal of clinical epidemiology}, year = {2003}, doi = {10.1016/s0895-4356(03)00003-9}, pmid = {12767414}, url = {https://doi.org/10.1016/s0895-4356(03)00003-9} } @article{chappell2007-17389305, author = {Chappell, A. S. and Gonzales, C. and Williams, J. and Witte, M. M. and Mohs, R. C. and Sperling, R.}, title = {{AMPA potentiator treatment of cognitive deficits in Alzheimer disease}}, journal = {Neurology}, year = {2007}, doi = {10.1212/01.wnl.0000260240.46070.7c}, pmid = {17389305}, url = {https://doi.org/10.1212/01.wnl.0000260240.46070.7c} } @article{feldman2004-15326236, author = {Feldman, H. and Gauthier, S. and Hecker, J. and Vellas, B. and Hux, M. and Xu, Y. and Schwam, E. M. and Shah, S. and others}, title = {{Economic evaluation of donepezil in moderate to severe Alzheimer disease}}, journal = {Neurology}, year = {2004}, doi = {10.1212/01.wnl.0000134663.79663.6e}, pmid = {15326236}, url = {https://doi.org/10.1212/01.wnl.0000134663.79663.6e} } @article{blesa2007-17646620, author = {Blesa, R. and Ballard, C. and Orgogozo, J. M. and Lane, R. and Thomas, S. K.}, title = {{Caregiver preference for rivastigmine patches versus capsules for the treatment of Alzheimer disease}}, journal = {Neurology}, year = {2007}, doi = {10.1212/01.wnl.0000281848.25142.11}, pmid = {17646620}, url = {https://doi.org/10.1212/01.wnl.0000281848.25142.11} } @article{matt2025-40009384, author = {Matt, E. and Mitterwallner, M. and Radjenovic, S. and Grigoryeva, D. and Weber, A. and Stögmann, E. and Domitner, A. and Zettl, A. and others}, title = {{Ultrasound Neuromodulation With Transcranial Pulse Stimulation in Alzheimer Disease: A Randomized Clinical Trial}}, journal = {JAMA network open}, year = {2025}, doi = {10.1001/jamanetworkopen.2024.59170}, pmid = {40009384}, url = {https://doi.org/10.1001/jamanetworkopen.2024.59170} } @article{viswanathan2009-19153374, author = {Viswanathan, A. and Raj, S. and Greenberg, S. M. and Stampfer, M. and Campbell, S. and Hyman, B. T. and Irizarry, M. C.}, title = {{Plasma Abeta, homocysteine, and cognition: the Vitamin Intervention for Stroke Prevention (VISP) trial}}, journal = {Neurology}, year = {2009}, doi = {10.1212/01.wnl.0000339486.63862.db}, pmid = {19153374}, url = {https://doi.org/10.1212/01.wnl.0000339486.63862.db} } @article{mitchell2021-34251396, author = {Mitchell, S. L. and D'Agata, E. M. C. and Hanson, L. C. and Loizeau, A. J. and Habtemariam, D. A. and Tsai, T. and Anderson, R. A. and Shaffer, M. L.}, title = {{The Trial to Reduce Antimicrobial Use in Nursing Home Residents With Alzheimer Disease and Other Dementias (TRAIN-AD): A Cluster Randomized Clinical Trial}}, journal = {JAMA internal medicine}, year = {2021}, doi = {10.1001/jamainternmed.2021.3098}, pmid = {34251396}, url = {https://doi.org/10.1001/jamainternmed.2021.3098} } @article{flo2022-35771851, author = {Flo, B. K. and Matziorinis, A. M. and Skouras, S. and Sudmann, T. T. and Gold, C. and Koelsch, S.}, title = {{Study protocol for the Alzheimer and music therapy study: An RCT to compare the efficacy of music therapy and physical activity on brain plasticity, depressive symptoms, and cognitive decline, in a population with and at risk for Alzheimer's disease}}, journal = {PloS one}, year = {2022}, doi = {10.1371/journal.pone.0270682}, pmid = {35771851}, url = {https://doi.org/10.1371/journal.pone.0270682} } @article{baldereschi1998-9566385, author = {Baldereschi, M. and Di Carlo, A. and Lepore, V. and Bracco, L. and Maggi, S. and Grigoletto, F. and Scarlato, G. and Amaducci, L.}, title = {{Estrogen-replacement therapy and Alzheimer's disease in the Italian Longitudinal Study on Aging}}, journal = {Neurology}, year = {1998}, doi = {10.1212/wnl.50.4.996}, pmid = {9566385}, url = {https://doi.org/10.1212/wnl.50.4.996} } @article{pollock2007-17846102, author = {Pollock, B. G. and Mulsant, B. H. and Rosen, J. and Mazumdar, S. and Blakesley, R. E. and Houck, P. R. and Huber, K. A.}, title = {{A double-blind comparison of citalopram and risperidone for the treatment of behavioral and psychotic symptoms associated with dementia}}, journal = {The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry}, year = {2007}, doi = {10.1097/jgp.0b013e3180cc1ff5}, pmid = {17846102}, url = {https://doi.org/10.1097/jgp.0b013e3180cc1ff5} } @article{wang2016-27010616, author = {Wang, J. and Logovinsky, V. and Hendrix, S. B. and Stanworth, S. H. and Perdomo, C. and Xu, L. and Dhadda, S. and Do, I. and others}, title = {{ADCOMS: a composite clinical outcome for prodromal Alzheimer's disease trials}}, journal = {Journal of neurology, neurosurgery, and psychiatry}, year = {2016}, doi = {10.1136/jnnp-2015-312383}, pmid = {27010616}, url = {https://doi.org/10.1136/jnnp-2015-312383} } @article{tariot2001-11843990, author = {Tariot, P. N. and Cummings, J. L. and Katz, I. R. and Mintzer, J. and Perdomo, C. A. and Schwam, E. M. and Whalen, E.}, title = {{A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting}}, journal = {Journal of the American Geriatrics Society}, year = {2001}, doi = {10.1111/j.1532-5415.2001.49266.x}, pmid = {11843990}, url = {https://doi.org/10.1111/j.1532-5415.2001.49266.x} } @article{rogers2000-10793322, author = {Rogers, S. L. and Doody, R. S. and Pratt, R. D. and Ieni, JR.}, title = {{Long-term efficacy and safety of donepezil in the treatment of Alzheimer's disease: final analysis of a US multicentre open-label study}}, journal = {European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology}, year = {2000}, doi = {10.1016/s0924-977x(00)00067-5}, pmid = {10793322}, url = {https://doi.org/10.1016/s0924-977x(00)00067-5} } @article{wang2015-24828899, author = {Wang, H. F. and Yu, J. T. and Tang, S. W. and Jiang, T. and Tan, C. C. and Meng, X. F. and Wang, C. and Tan, M. S. and others}, title = {{Efficacy and safety of cholinesterase inhibitors and memantine in cognitive impairment in Parkinson's disease, Parkinson's disease dementia, and dementia with Lewy bodies: systematic review with meta-analysis and trial sequential analysis}}, journal = {Journal of neurology, neurosurgery, and psychiatry}, year = {2015}, doi = {10.1136/jnnp-2014-307659}, pmid = {24828899}, url = {https://doi.org/10.1136/jnnp-2014-307659} } @article{yang2013-24086396, author = {Yang, G. and Wang, Y. and Tian, J. and Liu, J. P.}, title = {{Huperzine A for Alzheimer's disease: a systematic review and meta-analysis of randomized clinical trials}}, journal = {PloS one}, year = {2013}, doi = {10.1371/journal.pone.0074916}, pmid = {24086396}, url = {https://doi.org/10.1371/journal.pone.0074916} } @article{jia2017-29284465, author = {Jia, Y. and Zhang, X. and Yu, J. and Han, J. and Yu, T. and Shi, J. and Zhao, L. and Nie, K.}, title = {{Acupuncture for patients with mild to moderate Alzheimer's disease: a randomized controlled trial}}, journal = {BMC complementary and alternative medicine}, year = {2017}, doi = {10.1186/s12906-017-2064-x}, pmid = {29284465}, url = {https://doi.org/10.1186/s12906-017-2064-x} } @article{dejong2008-18213383, author = {de Jong, D. and Jansen, R. and Hoefnagels, W. and Jellesma-Eggenkamp, M. and Verbeek, M. and Borm, G. and Kremer, B.}, title = {{No effect of one-year treatment with indomethacin on Alzheimer's disease progression: a randomized controlled trial}}, journal = {PloS one}, year = {2008}, doi = {10.1371/journal.pone.0001475}, pmid = {18213383}, url = {https://doi.org/10.1371/journal.pone.0001475} } @article{scheltens2018-30309389, author = {Scheltens, P. and Hallikainen, M. and Grimmer, T. and Duning, T. and Gouw, A. A. and Teunissen, C. E. and Wink, A. M. and Maruff, P. and others}, title = {{Safety, tolerability and efficacy of the glutaminyl cyclase inhibitor PQ912 in Alzheimer's disease: results of a randomized, double-blind, placebo-controlled phase 2a study}}, journal = {Alzheimer's research \& therapy}, year = {2018}, doi = {10.1186/s13195-018-0431-6}, pmid = {30309389}, url = {https://doi.org/10.1186/s13195-018-0431-6} } @article{roman2019-31521394, author = {Román, G. C. and Jackson, R. E. and Reis, J. and Román, A. N. and Toledo, J. B. and Toledo, E.}, title = {{Extra-virgin olive oil for potential prevention of Alzheimer disease}}, journal = {Revue neurologique}, year = {2019}, doi = {10.1016/j.neurol.2019.07.017}, pmid = {31521394}, url = {https://doi.org/10.1016/j.neurol.2019.07.017} } @article{monteiro2023-1c8f9366, author = {Monteiro, C. and Toth, B. and Brunstein, F. and Bobbala, A. and Datta, S. and Ceniceros, R. and Sanabria Bohorquez, S. M. and Anania, V. G. and Wildsmith, K. R. and Schauer, S. P. and Lee, J. and Dolton, M. J. and Ramakrishnan, V. and Abramzon, D. and Teng, E. and {the Lauriet investigators}}, title = {{Randomized Phase II Study of the Safety and Efficacy of Semorinemab in Participants With Mild-to-Moderate Alzheimer Disease: Lauriet}}, journal = {Neurology}, year = {2023}, doi = {10.1212/wnl.0000000000207663}, pmid = {37643887}, url = {https://doi.org/10.1212/wnl.0000000000207663} } @article{schneider2005-16375657, author = {Schneider, L. S. and DeKosky, S. T. and Farlow, M. R. and Tariot, P. N. and Hoerr, R. and Kieser, M.}, title = {{A randomized, double-blind, placebo-controlled trial of two doses of Ginkgo biloba extract in dementia of the Alzheimer's type}}, journal = {Current Alzheimer research}, year = {2005}, doi = {10.2174/156720505774932287}, pmid = {16375657}, url = {https://doi.org/10.2174/156720505774932287} } @article{reisberg2006-16401736, author = {Reisberg, B. and Doody, R. and Stöffler, A. and Schmitt, F. and Ferris, S. and Möbius, H. J.}, title = {{A 24-week open-label extension study of memantine in moderate to severe Alzheimer disease}}, journal = {Archives of neurology}, year = {2006}, doi = {10.1001/archneur.63.1.49}, pmid = {16401736}, url = {https://doi.org/10.1001/archneur.63.1.49} } @article{lee2023-37930669, author = {Lee, D. and Slomkowski, M. and Hefting, N. and Chen, D. and Larsen, K. G. and Kohegyi, E. and Hobart, M. and Cummings, J. L. and others}, title = {{Brexpiprazole for the Treatment of Agitation in Alzheimer Dementia: A Randomized Clinical Trial}}, journal = {JAMA neurology}, year = {2023}, doi = {10.1001/jamaneurol.2023.3810}, pmid = {37930669}, url = {https://doi.org/10.1001/jamaneurol.2023.3810} } @article{dejesusmorenomoreno2003-12637119, author = {De Jesus Moreno Moreno, M.}, title = {{Cognitive improvement in mild to moderate Alzheimer's dementia after treatment with the acetylcholine precursor choline alfoscerate: a multicenter, double-blind, randomized, placebo-controlled trial}}, journal = {Clinical therapeutics}, year = {2003}, doi = {10.1016/s0149-2918(03)90023-3}, pmid = {12637119}, url = {https://doi.org/10.1016/s0149-2918(03)90023-3} } @article{tariot2006-16905684, author = {Tariot, P. N. and Schneider, L. and Katz, I. R. and Mintzer, J. E. and Street, J. and Copenhaver, M. and Williams-Hughes, C.}, title = {{Quetiapine treatment of psychosis associated with dementia: a double-blind, randomized, placebo-controlled clinical trial}}, journal = {The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry}, year = {2006}, doi = {10.1097/01.jgp.0000196628.12010.35}, pmid = {16905684}, url = {https://doi.org/10.1097/01.jgp.0000196628.12010.35} } @article{moraes2008-18198262, author = {Moraes, W. and Poyares, D. and Sukys-Claudino, L. and Guilleminault, C. and Tufik, S.}, title = {{Donepezil improves obstructive sleep apnea in Alzheimer disease: a double-blind, placebo-controlled study}}, journal = {Chest}, year = {2008}, doi = {10.1378/chest.07-1446}, pmid = {18198262}, url = {https://doi.org/10.1378/chest.07-1446} } @article{ballard2009-19700946, author = {Ballard, C. and Brown, R. and Fossey, J. and Douglas, S. and Bradley, P. and Hancock, J. and James, I. A. and Juszczak, E. and others}, title = {{Brief psychosocial therapy for the treatment of agitation in Alzheimer disease (the CALM-AD trial)}}, journal = {The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry}, year = {2009}, doi = {10.1097/jgp.0b013e3181b0f8c0}, pmid = {19700946}, url = {https://doi.org/10.1097/jgp.0b013e3181b0f8c0} } @article{dejong2019-31203725, author = {de Jong, D. L. K. and de Heus, R. A. A. and Rijpma, A. and Donders, R. and Olde Rikkert, M. G. M. and Günther, M. and Lawlor, B. A. and van Osch, M. J. P. and others}, title = {{Effects of Nilvadipine on Cerebral Blood Flow in Patients With Alzheimer Disease}}, journal = {Hypertension (Dallas, Tex. : 1979)}, year = {2019}, doi = {10.1161/hypertensionaha.119.12892}, pmid = {31203725}, url = {https://doi.org/10.1161/hypertensionaha.119.12892} } @article{koch2020-32667654, author = {Koch, G. and Motta, C. and Bonnì, S. and Pellicciari, M. C. and Picazio, S. and Casula, E. P. and Maiella, M. and Di Lorenzo, F. and others}, title = {{Effect of Rotigotine vs Placebo on Cognitive Functions Among Patients With Mild to Moderate Alzheimer Disease: A Randomized Clinical Trial}}, journal = {JAMA network open}, year = {2020}, doi = {10.1001/jamanetworkopen.2020.10372}, pmid = {32667654}, url = {https://doi.org/10.1001/jamanetworkopen.2020.10372} } @article{vellas2006-17101932, author = {Vellas, B. and Andrieu, S. and Ousset, P. J. and Ouzid, M. and Mathiex-Fortunet, H. and {GuidAge Study Group}}, title = {{The GuidAge study: methodological issues. A 5-year double-blind randomized trial of the efficacy of EGb 761 for prevention of Alzheimer disease in patients over 70 with a memory complaint}}, journal = {Neurology}, year = {2006}, doi = {10.1212/wnl.67.9_suppl_3.s6}, pmid = {17101932}, url = {https://doi.org/10.1212/wnl.67.9_suppl_3.s6} } @article{bracco2023-37875856, author = {Bracco, L. and Pinto-Carral, A. and Hillaert, L. and Mourey, F.}, title = {{Tango-therapy vs physical exercise in older people with dementia; a randomized controlled trial}}, journal = {BMC geriatrics}, year = {2023}, doi = {10.1186/s12877-023-04342-x}, pmid = {37875856}, url = {https://doi.org/10.1186/s12877-023-04342-x} } @article{jeste2008-17637610, author = {Jeste, D. V. and Blazer, D. and Casey, D. and Meeks, T. and Salzman, C. and Schneider, L. and Tariot, P. and Yaffe, K.}, title = {{ACNP White Paper: update on use of antipsychotic drugs in elderly persons with dementia}}, journal = {Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology}, year = {2008}, doi = {10.1038/sj.npp.1301492}, pmid = {17637610}, url = {https://doi.org/10.1038/sj.npp.1301492} } @article{cummings2016-26822146, author = {Cummings, J. L. and Zhong, K. and Kinney, J. W. and Heaney, C. and Moll-Tudla, J. and Joshi, A. and Pontecorvo, M. and Devous, M. and others}, title = {{Double-blind, placebo-controlled, proof-of-concept trial of bexarotene Xin moderate Alzheimer's disease}}, journal = {Alzheimer's research \& therapy}, year = {2016}, doi = {10.1186/s13195-016-0173-2}, pmid = {26822146}, url = {https://doi.org/10.1186/s13195-016-0173-2} } @article{watson2005-16286438, author = {Watson, G. S. and Cholerton, B. A. and Reger, M. A. and Baker, L. D. and Plymate, SR. and Asthana, S. and Fishel, M. A. and Kulstad, J. J. and others}, title = {{Preserved cognition in patients with early Alzheimer disease and amnestic mild cognitive impairment during treatment with rosiglitazone: a preliminary study}}, journal = {The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry}, year = {2005}, doi = {10.1176/appi.ajgp.13.11.950}, pmid = {16286438}, url = {https://doi.org/10.1176/appi.ajgp.13.11.950} } @article{orgogozo2002-12105362, author = {Orgogozo, J. M. and Rigaud, A. S. and Stöffler, A. and Möbius, H. J. and Forette, F.}, title = {{Efficacy and safety of memantine in patients with mild to moderate vascular dementia: a randomized, placebo-controlled trial (MMM 300)}}, journal = {Stroke}, year = {2002}, doi = {10.1161/01.str.0000020094.08790.49}, pmid = {12105362}, url = {https://doi.org/10.1161/01.str.0000020094.08790.49} } @article{diener2008-18757238, author = {Diener, H. C. and Sacco, R. L. and Yusuf, S. and Cotton, D. and Ounpuu, S. and Lawton, W. A. and Palesch, Y. and Martin, R. H. and others}, title = {{Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) trial: a double-blind, active and placebo-controlled study}}, journal = {The Lancet. Neurology}, year = {2008}, doi = {10.1016/s1474-4422(08)70198-4}, pmid = {18757238}, url = {https://doi.org/10.1016/s1474-4422(08)70198-4} } @article{wilcock2002-12409683, author = {Wilcock, G. and Möbius, H. J. and Stöffler, A. and {MMM 500 group}}, title = {{A double-blind, placebo-controlled multicentre study of memantine in mild to moderate vascular dementia (MMM500)}}, journal = {International clinical psychopharmacology}, year = {2002}, doi = {10.1097/00004850-200211000-00005}, pmid = {12409683}, url = {https://doi.org/10.1097/00004850-200211000-00005} } @article{rogers1998-9452942, author = {Rogers, S. L. and Friedhoff, L. T.}, title = {{Long-term efficacy and safety of donepezil in the treatment of Alzheimer's disease: an interim analysis of the results of a US multicentre open label extension study}}, journal = {European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology}, year = {1998}, doi = {10.1016/s0924-977x(97)00079-5}, pmid = {9452942}, url = {https://doi.org/10.1016/s0924-977x(97)00079-5} } @article{burn2006-16960863, author = {Burn, D. and Emre, M. and McKeith, I. and De Deyn, P. P. and Aarsland, D. and Hsu, C. and Lane, R.}, title = {{Effects of rivastigmine in patients with and without visual hallucinations in dementia associated with Parkinson's disease}}, journal = {Movement disorders : official journal of the Movement Disorder Society}, year = {2006}, doi = {10.1002/mds.21077}, pmid = {16960863}, url = {https://doi.org/10.1002/mds.21077} } @article{xu2021-33741639, author = {Xu, H. and Garcia-Ptacek, S. and Jönsson, L. and Wimo, A. and Nordström, P. and Eriksdotter, M.}, title = {{Long-term Effects of Cholinesterase Inhibitors on Cognitive Decline and Mortality}}, journal = {Neurology}, year = {2021}, doi = {10.1212/wnl.0000000000011832}, pmid = {33741639}, url = {https://doi.org/10.1212/wnl.0000000000011832} } @article{wang2022-36150665, author = {Wang, L. and Zhang, J. and Guo, C. and He, J. and Zhang, S. and Wang, Y. and Zhao, Y. and Li, L. and others}, title = {{The efficacy and safety of transcutaneous auricular vagus nerve stimulation in patients with mild cognitive impairment: A double blinded randomized clinical trial}}, journal = {Brain stimulation}, year = {2022}, doi = {10.1016/j.brs.2022.09.003}, pmid = {36150665}, url = {https://doi.org/10.1016/j.brs.2022.09.003} } @article{burstein2014-24423155, author = {Burstein, A. H. and Grimes, I. and Galasko, D. R. and Aisen, P. S. and Sabbagh, M. and Mjalli, A. M.}, title = {{Effect of TTP488 in patients with mild to moderate Alzheimer's disease}}, journal = {BMC neurology}, year = {2014}, doi = {10.1186/1471-2377-14-12}, pmid = {24423155}, url = {https://doi.org/10.1186/1471-2377-14-12} } @article{freundlevi2008-17582225, author = {Freund-Levi, Y. and Basun, H. and Cederholm, T. and Faxén-Irving, G. and Garlind, A. and Grut, M. and Vedin, I. and Palmblad, J. and others}, title = {{Omega-3 supplementation in mild to moderate Alzheimer's disease: effects on neuropsychiatric symptoms}}, journal = {International journal of geriatric psychiatry}, year = {2008}, doi = {10.1002/gps.1857}, pmid = {17582225}, url = {https://doi.org/10.1002/gps.1857} } @article{study2008-18068522, author = {{AD2000 Collaborative Group} and Bentham, P. and Gray, R. and Sellwood, E. and Hills, R. and Crome, P. and Raftery, J.}, title = {{Aspirin in Alzheimer's disease (AD2000): a randomised open-label trial}}, journal = {The Lancet. Neurology}, year = {2008}, doi = {10.1016/s1474-4422(07)70293-4}, pmid = {18068522}, url = {https://doi.org/10.1016/s1474-4422(07)70293-4} } @article{richards2025-39909068, author = {Richards, Kathy Culpepper and Fry, Liam and Lozano, Alicia J and Ji, Wenyan and Morrison, Janet and Britt, Katherine Carroll and Bliwise, Donald L. and Gooneratne, Nalaka Sudheera and others}, title = {{Treatment of Restless Legs Syndrome Improves Agitation and Sleep in Persons with Dementia: A Randomized Trial}}, journal = {Journal of the American Medical Directors Association}, year = {2025}, doi = {10.1016/j.jamda.2025.105485}, pmid = {39909068}, url = {https://doi.org/10.1016/j.jamda.2025.105485} } @article{yuan2024-38824515, author = {Yuan, Y. and Yang, Y. and Hu, X. and Zhang, L. and Xiong, Z. and Bai, Y. and others}, title = {{Effective dosage and mode of exercise for enhancing cognitive function in Alzheimer's disease and dementia: a systematic review and Bayesian Model-Based Network Meta-analysis of RCTs}}, journal = {BMC Geriatrics}, year = {2024}, doi = {10.1186/s12877-024-05060-8}, pmid = {38824515}, url = {https://doi.org/10.1186/s12877-024-05060-8} } @article{xu2024-39177108, author = {Xu, H. and Habich, A. and Ferreira, D. and Elisabet, L. and Westman, E. and Eriksdotter, M.}, title = {{Long-term effects of cholinesterase inhibitors and memantine on cognitive decline, cardiovascular events, and mortality in dementia with Lewy bodies: An up to 10-year follow-up study}}, journal = {Alzheimer's \& Dementia}, year = {2024}, doi = {10.1002/alz.14118}, pmid = {39177108}, url = {https://doi.org/10.1002/alz.14118} } @article{fleisher2026-42441396, author = {Fleisher, Adam S and Munsie, Leanne and Mancini, Michele and Cheng, Yun-Ju and Guo, Jiaying and Nuthall, Hugh and Otero, Diana Svaldi and Kotari, Vikas and others}, title = {{Ceperognastat in Early Symptomatic Alzheimer Disease: A Randomized Clinical Trial}}, journal = {JAMA}, year = {2026}, doi = {10.1001/jama.2026.12768}, pmid = {42441396}, url = {https://doi.org/10.1001/jama.2026.12768} } @article{lin2014-24074637, author = {Lin, C. H. and Chen, P. K. and Chang, Y. C. and Chuo, L. J. and Chen, Y. S. and Tsai, G. E. and Lane, H. Y.}, title = {{Benzoate, a D-amino acid oxidase inhibitor, for the treatment of early-phase Alzheimer disease: a randomized, double-blind, placebo-controlled trial}}, journal = {Biological psychiatry}, year = {2014}, doi = {10.1016/j.biopsych.2013.08.010}, pmid = {24074637}, url = {https://doi.org/10.1016/j.biopsych.2013.08.010} } @article{tariot2005-16286437, author = {Tariot, P. N. and Raman, R. and Jakimovich, L. and Schneider, L. and Porsteinsson, A. and Thomas, R. and Mintzer, J. and Brenner, R. and others}, title = {{Divalproex sodium in nursing home residents with possible or probable Alzheimer Disease complicated by agitation: a randomized, controlled trial}}, journal = {The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry}, year = {2005}, doi = {10.1176/appi.ajgp.13.11.942}, pmid = {16286437}, url = {https://doi.org/10.1176/appi.ajgp.13.11.942} } @article{streim2008-18591574, author = {Streim, J. E. and Porsteinsson, A. P. and Breder, C. D. and Swanink, R. and Marcus, R. and McQuade, R. and Carson, W. H.}, title = {{A randomized, double-blind, placebo-controlled study of aripiprazole for the treatment of psychosis in nursing home patients with Alzheimer disease}}, journal = {The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry}, year = {2008}, doi = {10.1097/jgp.0b013e318165db77}, pmid = {18591574}, url = {https://doi.org/10.1097/jgp.0b013e318165db77} } @article{mintzer2006-16505133, author = {Mintzer, J. and Greenspan, A. and Caers, I. and Van Hove, I. and Kushner, S. and Weiner, M. and Gharabawi, G. and Schneider, L. S.}, title = {{Risperidone in the treatment of psychosis of Alzheimer disease: results from a prospective clinical trial}}, journal = {The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry}, year = {2006}, doi = {10.1097/01.jgp.0000194643.63245.8c}, pmid = {16505133}, url = {https://doi.org/10.1097/01.jgp.0000194643.63245.8c} } @article{schneider2016-26771737, author = {Schneider, L. S. and Frangakis, C. and Drye, L. T. and Devanand, D. P. and Marano, C. M. and Mintzer, J. and Mulsant, B. H. and Munro, C. A. and others}, title = {{Heterogeneity of Treatment Response to Citalopram for Patients With Alzheimer's Disease With Aggression or Agitation: The CitAD Randomized Clinical Trial}}, journal = {The American journal of psychiatry}, year = {2016}, doi = {10.1176/appi.ajp.2015.15050648}, pmid = {26771737}, url = {https://doi.org/10.1176/appi.ajp.2015.15050648} } @article{rosenheck2007-17984395, author = {Rosenheck, R. A. and Leslie, D. L. and Sindelar, J. L. and Miller, E. A. and Tariot, P. N. and Dagerman, K. S. and Davis, S. M. and Lebowitz, B. D. and others}, title = {{Cost-benefit analysis of second-generation antipsychotics and placebo in a randomized trial of the treatment of psychosis and aggression in Alzheimer disease}}, journal = {Archives of general psychiatry}, year = {2007}, doi = {10.1001/archpsyc.64.11.1259}, pmid = {17984395}, url = {https://doi.org/10.1001/archpsyc.64.11.1259} } @article{munro2012-23032478, author = {Munro, C. A. and Longmire, C. F. and Drye, L. T. and Martin, B. K. and Frangakis, C. E. and Meinert, C. L. and Mintzer, J. E. and Porsteinsson, A. P. and others}, title = {{Cognitive outcomes after sertaline treatment in patients with depression of Alzheimer disease}}, journal = {The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry}, year = {2012}, doi = {10.1097/jgp.0b013e31826ce4c5}, pmid = {23032478}, url = {https://doi.org/10.1097/jgp.0b013e31826ce4c5} } @article{dyer2020-31604674, author = {Dyer, A. H. and Murphy, C. and Lawlor, B. and Kennelly, S. P. and {NILVAD Study Group}}, title = {{Cognitive Outcomes of Long-term Benzodiazepine and Related Drug (BDZR) Use in People Living With Mild to Moderate Alzheimer's Disease: Results From NILVAD}}, journal = {Journal of the American Medical Directors Association}, year = {2020}, doi = {10.1016/j.jamda.2019.08.006}, pmid = {31604674}, url = {https://doi.org/10.1016/j.jamda.2019.08.006} } @article{flicker2001-11405971, author = {Flicker, L. and Grimley Evans, G.}, title = {{Piracetam for dementia or cognitive impairment}}, journal = {The Cochrane database of systematic reviews}, year = {2001}, doi = {10.1002/14651858.cd001011}, pmid = {11405971}, url = {https://doi.org/10.1002/14651858.cd001011} } @article{higgins2000-11034695, author = {Higgins, J. P. and Flicker, L.}, title = {{Lecithin for dementia and cognitive impairment}}, journal = {The Cochrane database of systematic reviews}, year = {2000}, doi = {10.1002/14651858.cd001015}, pmid = {11034695}, url = {https://doi.org/10.1002/14651858.cd001015} } @article{forcano2025-40664536, author = {Forcano, L. and Soldevila-Domenech, N. and Boronat, A. and Sánchez-Benavides, G. and Puig-Pijoan, A. and Lorenzo, T. and Aldea-Perona, A. and Suárez-Calvet, M. and others}, title = {{A multimodal lifestyle intervention complemented with epigallocatechin gallate to prevent cognitive decline in APOE- ɛ4 carriers with Subjective Cognitive Decline: a randomized, double-blinded clinical trial (PENSA study)}}, journal = {The journal of prevention of Alzheimer's disease}, year = {2025}, doi = {10.1016/j.tjpad.2025.100271}, pmid = {40664536}, url = {https://doi.org/10.1016/j.tjpad.2025.100271} } @article{vanderlip2026-41653883, author = {Vanderlip, C. R. and Gillen, D. L. and Grill, J. D. and Stark, C. E. L.}, title = {{Digital memory assessments and plasma pTau217 enable efficient preclinical Alzheimer's trials}}, journal = {The journal of prevention of Alzheimer's disease}, year = {2026}, doi = {10.1016/j.tjpad.2026.100503}, pmid = {41653883}, url = {https://doi.org/10.1016/j.tjpad.2026.100503} } @article{wilcock2000-11110737, author = {Wilcock, G. K. and Lilienfeld, S. and Gaens, E.}, title = {{Efficacy and safety of galantamine in patients with mild to moderate Alzheimer's disease: multicentre randomised controlled trial. Galantamine International-1 Study Group}}, journal = {BMJ (Clinical research ed.)}, year = {2000}, doi = {10.1136/bmj.321.7274.1445}, pmid = {11110737}, url = {https://doi.org/10.1136/bmj.321.7274.1445} } @article{banerjee2011-21764118, author = {Banerjee, S. and Hellier, J. and Dewey, M. and Romeo, R. and Ballard, C. and Baldwin, R. and Bentham, P. and Fox, C. and others}, title = {{Sertraline or mirtazapine for depression in dementia (HTA-SADD): a randomised, multicentre, double-blind, placebo-controlled trial}}, journal = {Lancet (London, England)}, year = {2011}, doi = {10.1016/s0140-6736(11)60830-1}, pmid = {21764118}, url = {https://doi.org/10.1016/s0140-6736(11)60830-1} } @article{feldman2003-12757558, author = {Feldman, H. and Gauthier, S. and Hecker, J. and Vellas, B. and Emir, B. and Mastey, V. and Subbiah, P. and {Donepezil MSAD Study Investigators Group}}, title = {{Efficacy of donepezil on maintenance of activities of daily living in patients with moderate to severe Alzheimer's disease and the effect on caregiver burden}}, journal = {Journal of the American Geriatrics Society}, year = {2003}, doi = {10.1046/j.1365-2389.2003.51260.x}, pmid = {12757558}, url = {https://doi.org/10.1046/j.1365-2389.2003.51260.x} } @article{molloy2013-22718435, author = {Molloy, D. W. and Standish, T. I. and Zhou, Q. and Guyatt, G. and {DARAD Study Group}}, title = {{A multicenter, blinded, randomized, factorial controlled trial of doxycycline and rifampin for treatment of Alzheimer's disease: the DARAD trial}}, journal = {International journal of geriatric psychiatry}, year = {2013}, doi = {10.1002/gps.3846}, pmid = {22718435}, url = {https://doi.org/10.1002/gps.3846} } @article{harrington2011-21592048, author = {Harrington, C. and Sawchak, S. and Chiang, C. and Davies, J. and Donovan, C. and Saunders, A. M. and Irizarry, M. and Jeter, B. and others}, title = {{Rosiglitazone does not improve cognition or global function when used as adjunctive therapy to AChE inhibitors in mild-to-moderate Alzheimer's disease: two phase 3 studies}}, journal = {Current Alzheimer research}, year = {2011}, doi = {10.2174/156720511796391935}, pmid = {21592048}, url = {https://doi.org/10.2174/156720511796391935} } @article{akhondzadeh2003-12810768, author = {Akhondzadeh, S. and Noroozian, M. and Mohammadi, M. and Ohadinia, S. and Jamshidi, A. H. and Khani, M.}, title = {{Melissa officinalis extract in the treatment of patients with mild to moderate Alzheimer's disease: a double blind, randomised, placebo controlled trial}}, journal = {Journal of neurology, neurosurgery, and psychiatry}, year = {2003}, doi = {10.1136/jnnp.74.7.863}, pmid = {12810768}, url = {https://doi.org/10.1136/jnnp.74.7.863} } @article{otto2004-15007119, author = {Otto, M. and Cepek, L. and Ratzka, P. and Doehlinger, S. and Boekhoff, I. and Wiltfang, J. and Irle, E. and Pergande, G. and others}, title = {{Efficacy of flupirtine on cognitive function in patients with CJD: A double-blind study}}, journal = {Neurology}, year = {2004}, doi = {10.1212/01.wnl.0000113764.35026.ef}, pmid = {15007119}, url = {https://doi.org/10.1212/01.wnl.0000113764.35026.ef} } @article{rockwood2006-16554498, author = {Rockwood, K. and Fay, S. and Song, X. and MacKnight, C. and Gorman, M.}, title = {{Attainment of treatment goals by people with Alzheimer's disease receiving galantamine: a randomized controlled trial}}, journal = {CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne}, year = {2006}, doi = {10.1503/cmaj.051432}, pmid = {16554498}, url = {https://doi.org/10.1503/cmaj.051432} } @article{vandyck2025-41355080, author = {van Dyck, C. H. and Sperling, R. and Johnson, K. and Dhadda, S. and Kanekiyo, M. and Li, D. and Gee, M. and Hersch, S. and Irizarry, M. and Kramer, L.}, title = {{Long-term safety and efficacy of lecanemab in early Alzheimer's disease: Results from the Clarity AD open-label extension study}}, journal = {Alzheimer's \& Dementia}, year = {2025}, doi = {10.1002/alz.70905}, pmid = {41355080}, url = {https://doi.org/10.1002/alz.70905} } @article{atri2026-42128444, author = {Atri, A. and Apostolova, L. G. and Iwata, A. and Wessels, A. M. and Atkins, A. and Lu, M. and Ye, W. and Ryan, S. and Doty, E. G.}, title = {{Clinical Meaningfulness of Donanemab in Early Symptomatic Alzheimer Disease: Data From the Randomized Phase 3 TRAILBLAZER-ALZ 2 Trial}}, journal = {Neurology: Clinical Practice}, year = {2026}, doi = {10.1212/CPJ.0000000000200621}, pmid = {42128444}, url = {https://doi.org/10.1212/CPJ.0000000000200621} } @article{delrieu2023-37872582, author = {Delrieu, J. and Vellas, B. and Guyonnet, S. and Cantet, C. and Ovod, V. and Li, Y. and Bollinger, J. and Bateman, R. and others}, title = {{Cognitive impact of multidomain intervention and omega 3 according to blood Aβ42/40 ratio: a subgroup analysis from the randomized MAPT trial}}, journal = {Alzheimer's research \& therapy}, year = {2023}, doi = {10.1186/s13195-023-01325-3}, pmid = {37872582}, url = {https://doi.org/10.1186/s13195-023-01325-3} } @article{camargos2014-24495406, author = {Camargos, E. F. and Louzada, L. L. and Quintas, J. L. and Naves, J. O. and Louzada, F. M. and Nóbrega, O. T.}, title = {{Trazodone improves sleep parameters in Alzheimer disease patients: a randomized, double-blind, and placebo-controlled study}}, journal = {The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry}, year = {2014}, doi = {10.1016/j.jagp.2013.12.174}, pmid = {24495406}, url = {https://doi.org/10.1016/j.jagp.2013.12.174} } @article{herrmann2008-18480686, author = {Herrmann, N. and Rothenburg, L. S. and Black, S. E. and Ryan, M. and Liu, B. A. and Busto, U. E. and Lanctôt, K. L.}, title = {{Methylphenidate for the treatment of apathy in Alzheimer disease: prediction of response using dextroamphetamine challenge}}, journal = {Journal of clinical psychopharmacology}, year = {2008}, doi = {10.1097/jcp.0b013e318172b479}, pmid = {18480686}, url = {https://doi.org/10.1097/jcp.0b013e318172b479} } @article{lok2019-30246408, author = {Lök, N. and Bademli, K. and Selçuk-Tosun, A.}, title = {{The effect of reminiscence therapy on cognitive functions, depression, and quality of life in Alzheimer patients: Randomized controlled trial}}, journal = {International journal of geriatric psychiatry}, year = {2019}, doi = {10.1002/gps.4980}, pmid = {30246408}, url = {https://doi.org/10.1002/gps.4980} } @article{fields2012-21775876, author = {Fields, C. and Drye, L. and Vaidya, V. and Lyketsos, C. and {ADAPT Research Group}}, title = {{Celecoxib or naproxen treatment does not benefit depressive symptoms in persons age 70 and older: findings from a randomized controlled trial}}, journal = {The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry}, year = {2012}, doi = {10.1097/jgp.0b013e318227f4da}, pmid = {21775876}, url = {https://doi.org/10.1097/jgp.0b013e318227f4da} } @article{leoutsakos2012-21560159, author = {Leoutsakos, J. M. and Muthen, B. O. and Breitner, J. C. and Lyketsos, C. G. and {ADAPT Research Team}}, title = {{Effects of non-steroidal anti-inflammatory drug treatments on cognitive decline vary by phase of pre-clinical Alzheimer disease: findings from the randomized controlled Alzheimer's Disease Anti-inflammatory Prevention Trial}}, journal = {International journal of geriatric psychiatry}, year = {2012}, doi = {10.1002/gps.2723}, pmid = {21560159}, url = {https://doi.org/10.1002/gps.2723} } @article{ballard2008-18674411, author = {Ballard, C. and Sauter, M. and Scheltens, P. and He, Y. and Barkhof, F. and van Straaten, E. C. and van der Flier, W. M. and Hsu, C. and others}, title = {{Efficacy, safety and tolerability of rivastigmine capsules in patients with probable vascular dementia: the VantagE study}}, journal = {Current medical research and opinion}, year = {2008}, doi = {10.1185/03007990802328142}, pmid = {18674411}, url = {https://doi.org/10.1185/03007990802328142} } @article{hartin2016-27485822, author = {Hartin, P. J. and Nugent, C. D. and McClean, S. I. and Cleland, I. and Tschanz, J. T. and Clark, C. J. and Norton, M. C.}, title = {{The Empowering Role of Mobile Apps in Behavior Change Interventions: The Gray Matters Randomized Controlled Trial}}, journal = {JMIR mHealth and uHealth}, year = {2016}, doi = {10.2196/mhealth.4878}, pmid = {27485822}, url = {https://doi.org/10.2196/mhealth.4878} } @article{coelho2001-11405996, author = {Coelho, F. and Birks, J.}, title = {{Physostigmine for Alzheimer's disease}}, journal = {The Cochrane database of systematic reviews}, year = {2001}, doi = {10.1002/14651858.cd001499}, pmid = {11405996}, url = {https://doi.org/10.1002/14651858.cd001499} } @article{grill2024-37830926, author = {Grill, J. D. and Flournoy, C. and Dhadda, S. and Ernstrom, K. and Sperling, R. and Molina-Henry, D. and Tranotti, K. and Harris, R. and others}, title = {{Eligibility Rates among Racially and Ethnically Diverse US Participants in Phase 2 and Phase 3 Placebo-Controlled, Double-Blind, Randomized Trials of Lecanemab and Elenbecestat in Early Alzheimer Disease}}, journal = {Annals of neurology}, year = {2024}, doi = {10.1002/ana.26819}, pmid = {37830926}, url = {https://doi.org/10.1002/ana.26819} } @article{boespflug2018-28221821, author = {Boespflug, E. L. and Eliassen, J. C. and Dudley, J. A. and Shidler, M. D. and Kalt, W. and Summer, S. S. and Stein, A. L. and Stover, A. N. and others}, title = {{Enhanced neural activation with blueberry supplementation in mild cognitive impairment}}, journal = {Nutritional neuroscience}, year = {2018}, doi = {10.1080/1028415x.2017.1287833}, pmid = {28221821}, url = {https://doi.org/10.1080/1028415x.2017.1287833} } @article{reisberg2003-12672860, author = {Reisberg, B. and Doody, R. and Stöffler, A. and Schmitt, F. and Ferris, S. and Möbius, H. J. and {Memantine Study Group}}, title = {{Memantine in moderate-to-severe Alzheimer's disease}}, journal = {The New England journal of medicine}, year = {2003}, doi = {10.1056/nejmoa013128}, pmid = {12672860}, url = {https://doi.org/10.1056/nejmoa013128} } @article{johnson2013-23375563, author = {Johnson, K. A. and Sperling, R. A. and Gidicsin, C. M. and Carmasin, J. S. and Maye, J. E. and Coleman, R. E. and Reiman, E. M. and Sabbagh, M. N. and others}, title = {{Florbetapir (F18-AV-45) PET to assess amyloid burden in Alzheimer's disease dementia, mild cognitive impairment, and normal aging}}, journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association}, year = {2013}, doi = {10.1016/j.jalz.2012.10.007}, pmid = {23375563}, url = {https://doi.org/10.1016/j.jalz.2012.10.007} } @article{jack2008-17452062, author = {Jack, C. R. and Petersen, R. C. and Grundman, M. and Jin, S. and Gamst, A. and Ward, C. P. and Sencakova, D. and Doody, R. S. and others}, title = {{Longitudinal MRI findings from the vitamin E and donepezil treatment study for MCI}}, journal = {Neurobiology of aging}, year = {2008}, doi = {10.1016/j.neurobiolaging.2007.03.004}, pmid = {17452062}, url = {https://doi.org/10.1016/j.neurobiolaging.2007.03.004} } @article{endres2014-25344383, author = {Endres, K. and Fahrenholz, F. and Lotz, J. and Hiemke, C. and Teipel, S. and Lieb, K. and Tüscher, O. and Fellgiebel, A.}, title = {{Increased CSF APPs-α levels in patients with Alzheimer disease treated with acitretin}}, journal = {Neurology}, year = {2014}, doi = {10.1212/wnl.0000000000001017}, pmid = {25344383}, url = {https://doi.org/10.1212/wnl.0000000000001017} } @article{stein2011-21694461, author = {Stein, M. S. and Scherer, S. C. and Ladd, K. S. and Harrison, L. C.}, title = {{A randomized controlled trial of high-dose vitamin D2 followed by intranasal insulin in Alzheimer's disease}}, journal = {Journal of Alzheimer's disease : JAD}, year = {2011}, doi = {10.3233/jad-2011-110149}, pmid = {21694461}, url = {https://doi.org/10.3233/jad-2011-110149} } @article{mazza2006-16930364, author = {Mazza, M. and Capuano, A. and Bria, P. and Mazza, S.}, title = {{Ginkgo biloba and donepezil: a comparison in the treatment of Alzheimer's dementia in a randomized placebo-controlled double-blind study}}, journal = {European journal of neurology}, year = {2006}, doi = {10.1111/j.1468-1331.2006.01409.x}, pmid = {16930364}, url = {https://doi.org/10.1111/j.1468-1331.2006.01409.x} } @article{politis2004-15481065, author = {Politis, A. M. and Vozzella, S. and Mayer, L. S. and Onyike, C. U. and Baker, A. S. and Lyketsos, C. G.}, title = {{A randomized, controlled, clinical trial of activity therapy for apathy in patients with dementia residing in long-term care}}, journal = {International journal of geriatric psychiatry}, year = {2004}, doi = {10.1002/gps.1215}, pmid = {15481065}, url = {https://doi.org/10.1002/gps.1215} } @article{kurz2012-21986341, author = {Kurz, A. and Thöne-Otto, A. and Cramer, B. and Egert, S. and Frölich, L. and Gertz, H. J. and Kehl, V. and Wagenpfeil, S. and others}, title = {{CORDIAL: cognitive rehabilitation and cognitive-behavioral treatment for early dementia in Alzheimer disease: a multicenter, randomized, controlled trial}}, journal = {Alzheimer disease and associated disorders}, year = {2012}, doi = {10.1097/wad.0b013e318231e46e}, pmid = {21986341}, url = {https://doi.org/10.1097/wad.0b013e318231e46e} } @article{mittelman2008-18978250, author = {Mittelman, M. S. and Brodaty, H. and Wallen, A. S. and Burns, A.}, title = {{A three-country randomized controlled trial of a psychosocial intervention for caregivers combined with pharmacological treatment for patients with Alzheimer disease: effects on caregiver depression}}, journal = {The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry}, year = {2008}, doi = {10.1097/jgp.0b013e3181898095}, pmid = {18978250}, url = {https://doi.org/10.1097/jgp.0b013e3181898095} } @article{farlow2001-11255445, author = {Farlow, M. R. and Hake, A. and Messina, J. and Hartman, R. and Veach, J. and Anand, R.}, title = {{Response of patients with Alzheimer disease to rivastigmine treatment is predicted by the rate of disease progression}}, journal = {Archives of neurology}, year = {2001}, doi = {10.1001/archneur.58.3.417}, pmid = {11255445}, url = {https://doi.org/10.1001/archneur.58.3.417} } @article{stanley2013-23567399, author = {Stanley, M. A. and Calleo, J. and Bush, A. L. and Wilson, N. and Snow, A. L. and Kraus-Schuman, C. and Paukert, A. L. and Petersen, N. J. and others}, title = {{The peaceful mind program: a pilot test of a cognitive-behavioral therapy-based intervention for anxious patients with dementia}}, journal = {The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry}, year = {2013}, doi = {10.1016/j.jagp.2013.01.007}, pmid = {23567399}, url = {https://doi.org/10.1016/j.jagp.2013.01.007} } @article{roberts2012-22498844, author = {Roberts, J. S. and Chen, C. A. and Uhlmann, W. R. and Green, R. C.}, title = {{Effectiveness of a condensed protocol for disclosing APOE genotype and providing risk education for Alzheimer disease}}, journal = {Genetics in medicine : official journal of the American College of Medical Genetics}, year = {2012}, doi = {10.1038/gim.2012.37}, pmid = {22498844}, url = {https://doi.org/10.1038/gim.2012.37} } @article{sekikawa2025-40838083, author = {Sekikawa, A. and Wharton, W. and Murray-Krezan, C. and Wu, M. and Chang, Y. and Snitz, B. E. and Coccari, M. and Yang, S. and others}, title = {{ACE trial design: Equol targeting estrogen receptor-β in vascular and cognitive aging}}, journal = {Alzheimer's \& dementia (New York, N. Y.)}, year = {2025}, doi = {10.1002/trc2.70144}, pmid = {40838083}, url = {https://doi.org/10.1002/trc2.70144} } @article{szekely2004-15279021, author = {Szekely, C. A. and Thorne, J. E. and Zandi, P. P. and Ek, M. and Messias, E. and Breitner, J. C. and Goodman, S. N.}, title = {{Nonsteroidal anti-inflammatory drugs for the prevention of Alzheimer's disease: a systematic review}}, journal = {Neuroepidemiology}, year = {2004}, doi = {10.1159/000078501}, pmid = {15279021}, url = {https://doi.org/10.1159/000078501} } @article{zandi2002-12297571, author = {Zandi, P. P. and Anthony, J. C. and Hayden, K. M. and Mehta, K. and Mayer, L. and Breitner, J. C. and {Cache County Study Investigators}}, title = {{Reduced incidence of AD with NSAID but not H2 receptor antagonists: the Cache County Study}}, journal = {Neurology}, year = {2002}, doi = {10.1212/wnl.59.6.880}, pmid = {12297571}, url = {https://doi.org/10.1212/wnl.59.6.880} } @article{burns1999-10325453, author = {Burns, A. and Rossor, M. and Hecker, J. and Gauthier, S. and Petit, H. and Möller, H. J. and Rogers, S. L. and Friedhoff, L. T.}, title = {{The effects of donepezil in Alzheimer's disease - results from a multinational trial}}, journal = {Dementia and geriatric cognitive disorders}, year = {1999}, doi = {10.1159/000017126}, pmid = {10325453}, url = {https://doi.org/10.1159/000017126} } @article{rozzini2007-17117398, author = {Rozzini, L. and Costardi, D. and Chilovi, B. V. and Franzoni, S. and Trabucchi, M. and Padovani, A.}, title = {{Efficacy of cognitive rehabilitation in patients with mild cognitive impairment treated with cholinesterase inhibitors}}, journal = {International journal of geriatric psychiatry}, year = {2007}, doi = {10.1002/gps.1681}, pmid = {17117398}, url = {https://doi.org/10.1002/gps.1681} } @article{jeremic2025-40194268, author = {Jeremic, D. and Navarro-Lopez, J. D. and Jimenez-Diaz, L.}, title = {{Clinical Benefits and Risks of Antiamyloid Antibodies in Sporadic Alzheimer Disease: Systematic Review and Network Meta-Analysis With a Web Application}}, journal = {Journal of medical Internet research}, year = {2025}, doi = {10.2196/68454}, pmid = {40194268}, url = {https://doi.org/10.2196/68454} } @article{gibson2020-33074237, author = {Gibson, G. E. and Luchsinger, J. A. and Cirio, R. and Chen, H. and Franchino-Elder, J. and Hirsch, J. A. and Bettendorff, L. and Chen, Z. and others}, title = {{Benfotiamine and Cognitive Decline in Alzheimer's Disease: Results of a Randomized Placebo-Controlled Phase IIa Clinical Trial}}, journal = {Journal of Alzheimer's disease : JAD}, year = {2020}, doi = {10.3233/jad-200896}, pmid = {33074237}, url = {https://doi.org/10.3233/jad-200896} } @article{doody2014-24450890, author = {Doody, Rachelle Smith and Thomas, Ronald G. and Farlow, Martin Rhys and Iwatsubo, Takeshi and Vellas, Bruno J. and Joffe, Steven and Kieburtz, Karl D. and Raman, Rema and Sun, Xiaoying and Aisen, Paul S. S. and Siemers, Eric and Liu‐Seifert, Hong and Mohs, Richard C.}, title = {{Phase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's Disease}}, journal = {New England Journal of Medicine}, year = {2014}, doi = {10.1056/nejmoa1312889}, pmid = {24450890}, url = {https://doi.org/10.1056/nejmoa1312889} } @article{wilkinson2003-12939421, author = {Wilkinson, D. and Doody, R. and Helme, R. and Taubman, K. and Mintzer, J. and Kertesz, A. and Pratt, R. D. and {Donepezil 308 Study Group}}, title = {{Donepezil in vascular dementia: a randomized, placebo-controlled study}}, journal = {Neurology}, year = {2003}, doi = {10.1212/01.wnl.0000078943.50032.fc}, pmid = {12939421}, url = {https://doi.org/10.1212/01.wnl.0000078943.50032.fc} } @article{nakamura2024-39369280, author = {Nakamura, Y. and Adachi, J. and Hirota, N. and Iba, K. and Shimizu, K. and Nakai, M. and Takahashi, K. and Mori, N.}, title = {{Brexpiprazole treatment for agitation in Alzheimer's dementia: A randomized study}}, journal = {Alzheimer's \& Dementia}, year = {2024}, doi = {10.1002/alz.14282}, pmid = {39369280}, url = {https://doi.org/10.1002/alz.14282} } @article{nguyen2024-38484190, author = {Nguyen, H. V. and Mital, S. and Knopman, D. S. and Alexander, G. C.}, title = {{Cost-Effectiveness of Lecanemab for Individuals With Early-Stage Alzheimer Disease}}, journal = {Neurology}, year = {2024}, doi = {10.1212/WNL.0000000000209218}, pmid = {38484190}, url = {https://doi.org/10.1212/WNL.0000000000209218} } @article{havrengthery2024-38812028, author = {Havreng-Théry, C. and Oquendo, B. and Zolnowski-Kolp, V. and Krolak-Salmon, P. and Bertin-Hugault, F. and Lafuente-Lafuente, C. and Belmin, J.}, title = {{Cholinesterase inhibitors and memantine are associated with a reduced mortality in nursing home residents with dementia: a longitudinal observational study}}, journal = {Alzheimer's Research \& Therapy}, year = {2024}, doi = {10.1186/s13195-024-01481-0}, pmid = {38812028}, url = {https://doi.org/10.1186/s13195-024-01481-0} } @article{pilotto2009-19738170, author = {Pilotto, A. and Franceschi, M. and D'Onofrio, G. and Bizzarro, A. and Mangialasche, F. and Cascavilla, L. and Paris, F. and Matera, M. G. and others}, title = {{Effect of a CYP2D6 polymorphism on the efficacy of donepezil in patients with Alzheimer disease}}, journal = {Neurology}, year = {2009}, doi = {10.1212/wnl.0b013e3181b6bbe3}, pmid = {19738170}, url = {https://doi.org/10.1212/wnl.0b013e3181b6bbe3} } @article{aisen2003-12783912, author = {Aisen, P. S. and Schafer, K. A. and Grundman, M. and Pfeiffer, E. and Sano, M. and Davis, K. L. and Farlow, M. R. and Jin, S. and others}, title = {{Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized controlled trial}}, journal = {JAMA}, year = {2003}, doi = {10.1001/jama.289.21.2819}, pmid = {12783912}, url = {https://doi.org/10.1001/jama.289.21.2819} } @article{kanowski2003-14663654, author = {Kanowski, S. and Hoerr, R.}, title = {{Ginkgo biloba extract EGb 761 in dementia: intent-to-treat analyses of a 24-week, multi-center, double-blind, placebo-controlled, randomized trial}}, journal = {Pharmacopsychiatry}, year = {2003}, doi = {10.1055/s-2003-45117}, pmid = {14663654}, url = {https://doi.org/10.1055/s-2003-45117} } @article{yao2022-35700915, author = {Yao, Q. and Tang, F. and Wang, Y. and Yan, Y. and Dong, L. and Wang, T. and Zhu, D. and Tian, M. and others}, title = {{Effect of cerebellum stimulation on cognitive recovery in patients with Alzheimer disease: A randomized clinical trial}}, journal = {Brain stimulation}, year = {2022}, doi = {10.1016/j.brs.2022.06.004}, pmid = {35700915}, url = {https://doi.org/10.1016/j.brs.2022.06.004} } @article{kieburtz2010-20142523, author = {Kieburtz, K. and McDermott, M. P. and Voss, T. S. and Corey-Bloom, J. and Deuel, L. M. and Dorsey, E. R. and Factor, S. and Geschwind, M. D. and others}, title = {{A randomized, placebo-controlled trial of latrepirdine in Huntington disease}}, journal = {Archives of neurology}, year = {2010}, doi = {10.1001/archneurol.2009.334}, pmid = {20142523}, url = {https://doi.org/10.1001/archneurol.2009.334} } @article{raskind1997-9236571, author = {Raskind, M. A. and Sadowsky, C. H. and Sigmund, W. R. and Beitler, P. J. and Auster, S. B.}, title = {{Effect of tacrine on language, praxis, and noncognitive behavioral problems in Alzheimer disease}}, journal = {Archives of neurology}, year = {1997}, doi = {10.1001/archneur.1997.00550190026010}, pmid = {9236571}, url = {https://doi.org/10.1001/archneur.1997.00550190026010} } @article{karlawish2008-18310554, author = {Karlawish, J. and Kim, S. Y. and Knopman, D. and van Dyck, C. H. and James, B. D. and Marson, D.}, title = {{The views of Alzheimer disease patients and their study partners on proxy consent for clinical trial enrollment}}, journal = {The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry}, year = {2008}, doi = {10.1097/jgp.0b013e318162992d}, pmid = {18310554}, url = {https://doi.org/10.1097/jgp.0b013e318162992d} } @article{rockwood2007-17404193, author = {Rockwood, K. and Fay, S. and Jarrett, P. and Asp, E.}, title = {{Effect of galantamine on verbal repetition in AD: a secondary analysis of the VISTA trial}}, journal = {Neurology}, year = {2007}, doi = {10.1212/01.wnl.0000258661.61577.b7}, pmid = {17404193}, url = {https://doi.org/10.1212/01.wnl.0000258661.61577.b7} } @article{brody2016-27589523, author = {Brody, M. and Liu, E. and Di, J. and Lu, M. and Margolin, R. A. and Werth, J. L. and Booth, K. and Shadman, A. and others}, title = {{A Phase II, Randomized, Double-Blind, Placebo-Controlled Study of Safety, Pharmacokinetics, and Biomarker Results of Subcutaneous Bapineuzumab in Patients with mild to moderate Alzheimer's disease}}, journal = {Journal of Alzheimer's disease : JAD}, year = {2016}, doi = {10.3233/jad-160369}, pmid = {27589523}, url = {https://doi.org/10.3233/jad-160369} } @article{deheus2019-31088188, author = {de Heus, R. A. A. and Donders, R. and Santoso, A. M. M. and Olde Rikkert, M. G. M. and Lawlor, B. A. and Claassen, J. A. H. R. and {Nilvad Study Group}}, title = {{Blood Pressure Lowering With Nilvadipine in Patients With Mild-to-Moderate Alzheimer Disease Does Not Increase the Prevalence of Orthostatic Hypotension}}, journal = {Journal of the American Heart Association}, year = {2019}, doi = {10.1161/jaha.119.011938}, pmid = {31088188}, url = {https://doi.org/10.1161/jaha.119.011938} } @article{lee2024-38875437, author = {Lee, W. and Kim, M.}, title = {{Comparative study of choline alfoscerate as a combination therapy with donepezil: A mixed double-blind randomized controlled and open-label observation trial}}, journal = {Medicine}, year = {2024}, doi = {10.1097/md.0000000000038067}, pmid = {38875437}, url = {https://doi.org/10.1097/md.0000000000038067} } @article{jacobson2025-40844772, author = {Jacobson, M. and Molina-Henry, D. and Chang, T. Y. and Jimenez-Maggiora, G. A. and Pramanik, R. and Shah, S. B. and Aisen, P. S.}, title = {{Financial Incentives to Increase Diversity of Older Participants in a Memory Concerns Registry: A Randomized Clinical Trial}}, journal = {JAMA health forum}, year = {2025}, doi = {10.1001/jamahealthforum.2025.2273}, pmid = {40844772}, url = {https://doi.org/10.1001/jamahealthforum.2025.2273} } @article{cai2013-23183138, author = {Cai, X. and Campbell, N. and Khan, B. and Callahan, C. and Boustani, M.}, title = {{Long-term anticholinergic use and the aging brain}}, journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association}, year = {2013}, doi = {10.1016/j.jalz.2012.02.005}, pmid = {23183138}, url = {https://doi.org/10.1016/j.jalz.2012.02.005} } @article{iwasaki2005-15705012, author = {Iwasaki, K. and Satoh-Nakagawa, T. and Maruyama, M. and Monma, Y. and Nemoto, M. and Tomita, N. and Tanji, H. and Fujiwara, H. and others}, title = {{A randomized, observer-blind, controlled trial of the traditional Chinese medicine Yi-Gan San for improvement of behavioral and psychological symptoms and activities of daily living in dementia patients}}, journal = {The Journal of clinical psychiatry}, year = {2005}, doi = {10.4088/jcp.v66n0214}, pmid = {15705012}, url = {https://doi.org/10.4088/jcp.v66n0214} } @article{akhondzadeh2003-12605619, author = {Akhondzadeh, S. and Noroozian, M. and Mohammadi, M. and Ohadinia, S. and Jamshidi, A. H. and Khani, M.}, title = {{Salvia officinalis extract in the treatment of patients with mild to moderate Alzheimer's disease: a double blind, randomized and placebo-controlled trial}}, journal = {Journal of clinical pharmacy and therapeutics}, year = {2003}, doi = {10.1046/j.1365-2710.2003.00463.x}, pmid = {12605619}, url = {https://doi.org/10.1046/j.1365-2710.2003.00463.x} } @article{schneider2011-21220675, author = {Schneider, L. S. and Insel, P. S. and Weiner, M. W. and {Alzheimer's Disease Neuroimaging Initiative}}, title = {{Treatment with cholinesterase inhibitors and memantine of patients in the Alzheimer's Disease Neuroimaging Initiative}}, journal = {Archives of neurology}, year = {2011}, doi = {10.1001/archneurol.2010.343}, pmid = {21220675}, url = {https://doi.org/10.1001/archneurol.2010.343} } @article{tang2025-40193118, author = {Tang, Huilin and Donahoo, William Troy and DeKosky, Steven T. and Lee, Yao An and Kotecha, Pareeta and Svensson, Mikael A. and Bian, Jiang and Guo, Jingchuan Serena}, title = {{GLP-1RA and SGLT2i Medications for Type 2 Diabetes and Alzheimer Disease and Related Dementias}}, journal = {JAMA Neurology}, year = {2025}, doi = {10.1001/jamaneurol.2025.0353}, pmid = {40193118}, url = {https://doi.org/10.1001/jamaneurol.2025.0353} } @article{sano1997-9110909, author = {Sano, Mary and Ernesto, Christopher and Thomas, Ronald G. and Klauber, Melville R. and Schafer, Kimberly A and Grundman, Michael and Woodbury, Peter and Growdon, John H. and Cotman, Carl W. and Pfeiffer, Eric A. and Schneider, Lon S. and Thal, Leon J.}, title = {{A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study}}, journal = {New England Journal of Medicine}, year = {1997}, doi = {10.1056/nejm199704243361704}, pmid = {9110909}, url = {https://doi.org/10.1056/nejm199704243361704} } @article{rosenberg2025-41350162, author = {Rosenberg, P. B. and Amjad, H. and Burhanullah, H. and Nowrangi, M. and Vandrey, R. and Pierre, M. J. and Outen, J. D. and Schultz, M. and Marano, C. and Agronin, M. and others}, title = {{A Randomized Controlled Trial of the Safety and Efficacy of Dronabinol for Agitation in Alzheimer's Disease}}, journal = {The American Journal of Geriatric Psychiatry}, year = {2025}, doi = {10.1016/j.jagp.2025.10.011}, pmid = {41350162}, url = {https://doi.org/10.1016/j.jagp.2025.10.011} } @article{sparks2006-16866904, author = {Sparks, D. L. and Connor, D. J. and Sabbagh, M. N. and Petersen, R. B. and Lopez, J. and Browne, P.}, title = {{Circulating cholesterol levels, apolipoprotein E genotype and dementia severity influence the benefit of atorvastatin treatment in Alzheimer's disease: results of the Alzheimer's Disease Cholesterol-Lowering Treatment (ADCLT) trial}}, journal = {Acta neurologica Scandinavica. Supplementum}, year = {2006}, doi = {10.1111/j.1600-0404.2006.00690.x}, pmid = {16866904}, url = {https://doi.org/10.1111/j.1600-0404.2006.00690.x} } @article{landen2013-23334070, author = {Landen, J. W. and Zhao, Q. and Cohen, S. and Borrie, M. and Woodward, M. and Billing, C. B. and Bales, K. and Alvey, C. and others}, title = {{Safety and pharmacology of a single intravenous dose of ponezumab in subjects with mild-to-moderate Alzheimer disease: a phase I, randomized, placebo-controlled, double-blind, dose-escalation study}}, journal = {Clinical neuropharmacology}, year = {2013}, doi = {10.1097/wnf.0b013e31827db49b}, pmid = {23334070}, url = {https://doi.org/10.1097/wnf.0b013e31827db49b} } @article{gomezisla2008-18317243, author = {Gómez-Isla, T. and Blesa, R. and Boada, M. and Clarimón, J. and Del Ser, T. and Domenech, G. and Ferro, J. M. and Gómez-Ansón, B. and others}, title = {{A randomized, double-blind, placebo controlled-trial of triflusal in mild cognitive impairment: the TRIMCI study}}, journal = {Alzheimer disease and associated disorders}, year = {2008}, doi = {10.1097/wad.0b013e3181611024}, pmid = {18317243}, url = {https://doi.org/10.1097/wad.0b013e3181611024} } @article{dysken1992-1634705, author = {Dysken, M. W. and Mendels, J. and LeWitt, P. and Reisberg, B. and Pomara, N. and Wood, J. and Skare, S. and Fakouhi, J. D. and others}, title = {{Milacemide: a placebo-controlled study in senile dementia of the Alzheimer type}}, journal = {Journal of the American Geriatrics Society}, year = {1992}, doi = {10.1111/j.1532-5415.1992.tb02019.x}, pmid = {1634705}, url = {https://doi.org/10.1111/j.1532-5415.1992.tb02019.x} } @article{ballard2015-25523285, author = {Ballard, C. and Thomas, A. and Gerry, S. and Yu, L. M. and Aarsland, D. and Merritt, C. and Corbett, A. and Davison, C. and others}, title = {{A double-blind randomized placebo-controlled withdrawal trial comparing memantine and antipsychotics for the long-term treatment of function and neuropsychiatric symptoms in people with Alzheimer's disease (MAIN-AD)}}, journal = {Journal of the American Medical Directors Association}, year = {2015}, doi = {10.1016/j.jamda.2014.11.002}, pmid = {25523285}, url = {https://doi.org/10.1016/j.jamda.2014.11.002} } @article{woodworth2023-37831492, author = {Woodworth, E. C. and Briskin, E. A. and Plys, E. and Macklin, E. and Tatar, R. G. and Huberty, J. and Vranceanu, A. M.}, title = {{Mindfulness-Based App to Reduce Stress in Caregivers of Persons With Alzheimer Disease and Related Dementias: Protocol for a Single-Blind Feasibility Proof-of-Concept Randomized Controlled Trial}}, journal = {JMIR research protocols}, year = {2023}, doi = {10.2196/50108}, pmid = {37831492}, url = {https://doi.org/10.2196/50108} } @article{saleh2023-36624497, author = {Saleh, R. N. M. and Hornberger, M. and Ritchie, C. W. and Minihane, A. M.}, title = {{Hormone replacement therapy is associated with improved cognition and larger brain volumes in at-risk APOE4 women: results from the European Prevention of Alzheimer's Disease (EPAD) cohort}}, journal = {Alzheimer's research \& therapy}, year = {2023}, doi = {10.1186/s13195-022-01121-5}, pmid = {36624497}, url = {https://doi.org/10.1186/s13195-022-01121-5} } @article{akhondzadeh2010-20831681, author = {Akhondzadeh, S. and Sabet, M. S. and Harirchian, M. H. and Togha, M. and Cheraghmakani, H. and Razeghi, S. and SSh, Hejazi and Yousefi, M. H. and others}, title = {{Saffron in the treatment of patients with mild to moderate Alzheimer's disease: a 16-week, randomized and placebo-controlled trial}}, journal = {Journal of clinical pharmacy and therapeutics}, year = {2010}, doi = {10.1111/j.1365-2710.2009.01133.x}, pmid = {20831681}, url = {https://doi.org/10.1111/j.1365-2710.2009.01133.x} } @article{onder2005-16260821, author = {Onder, G. and Zanetti, O. and Giacobini, E. and Frisoni, G. B. and Bartorelli, L. and Carbone, G. and Lambertucci, P. and others}, title = {{Reality orientation therapy combined with cholinesterase inhibitors in Alzheimer's disease: randomised controlled trial}}, journal = {The British journal of psychiatry : the journal of mental science}, year = {2005}, doi = {10.1192/bjp.187.5.450}, pmid = {16260821}, url = {https://doi.org/10.1192/bjp.187.5.450} } @article{sevigny2016-27582220, author = {Sevigny, Jeff and Chiao, Ping and Bussière, Thierry and Weinreb, Paul H. and Williams, Leslie J. and Maier, Marcel and Dunstan, Robert W. and Salloway, Stephen and others}, title = {{The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease}}, journal = {Nature}, year = {2016}, doi = {10.1038/nature19323}, pmid = {27582220}, url = {https://doi.org/10.1038/nature19323} } @article{albertyn2025-40479610, author = {Albertyn, C. P. and Guu, T. W. and Chu, P. and Creese, B. and Young, A. and Velayudhan, L. and Bhattacharyya, S. and Jafari, H. and Kaur, S. and Kandangwa, P. and others}, title = {{Sativex (nabiximols) for the treatment of Agitation \& Aggression in Alzheimer's dementia in UK nursing homes: a randomised, double-blind, placebo-controlled feasibility trial}}, journal = {Age and Ageing}, year = {2025}, doi = {10.1093/ageing/afaf149}, pmid = {40479610}, url = {https://doi.org/10.1093/ageing/afaf149} } @article{lyketsos1999-10440971, author = {Lyketsos, C. G. and Lindell Veiel, L. and Baker, A. and Steele, C.}, title = {{A randomized, controlled trial of bright light therapy for agitated behaviors in dementia patients residing in long-term care}}, journal = {International journal of geriatric psychiatry}, year = {1999}, doi = {10.1002/(sici)1099-1166(199907)14:7<520::aid-gps983>3.0.co;2-m}, pmid = {10440971}, url = {https://doi.org/10.1002/(sici)1099-1166(199907)14:7<520::aid-gps983>3.0.co;2-m} } @article{kwok2011-21216507, author = {Kwok, T. and Lee, J. and Law, C. B. and Pan, P. C. and Yung, C. Y. and Choi, K. C. and Lam, L. C.}, title = {{A randomized placebo controlled trial of homocysteine lowering to reduce cognitive decline in older demented people}}, journal = {Clinical nutrition (Edinburgh, Scotland)}, year = {2011}, doi = {10.1016/j.clnu.2010.12.004}, pmid = {21216507}, url = {https://doi.org/10.1016/j.clnu.2010.12.004} } @article{carrie2012-22499458, author = {Carrié, I. and van Kan, G. A. and Gillette-Guyonnet, S. and Andrieu, S. and Dartigues, J. F. and Touchon, J. and Dantoine, T. and Rouaud, O. and others}, title = {{Recruitment strategies for preventive trials. The MAPT study (MultiDomain Alzheimer Preventive Trial)}}, journal = {The journal of nutrition, health \& aging}, year = {2012}, doi = {10.1007/s12603-012-0046-8}, pmid = {22499458}, url = {https://doi.org/10.1007/s12603-012-0046-8} } @article{roach2011-21937893, author = {Roach, K. E. and Tappen, R. M. and Kirk-Sanchez, N. and Williams, C. L. and Loewenstein, D.}, title = {{A randomized controlled trial of an activity specific exercise program for individuals with Alzheimer disease in long-term care settings}}, journal = {Journal of geriatric physical therapy (2001)}, year = {2011}, doi = {10.1519/jpt.0b013e31820aab9c}, pmid = {21937893}, url = {https://doi.org/10.1519/jpt.0b013e31820aab9c} } @article{mohs2009-19700948, author = {Mohs, R. C. and Shiovitz, T. M. and Tariot, P. N. and Porsteinsson, A. P. and Baker, K. D. and Feldman, P. D.}, title = {{Atomoxetine augmentation of cholinesterase inhibitor therapy in patients with Alzheimer disease: 6-month, randomized, double-blind, placebo-controlled, parallel-trial study}}, journal = {The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry}, year = {2009}, doi = {10.1097/jgp.0b013e3181aad585}, pmid = {19700948}, url = {https://doi.org/10.1097/jgp.0b013e3181aad585} } @article{feldman2006-17132971, author = {Feldman, H. H. and Schmitt, F. A. and Olin, J. T. and {Memantine MEM-MD-02 Study Group}}, title = {{Activities of daily living in moderate-to-severe Alzheimer disease: an analysis of the treatment effects of memantine in patients receiving stable donepezil treatment}}, journal = {Alzheimer disease and associated disorders}, year = {2006}, doi = {10.1097/01.wad.0000213859.35355.59}, pmid = {17132971}, url = {https://doi.org/10.1097/01.wad.0000213859.35355.59} } @article{brodaty2009-19705519, author = {Brodaty, H. and Mittelman, M. and Gibson, L. and Seeher, K. and Burns, A.}, title = {{The effects of counseling spouse caregivers of people with Alzheimer disease taking donepezil and of country of residence on rates of admission to nursing homes and mortality}}, journal = {The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry}, year = {2009}, doi = {10.1097/jgp.0b013e3181a65187}, pmid = {19705519}, url = {https://doi.org/10.1097/jgp.0b013e3181a65187} } @article{modrego2010-19874395, author = {Modrego, P. J. and Fayed, N. and Errea, J. M. and Rios, C. and Pina, M. A. and Sarasa, M.}, title = {{Memantine versus donepezil in mild to moderate Alzheimer's disease: a randomized trial with magnetic resonance spectroscopy}}, journal = {European journal of neurology}, year = {2010}, doi = {10.1111/j.1468-1331.2009.02816.x}, pmid = {19874395}, url = {https://doi.org/10.1111/j.1468-1331.2009.02816.x} } @article{egefjord2012-23158895, author = {Egefjord, L. and Gejl, M. and Møller, A. and Brændgaard, H. and Gottrup, H. and Antropova, O. and Møller, N. and Poulsen, H. E. and others}, title = {{Effects of liraglutide on neurodegeneration, blood flow and cognition in Alzheimer´s disease - protocol for a controlled, randomized double-blinded trial}}, journal = {Danish medical journal}, year = {2012}, pmid = {23158895} } @article{vandyck2006-16670247, author = {van Dyck, C. H. and Schmitt, F. A. and Olin, J. T. and {Memantine MEM-MD-02 Study Group}}, title = {{A responder analysis of memantine treatment in patients with Alzheimer disease maintained on donepezil}}, journal = {The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry}, year = {2006}, doi = {10.1097/01.jgp.0000203151.17311.38}, pmid = {16670247}, url = {https://doi.org/10.1097/01.jgp.0000203151.17311.38} } @article{pomara2007-17334274, author = {Pomara, N. and Ott, B. R. and Peskind, E. and Resnick, E. M.}, title = {{Memantine treatment of cognitive symptoms in mild to moderate Alzheimer disease: secondary analyses from a placebo-controlled randomized trial}}, journal = {Alzheimer disease and associated disorders}, year = {2007}, doi = {10.1097/wad.0b013e318032cf29}, pmid = {17334274}, url = {https://doi.org/10.1097/wad.0b013e318032cf29} } @article{lenz2015-25973909, author = {Lenz, R. A. and Pritchett, Y. L. and Berry, S. M. and Llano, D. A. and Han, S. and Berry, D. A. and Sadowsky, C. H. and Abi-Saab, W. M. and others}, title = {{Adaptive, dose-finding phase 2 trial evaluating the safety and efficacy of ABT-089 in mild to moderate Alzheimer disease}}, journal = {Alzheimer disease and associated disorders}, year = {2015}, doi = {10.1097/wad.0000000000000093}, pmid = {25973909}, url = {https://doi.org/10.1097/wad.0000000000000093} } @article{drye2013-23567407, author = {Drye, L. T. and Scherer, R. W. and Lanctôt, K. L. and Rosenberg, P. B. and Herrmann, N. and Bachman, D. and Mintzer, J. E. and {ADMET Research Group}}, title = {{Designing a trial to evaluate potential treatments for apathy in dementia: the apathy in dementia methylphenidate trial (ADMET)}}, journal = {The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry}, year = {2013}, doi = {10.1016/j.jagp.2012.12.018}, pmid = {23567407}, url = {https://doi.org/10.1016/j.jagp.2012.12.018} } @article{mohamed2012-21939611, author = {Mohamed, S. and Rosenheck, R. and Lyketsos, C. G. and Kaczynski, R. and Sultzer, D. L. and Schneider, L. S.}, title = {{Effect of second-generation antipsychotics on caregiver burden in Alzheimer's disease}}, journal = {The Journal of clinical psychiatry}, year = {2012}, doi = {10.4088/jcp.10m06574}, pmid = {21939611}, url = {https://doi.org/10.4088/jcp.10m06574} } @article{zuidersma2019-31084994, author = {Zuidersma, M. and Chua, K. C. and Hellier, J. and Voshaar, R. O. and Banerjee, S. and {HTA-SADD Investigator Group}}, title = {{Sertraline and Mirtazapine Versus Placebo in Subgroups of Depression in Dementia: Findings From the HTA-SADD Randomized Controlled Trial}}, journal = {The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry}, year = {2019}, doi = {10.1016/j.jagp.2019.03.021}, pmid = {31084994}, url = {https://doi.org/10.1016/j.jagp.2019.03.021} } @article{mioshi2006-16977673, author = {Mioshi, E. and Dawson, K. and Mitchell, J. and Arnold, R. and Hodges, JR.}, title = {{The Addenbrooke's Cognitive Examination Revised (ACE-R): a brief cognitive test battery for dementia screening}}, journal = {International journal of geriatric psychiatry}, year = {2006}, doi = {10.1002/gps.1610}, pmid = {16977673}, url = {https://doi.org/10.1002/gps.1610} } @article{wang2019-31488882, author = {Wang, X. and Sun, G. and Feng, T. and Zhang, J. and Huang, X. and Wang, T. and Xie, Z. and Chu, X. and others}, title = {{Sodium oligomannate therapeutically remodels gut microbiota and suppresses gut bacterial amino acids-shaped neuroinflammation to inhibit Alzheimer's disease progression}}, journal = {Cell research}, year = {2019}, doi = {10.1038/s41422-019-0216-x}, pmid = {31488882}, url = {https://doi.org/10.1038/s41422-019-0216-x} } @article{tariot2018-29955659, author = {Tariot, P. N. and Lopera, F. and Langbaum, J. B. and Thomas, R. G. and Hendrix, S. and Schneider, L. S. and Rios-Romenets, S. and Giraldo, M. and others}, title = {{The Alzheimer's Prevention Initiative Autosomal-Dominant Alzheimer's Disease Trial: A study of crenezumab versus placebo in preclinical PSEN1 E280A mutation carriers to evaluate efficacy and safety in the treatment of autosomal-dominant Alzheimer's disease, including a placebo-treated noncarrier cohort}}, journal = {Alzheimer's \& dementia (New York, N. Y.)}, year = {2018}, doi = {10.1016/j.trci.2018.02.002}, pmid = {29955659}, url = {https://doi.org/10.1016/j.trci.2018.02.002} } @article{loomis2024-38165296, author = {Loomis, S. J. and Miller, R. and Castrillo-Viguera, C. and Umans, K. and Cheng, W. and O'Gorman, J. and Hughes, R. and Budd Haeberlein, S. and others}, title = {{Genome-Wide Association Studies of ARIA From the Aducanumab Phase 3 ENGAGE and EMERGE Studies}}, journal = {Neurology}, year = {2024}, doi = {10.1212/wnl.0000000000207919}, pmid = {38165296}, url = {https://doi.org/10.1212/wnl.0000000000207919} } @article{mizukami2009-19079814, author = {Mizukami, K. and Asada, T. and Kinoshita, T. and Tanaka, K. and Sonohara, K. and Nakai, R. and Yamaguchi, K. and Hanyu, H. and others}, title = {{A randomized cross-over study of a traditional Japanese medicine (kampo), yokukansan, in the treatment of the behavioural and psychological symptoms of dementia}}, journal = {The international journal of neuropsychopharmacology}, year = {2009}, doi = {10.1017/s146114570800970x}, pmid = {19079814}, url = {https://doi.org/10.1017/s146114570800970x} } @article{knight2018-29734182, author = {Knight, R. and Khondoker, M. and Magill, N. and Stewart, R. and Landau, S.}, title = {{A Systematic Review and Meta-Analysis of the Effectiveness of Acetylcholinesterase Inhibitors and Memantine in Treating the Cognitive Symptoms of Dementia}}, journal = {Dementia and geriatric cognitive disorders}, year = {2018}, doi = {10.1159/000486546}, pmid = {29734182}, url = {https://doi.org/10.1159/000486546} } @article{heo2008-18684311, author = {Heo, J. H. and Lee, S. T. and Chu, K. and Oh, M. J. and Park, H. J. and Shim, J. Y. and Kim, M.}, title = {{An open-label trial of Korean red ginseng as an adjuvant treatment for cognitive impairment in patients with Alzheimer's disease}}, journal = {European journal of neurology}, year = {2008}, doi = {10.1111/j.1468-1331.2008.02157.x}, pmid = {18684311}, url = {https://doi.org/10.1111/j.1468-1331.2008.02157.x} } @article{lebars2000-10867450, author = {Le Bars, P. L. and Kieser, M. and Itil, K. Z.}, title = {{A 26-week analysis of a double-blind, placebo-controlled trial of the ginkgo biloba extract EGb 761 in dementia}}, journal = {Dementia and geriatric cognitive disorders}, year = {2000}, doi = {10.1159/000017242}, pmid = {10867450}, url = {https://doi.org/10.1159/000017242} } @article{mamas2025-40980721, author = {Mamas, Mamas A. and Bays, Harold Edward and Li, Runjia and Upadhyay, Navneet and Irani, Tanya and Şenyücel, Çağrı and Dunn, Julia P. and Liu‐Seifert, Hong}, title = {{Tirzepatide compared with semaglutide and 10-year cardiovascular disease risk reduction in obesity: post-hoc analysis of the SURMOUNT-5 trial}}, journal = {European Heart Journal Open}, year = {2025}, doi = {10.1093/ehjopen/oeaf117}, pmid = {40980721}, url = {https://doi.org/10.1093/ehjopen/oeaf117} } @article{pardini2015-25592742, author = {Pardini, M. and Serrati, C. and Guida, S. and Mattei, C. and Abate, L. and Massucco, D. and Sassos, D. and Amore, M. and others}, title = {{Souvenaid reduces behavioral deficits and improves social cognition skills in frontotemporal dementia: a proof-of-concept study}}, journal = {Neuro-degenerative diseases}, year = {2015}, doi = {10.1159/000369811}, pmid = {25592742}, url = {https://doi.org/10.1159/000369811} } @article{turner2020-32468646, author = {Turner, R. S. and Hebron, M. L. and Lawler, A. and Mundel, E. E. and Yusuf, N. and Starr, J. N. and Anjum, M. and Pagan, F. and others}, title = {{Nilotinib Effects on Safety, Tolerability, and Biomarkers in Alzheimer's Disease}}, journal = {Annals of neurology}, year = {2020}, doi = {10.1002/ana.25775}, pmid = {32468646}, url = {https://doi.org/10.1002/ana.25775} } @article{wu2025-41420258, author = {Wu, C. Y. and Alkabbani, W. and Shah, B. R. and Kapral, M. K. and Edwards, J. D. and Maxwell, C. J. and others}, title = {{Comparative dementia risk with GLP1 receptor agonists, SGLT2 inhibitors, or DPP4 inhibitors: a population-based cohort study}}, journal = {Alzheimer's Research \& Therapy}, year = {2025}, doi = {10.1186/s13195-025-01929-x}, pmid = {41420258}, url = {https://doi.org/10.1186/s13195-025-01929-x} } @article{hashimoto2005-15800138, author = {Hashimoto, M. and Kazui, H. and Matsumoto, K. and Nakano, Y. and Yasuda, M. and Mori, E.}, title = {{Does donepezil treatment slow the progression of hippocampal atrophy in patients with Alzheimer's disease?}}, journal = {The American journal of psychiatry}, year = {2005}, doi = {10.1176/appi.ajp.162.4.676}, pmid = {15800138}, url = {https://doi.org/10.1176/appi.ajp.162.4.676} } @article{agarwal2023-36889921, author = {Agarwal, P. and Leurgans, S. E. and Agrawal, S. and Aggarwal, N. T. and Cherian, L. J. and James, B. D. and Dhana, K. and others}, title = {{Association of Mediterranean-DASH Intervention for Neurodegenerative Delay and Mediterranean Diets With Alzheimer Disease Pathology}}, journal = {Neurology}, year = {2023}, doi = {10.1212/wnl.0000000000207176}, pmid = {36889921}, url = {https://doi.org/10.1212/wnl.0000000000207176} } @article{black2010-20505438, author = {Black, R. S. and Sperling, R. A. and Safirstein, B. and Motter, R. N. and Pallay, A. and Nichols, A. and Grundman, M.}, title = {{A single ascending dose study of bapineuzumab in patients with Alzheimer disease}}, journal = {Alzheimer disease and associated disorders}, year = {2010}, doi = {10.1097/wad.0b013e3181c53b00}, pmid = {20505438}, url = {https://doi.org/10.1097/wad.0b013e3181c53b00} } @article{maheredwards2011-20872778, author = {Maher-Edwards, G. and Dixon, R. and Hunter, J. and Gold, M. and Hopton, G. and Jacobs, G. and Williams, P.}, title = {{SB-742457 and donepezil in Alzheimer disease: a randomized, placebo-controlled study}}, journal = {International journal of geriatric psychiatry}, year = {2011}, doi = {10.1002/gps.2562}, pmid = {20872778}, url = {https://doi.org/10.1002/gps.2562} } @article{gu2021-34402024, author = {Gu, J. and Li, Z. and Chen, H. and Xu, X. and Li, Y. and Gui, Y.}, title = {{Neuroprotective Effect of Trans-Resveratrol in Mild to Moderate Alzheimer Disease: A Randomized, Double-Blind Trial}}, journal = {Neurology and therapy}, year = {2021}, doi = {10.1007/s40120-021-00271-2}, pmid = {34402024}, url = {https://doi.org/10.1007/s40120-021-00271-2} } @article{zhang2002-12181083, author = {Zhang, Z. and Wang, X. and Chen, Q. and Shu, L. and Wang, J. and Shan, G.}, title = {{[Clinical efficacy and safety of huperzine Alpha in treatment of mild to moderate Alzheimer disease, a placebo-controlled, double-blind, randomized trial]}}, journal = {Zhonghua yi xue za zhi}, year = {2002}, pmid = {12181083} } @article{mokhber2014-24955552, author = {Mokhber, N. and Abdollahian, E. and Soltanifar, A. and Samadi, R. and Saghebi, A. and Haghighi, M. B. and Azarpazhooh, A.}, title = {{Comparison of sertraline, venlafaxine and desipramine effects on depression, cognition and the daily living activities in Alzheimer patients}}, journal = {Pharmacopsychiatry}, year = {2014}, doi = {10.1055/s-0034-1377041}, pmid = {24955552}, url = {https://doi.org/10.1055/s-0034-1377041} } @article{lavretsky2010-20104071, author = {Lavretsky, H. and Siddarth, P. and Irwin, M. R.}, title = {{Improving depression and enhancing resilience in family dementia caregivers: a pilot randomized placebo-controlled trial of escitalopram}}, journal = {The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry}, year = {2010}, doi = {10.1097/jgp.0b013e3181beab1e}, pmid = {20104071}, url = {https://doi.org/10.1097/jgp.0b013e3181beab1e} } @article{regan2017-28034509, author = {Regan, B. and Wells, Y. and Farrow, M. and O'Halloran, P. and Workman, B.}, title = {{MAXCOG-Maximizing Cognition: A Randomized Controlled Trial of the Efficacy of Goal-Oriented Cognitive Rehabilitation for People with Mild Cognitive Impairment and Early Alzheimer Disease}}, journal = {The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry}, year = {2017}, doi = {10.1016/j.jagp.2016.11.008}, pmid = {28034509}, url = {https://doi.org/10.1016/j.jagp.2016.11.008} } @article{schmitt2006-17132970, author = {Schmitt, F. A. and van Dyck, C. H. and Wichems, C. H. and Olin, J. T. and {Memantine MEM-MD-02 Study Group}}, title = {{Cognitive response to memantine in moderate to severe Alzheimer disease patients already receiving donepezil: an exploratory reanalysis}}, journal = {Alzheimer disease and associated disorders}, year = {2006}, doi = {10.1097/01.wad.0000213860.35355.d4}, pmid = {17132970}, url = {https://doi.org/10.1097/01.wad.0000213860.35355.d4} } @article{jelcic2012-22460609, author = {Jelcic, N. and Cagnin, A. and Meneghello, F. and Turolla, A. and Ermani, M. and Dam, M.}, title = {{Effects of lexical-semantic treatment on memory in early Alzheimer disease: an observer-blinded randomized controlled trial}}, journal = {Neurorehabilitation and neural repair}, year = {2012}, doi = {10.1177/1545968312440146}, pmid = {22460609}, url = {https://doi.org/10.1177/1545968312440146} } @article{morillasruiz2010-20850133, author = {Morillas-Ruiz, J. M. and Rubio-Perez, J. M. and Albaladejo, M. D. and Zafrilla, P. and Parra, S. and Vidal-Guevara, M. L.}, title = {{Effect of an antioxidant drink on homocysteine levels in Alzheimer's patients}}, journal = {Journal of the neurological sciences}, year = {2010}, doi = {10.1016/j.jns.2010.08.050}, pmid = {20850133}, url = {https://doi.org/10.1016/j.jns.2010.08.050} } @article{papatsimpas2023-37509042, author = {Papatsimpas, V. and Vrouva, S. and Papathanasiou, G. and Papadopoulou, M. and Bouzineki, C. and Kanellopoulou, S. and Moutafi, D. and Bakalidou, D.}, title = {{Does Therapeutic Exercise Support Improvement in Cognitive Function and Instrumental Activities of Daily Living in Patients with Mild Alzheimer's Disease? A Randomized Controlled Trial}}, journal = {Brain sciences}, year = {2023}, doi = {10.3390/brainsci13071112}, pmid = {37509042}, url = {https://doi.org/10.3390/brainsci13071112} } @article{cheng2022-34843329, author = {Cheng, S. T. and Chan, W. C. and Fung, H. H. and Lam, L. C. W.}, title = {{Self-efficacy in controlling upsetting thoughts, but not positive gains, mediates the effects of benefit-finding group intervention for Alzheimer family caregivers}}, journal = {Psychology and aging}, year = {2022}, doi = {10.1037/pag0000654}, pmid = {34843329}, url = {https://doi.org/10.1037/pag0000654} } @article{silveira2025-40587145, author = {Silveira, C. R. A. and Coleman, K. K. L. and Borron, K. and Tirona, R. G. and Rupar, C. A. and Zou, G. and Hegele, R. A. and Wellington, C. and others}, title = {{Ambroxol as a Treatment for Parkinson Disease Dementia: A Randomized Clinical Trial}}, journal = {JAMA neurology}, year = {2025}, doi = {10.1001/jamaneurol.2025.1687}, pmid = {40587145}, url = {https://doi.org/10.1001/jamaneurol.2025.1687} } @article{flynnlongmire2014-24314887, author = {Flynn Longmire, C. V. and Drye, L. T. and Frangakis, C. E. and Martin, B. K. and Meinert, C. L. and Mintzer, J. E. and Munro, C. A. and Porsteinsson, A. P. and others}, title = {{Is sertraline treatment or depression remission in depressed Alzheimer patients associated with improved caregiver well being? Depression in Alzheimer's Disease Study 2}}, journal = {The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry}, year = {2014}, doi = {10.1016/j.jagp.2013.02.014}, pmid = {24314887}, url = {https://doi.org/10.1016/j.jagp.2013.02.014} } @article{morgan2000-11140686, author = {Morgan, D. and Diamond, D. M. and Gottschall, P. E. and Ugen, K. E. and Dickey, C. and Hardy, J. and Duff, K. and Jantzen, P. and others}, title = {{A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease}}, journal = {Nature}, year = {2000}, doi = {10.1038/35050116}, pmid = {11140686}, url = {https://doi.org/10.1038/35050116} } @article{volak2013-22725836, author = {Volak, L. P. and Hanley, M. J. and Masse, G. and Hazarika, S. and Harmatz, J. S. and Badmaev, V. and Majeed, M. and Greenblatt, D. J. and others}, title = {{Effect of a herbal extract containing curcumin and piperine on midazolam, flurbiprofen and paracetamol (acetaminophen) pharmacokinetics in healthy volunteers}}, journal = {British journal of clinical pharmacology}, year = {2013}, doi = {10.1111/j.1365-2125.2012.04364.x}, pmid = {22725836}, url = {https://doi.org/10.1111/j.1365-2125.2012.04364.x} } @article{sadhu2014-25316430, author = {Sadhu, A. and Upadhyay, P. and Agrawal, A. and Ilango, K. and Karmakar, D. and Singh, G. P. and Dubey, G. P.}, title = {{Management of cognitive determinants in senile dementia of Alzheimer's type: therapeutic potential of a novel polyherbal drug product}}, journal = {Clinical drug investigation}, year = {2014}, doi = {10.1007/s40261-014-0235-9}, pmid = {25316430}, url = {https://doi.org/10.1007/s40261-014-0235-9} } @article{miguelalvarez2015-25644018, author = {Miguel-Álvarez, M. and Santos-Lozano, A. and Sanchis-Gomar, F. and Fiuza-Luces, C. and Pareja-Galeano, H. and Garatachea, N. and Lucia, A.}, title = {{Non-steroidal anti-inflammatory drugs as a treatment for Alzheimer's disease: a systematic review and meta-analysis of treatment effect}}, journal = {Drugs \& aging}, year = {2015}, doi = {10.1007/s40266-015-0239-z}, pmid = {25644018}, url = {https://doi.org/10.1007/s40266-015-0239-z} } @article{homma2000-11044775, author = {Homma, A. and Takeda, M. and Imai, Y. and Udaka, F. and Hasegawa, K. and Kameyama, M. and Nishimura, T.}, title = {{Clinical efficacy and safety of donepezil on cognitive and global function in patients with Alzheimer's disease. A 24-week, multicenter, double-blind, placebo-controlled study in Japan. E2020 Study Group}}, journal = {Dementia and geriatric cognitive disorders}, year = {2000}, doi = {10.1159/000017259}, pmid = {11044775}, url = {https://doi.org/10.1159/000017259} } @article{abushakra2025-41015981, author = {Abushakra, Susan R. and Power, Aidan and Watson, David and Porsteinsson, Anton P. and Sabbagh, Marwan and MacSweeney, Emer and Cohen, Sharon and Boada, Merçé and others}, title = {{Clinical Efficacy, Safety and Imaging Effects of Oral Valiltramiprosate in APOEε4/ε4 Homozygotes with Early Alzheimer’s Disease: Results of the Phase III, Randomized, Double-Blind, Placebo-Controlled, 78-Week APOLLOE4 Trial}}, journal = {Drugs}, year = {2025}, doi = {10.1007/s40265-025-02250-5}, pmid = {41015981}, url = {https://doi.org/10.1007/s40265-025-02250-5} } @article{chen2025-40189473, author = {Chen, Christopher and Katayama, Sadao and Lee, Jae Hong and Lee, Jun-Young and Nakagawa, Masaki and Torii, Kentaro and Ogawa, Tomoo and Dash, Amitabh and others}, title = {{Clarity AD: Asian regional analysis of a phase III trial of lecanemab in early Alzheimer's disease}}, journal = {The Journal of Prevention of Alzheimer s Disease}, year = {2025}, doi = {10.1016/j.tjpad.2025.100160}, pmid = {40189473}, url = {https://doi.org/10.1016/j.tjpad.2025.100160} } @article{kehinde2025-40725274, author = {Kehinde, S. A. and Lin, W. P. and Lay, B. B. and Phyo, K. Y. and San, M. M. and Pattanayaiying, R. and Chusri, S.}, title = {{Curcumin and Dementia: A Systematic Review of Its Effects on Oxidative Stress and Cognitive Outcomes in Animal Models}}, journal = {International journal of molecular sciences}, year = {2025}, doi = {10.3390/ijms26147026}, pmid = {40725274}, url = {https://doi.org/10.3390/ijms26147026} } @article{kupiec2026-41500915, author = {Kupiec, J. W. and Porsteinsson, A. P. and Turner, R. S. and Hendrix, S. and Mallinckrodt, C. and Khan, A. and Cohen, I. and Liss, J. and others}, title = {{Phase 3 randomized clinical trials of simufilam in mild-to-moderate Alzheimer's disease}}, journal = {The journal of prevention of Alzheimer's disease}, year = {2026}, doi = {10.1016/j.tjpad.2025.100469}, pmid = {41500915}, url = {https://doi.org/10.1016/j.tjpad.2025.100469} } @article{karima2023-37248896, author = {Karima, S. and Aghamollaii, V. and Mahmoodi Baram, S. and Balenci, L. and Lanctôt, K. L. and Kiss, A. and Tafakhori, A. and Mahdavi, M. and others}, title = {{Boswellic Acids Improve Clinical Cognitive Scores and Reduce Systemic Inflammation in Patients with Mild to Moderate Alzheimer's Disease}}, journal = {Journal of Alzheimer's disease : JAD}, year = {2023}, doi = {10.3233/jad-221026}, pmid = {37248896}, url = {https://doi.org/10.3233/jad-221026} } @article{doody2013-23883379, author = {Doody, Rachelle Smith and Raman, Rema and Farlow, Martin Rhys and Iwatsubo, Takeshi and Vellas, Bruno J. and Joffe, Steven and Kieburtz, Karl D. and He, Feng and Sun, Xiaoying and Thomas, Ronald G. and Aisen, Paul S. S. and Siemers, Eric and Sethuraman, Gopalan and Mohs, Richard C.}, title = {{A Phase 3 Trial of Semagacestat for Treatment of Alzheimer's Disease}}, journal = {New England Journal of Medicine}, year = {2013}, doi = {10.1056/nejmoa1210951}, pmid = {23883379}, url = {https://doi.org/10.1056/nejmoa1210951} } @article{bianchi2026-42613673, author = {Bianchi, Federica and Broers, Barbara and Desmeules, Jules Alexandre and Langlois, Angeline and Wampfler, James and Curtin, François and Pautex, Sophie}, title = {{A randomised, double-blind, placebo-controlled crossover trial on cannabinoid-based medication for behavioural disorders in old patients with severe dementia: the study results}}, journal = {Age and ageing}, year = {2026}, doi = {10.1093/ageing/afag239}, pmid = {42613673}, url = {https://doi.org/10.1093/ageing/afag239} } @article{portron2020-31883703, author = {Portron, A. and Jordan, P. and Draper, K. and Muenzer, C. and Dickerson, D. and van Iersel, T. and Hofmann, C.}, title = {{A Phase I Study to Assess the Effect of Speed of Injection on Pain, Tolerability, and Pharmacokinetics After High-volume Subcutaneous Administration of Gantenerumab in Healthy Volunteers}}, journal = {Clinical therapeutics}, year = {2020}, doi = {10.1016/j.clinthera.2019.11.015}, pmid = {31883703}, url = {https://doi.org/10.1016/j.clinthera.2019.11.015} } @article{panisset2002-12111446, author = {Panisset, M. and Gauthier, S. and Moessler, H. and Windisch, M. and {Cerebrolysin Study Group}}, title = {{Cerebrolysin in Alzheimer's disease: a randomized, double-blind, placebo-controlled trial with a neurotrophic agent}}, journal = {Journal of neural transmission (Vienna, Austria : 1996)}, year = {2002}, doi = {10.1007/s007020200092}, pmid = {12111446}, url = {https://doi.org/10.1007/s007020200092} } @article{olazaran2014-24898637, author = {Olazarán, J. and González, B. and Osa-Ruiz, E. and Felipe-Ruiz, S. and Boyano, I. and Fontani, V. and Castagna, A. and Mendoza, C. and others}, title = {{Motor effects of radio electric asymmetric conveyer in Alzheimer's disease: results from a cross-over trial}}, journal = {Journal of Alzheimer's disease : JAD}, year = {2014}, doi = {10.3233/jad-140417}, pmid = {24898637}, url = {https://doi.org/10.3233/jad-140417} } @article{lin2025-40405827, author = {Lin, C. H. and Wang, S. H. and Lane, H. Y.}, title = {{Sodium benzoate, a D-amino acid oxidase inhibitor, improved short-term memory in patients with mild cognitive impairment in a randomized, double-blind, placebo-controlled clinical trial}}, journal = {Psychiatry and clinical neurosciences}, year = {2025}, doi = {10.1111/pcn.13841}, pmid = {40405827}, url = {https://doi.org/10.1111/pcn.13841} } @article{ghorat2024-38069542, author = {Ghorat, F. and Sepidarkish, M. and Saadattalab, F. and Rezghi, M. and Shahrestani, S. and Gholamalizadeh, M. and Doaei, S.}, title = {{The clinical efficacy of Olibanum gum chewing in patients with Mild-to-Moderate Alzheimer disease: A randomized Parallel-Design controlled trial}}, journal = {Neuropsychopharmacology reports}, year = {2024}, doi = {10.1002/npr2.12398}, pmid = {38069542}, url = {https://doi.org/10.1002/npr2.12398} } @article{yaffe2005-15800139, author = {Yaffe, K. and Krueger, K. and Cummings, SR. and Blackwell, T. and Henderson, V. W. and Sarkar, S. and Ensrud, K. and Grady, D.}, title = {{Effect of raloxifene on prevention of dementia and cognitive impairment in older women: the Multiple Outcomes of Raloxifene Evaluation (MORE) randomized trial}}, journal = {The American journal of psychiatry}, year = {2005}, doi = {10.1176/appi.ajp.162.4.683}, pmid = {15800139}, url = {https://doi.org/10.1176/appi.ajp.162.4.683} } @article{andersen2011-21970467, author = {Andersen, F. and Viitanen, M. and Halvorsen, D. S. and Straume, B. and Engstad, T. A.}, title = {{Co-morbidity and drug treatment in Alzheimer's disease. A cross sectional study of participants in the dementia study in northern Norway}}, journal = {BMC geriatrics}, year = {2011}, doi = {10.1186/1471-2318-11-58}, pmid = {21970467}, url = {https://doi.org/10.1186/1471-2318-11-58} } @article{koch2025-40176122, author = {Koch, Giacomo and Casula, Elias Paolo and Bonnı̀, Sonia and Borghi, Ilaria and Assogna, Martina and Di Lorenzo, Francesco and Esposito, Romina and Maiella, Michele and others}, title = {{Effects of 52 weeks of precuneus rTMS in Alzheimer’s disease patients: a randomized trial}}, journal = {Alzheimer s Research \& Therapy}, year = {2025}, doi = {10.1186/s13195-025-01709-7}, pmid = {40176122}, url = {https://doi.org/10.1186/s13195-025-01709-7} } @article{krishnan2009-19370677, author = {Krishnan, S. and Cairns, R. and Howard, R.}, title = {{Cannabinoids for the treatment of dementia}}, journal = {The Cochrane database of systematic reviews}, year = {2009}, doi = {10.1002/14651858.cd007204.pub2}, pmid = {19370677}, url = {https://doi.org/10.1002/14651858.cd007204.pub2} } @article{rowe2015-25567553, author = {Rowe, A. R. and Mercer, L. and Casetti, V. and Sendt, K. V. and Giaroli, G. and Shergill, S. S. and Tracy, D. K.}, title = {{Dementia praecox redux: a systematic review of the nicotinic receptor as a target for cognitive symptoms of schizophrenia}}, journal = {Journal of psychopharmacology (Oxford, England)}, year = {2015}, doi = {10.1177/0269881114564096}, pmid = {25567553}, url = {https://doi.org/10.1177/0269881114564096} } @article{roman2010-20395618, author = {Román, G. C. and Salloway, S. and Black, S. E. and Royall, D. R. and Decarli, C. and Weiner, M. W. and Moline, M. and Kumar, D. and others}, title = {{Randomized, placebo-controlled, clinical trial of donepezil in vascular dementia: differential effects by hippocampal size}}, journal = {Stroke}, year = {2010}, doi = {10.1161/strokeaha.109.570077}, pmid = {20395618}, url = {https://doi.org/10.1161/strokeaha.109.570077} } @article{cott2002-12040303, author = {Cott, C. A. and Dawson, P. and Sidani, S. and Wells, D.}, title = {{The effects of a walking/talking program on communication, ambulation, and functional status in residents with Alzheimer disease}}, journal = {Alzheimer disease and associated disorders}, year = {2002}, doi = {10.1097/00002093-200204000-00005}, pmid = {12040303}, url = {https://doi.org/10.1097/00002093-200204000-00005} } @article{sparks2005-15974900, author = {Sparks, D. L. and Sabbagh, M. N. and Connor, D. J. and Lopez, J. and Launer, L. J. and Petanceska, S. and Browne, P. and Wassar, D. and others}, title = {{Atorvastatin therapy lowers circulating cholesterol but not free radical activity in advance of identifiable clinical benefit in the treatment of mild-to-moderate AD}}, journal = {Current Alzheimer research}, year = {2005}, doi = {10.2174/1567205054367900}, pmid = {15974900}, url = {https://doi.org/10.2174/1567205054367900} } @article{sano1996-8876776, author = {Sano, M. and Ernesto, C. and Klauber, M. R. and Schafer, K. and Woodbury, P. and Thomas, R. and Grundman, M. and Growdon, J. and others}, title = {{Rationale and design of a multicenter study of selegiline and alpha-tocopherol in the treatment of Alzheimer disease using novel clinical outcomes. Alzheimer's Disease Cooperative Study}}, journal = {Alzheimer disease and associated disorders}, year = {1996}, doi = {10.1097/00002093-199601030-00004}, pmid = {8876776}, url = {https://doi.org/10.1097/00002093-199601030-00004} } @article{wang2013-23948786, author = {Wang, T. and Huang, Q. and Reiman, E. M. and Chen, K. and Li, X. and Li, G. and Lin, Z. and Li, C. and others}, title = {{Effects of memantine on clinical ratings, fluorodeoxyglucose positron emission tomography measurements, and cerebrospinal fluid assays in patients with moderate to severe Alzheimer dementia: a 24-week, randomized, clinical trial}}, journal = {Journal of clinical psychopharmacology}, year = {2013}, doi = {10.1097/jcp.0b013e31829a876a}, pmid = {23948786}, url = {https://doi.org/10.1097/jcp.0b013e31829a876a} } @article{fitzgerald2008-18541979, author = {FitzGerald, D. B. and Crucian, G. P. and Mielke, J. B. and Shenal, B. V. and Burks, D. and Womack, K. B. and Ghacibeh, G. and Drago, V. and others}, title = {{Effects of donepezil on verbal memory after semantic processing in healthy older adults}}, journal = {Cognitive and behavioral neurology : official journal of the Society for Behavioral and Cognitive Neurology}, year = {2008}, doi = {10.1097/wnn.0b013e3181799df1}, pmid = {18541979}, url = {https://doi.org/10.1097/wnn.0b013e3181799df1} } @article{jones2009-19561444, author = {Jones, R. W. and Schwam, E. and Wilkinson, D. and Waldemar, G. and Feldman, H. H. and Zhang, R. and Albert, K. and Schindler, R.}, title = {{Rates of cognitive change in Alzheimer disease: observations across a decade of placebo-controlled clinical trials with donepezil}}, journal = {Alzheimer disease and associated disorders}, year = {2009}, doi = {10.1097/wad.0b013e31819cd4be}, pmid = {19561444}, url = {https://doi.org/10.1097/wad.0b013e31819cd4be} } @article{jyvakorpi2012-22624652, author = {Jyvakorpi, S. K. and Puranen, T. and Pitkala, K. H. and Suominen, M. H.}, title = {{Nutritional treatment of aged individuals with Alzheimer disease living at home with their spouses: study protocol for a randomized controlled trial}}, journal = {Trials}, year = {2012}, doi = {10.1186/1745-6215-13-66}, pmid = {22624652}, url = {https://doi.org/10.1186/1745-6215-13-66} } @article{chhetri2018-29405230, author = {Chhetri, J. K. and de Souto Barreto, P. and Cantet, C. and Cesari, M. and Coley, N. and Andrieu, S. and Vellas, B.}, title = {{Trajectory of the MAPT-PACC-Preclinical Alzheimer Cognitive Composite in the Placebo Group of a Randomized Control Trial: Results from the MAPT Study: Lessons for Further Trials}}, journal = {The journal of prevention of Alzheimer's disease}, year = {2018}, doi = {10.14283/jpad.2017.21}, pmid = {29405230}, url = {https://doi.org/10.14283/jpad.2017.21} } @article{caramelli2014-24964105, author = {Caramelli, P. and Laks, J. and Palmini, A. L. and Nitrini, R. and Chaves, M. L. and Forlenza, O. V. and Vale Fde, A. and Barbosa, M. T. and others}, title = {{Effects of galantamine and galantamine combined with nimodipine on cognitive speed and quality of life in mixed dementia: a 24-week, randomized, placebo-controlled exploratory trial (the REMIX study)}}, journal = {Arquivos de neuro-psiquiatria}, year = {2014}, doi = {10.1590/0004-282x20140055}, pmid = {24964105}, url = {https://doi.org/10.1590/0004-282x20140055} } @article{devanand2012-21407047, author = {Devanand, D. P. and Mintzer, J. and Schultz, S. and Sultzer, D. and de la Pena, D. and Gupta, S. and Colon, S. and Schimming, C. and others}, title = {{The antipsychotic discontinuation in Alzheimer disease trial: clinical rationale and study design}}, journal = {The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry}, year = {2012}, doi = {10.1097/jgp.0b013e3182110563}, pmid = {21407047}, url = {https://doi.org/10.1097/jgp.0b013e3182110563} } @article{maltais2019-30817982, author = {Maltais, M. and de Souto Barreto, P. and Pothier, K. and Cantet, C. and Andrieu, S. and Rolland, Y. and Vellas, B. and {MAPT/DSA Study Group}}, title = {{Lifestyle multidomain intervention, omega-3 supplementation, or both for reducing the risk of developing clinically relevant depressive symptoms in older adults with memory complaints? Secondary analysis from the MAPT trial}}, journal = {Experimental gerontology}, year = {2019}, doi = {10.1016/j.exger.2019.02.010}, pmid = {30817982}, url = {https://doi.org/10.1016/j.exger.2019.02.010} } @article{han2025-40159989, author = {Han, X. and Gong, S. and Gong, J. and Wang, P. and Li, R. and Chen, R. and Xu, C. and Sun, W. and others}, title = {{Structural and metabolic topological alterations associated with butylphthalide treatment in mild cognitive impairment: Data from a randomized, double-blind, placebo-controlled trial}}, journal = {Psychiatry and clinical neurosciences}, year = {2025}, doi = {10.1111/pcn.13812}, pmid = {40159989}, url = {https://doi.org/10.1111/pcn.13812} } @article{zandi2002-12413371, author = {Zandi, P. P. and Carlson, M. C. and Plassman, B. L. and Welsh-Bohmer, K. A. and Mayer, L. S. and Steffens, D. C. and Breitner, J. C. and {Cache County Memory Study Investigators}}, title = {{Hormone replacement therapy and incidence of Alzheimer disease in older women: the Cache County Study}}, journal = {JAMA}, year = {2002}, doi = {10.1001/jama.288.17.2123}, pmid = {12413371}, url = {https://doi.org/10.1001/jama.288.17.2123} } @article{doraiswamy2014-24614494, author = {Doraiswamy, P. M. and Sperling, R. A. and Johnson, K. and Reiman, E. M. and Wong, T. Z. and Sabbagh, M. N. and Sadowsky, C. H. and Fleisher, A. S. and others}, title = {{Florbetapir F 18 amyloid PET and 36-month cognitive decline: a prospective multicenter study}}, journal = {Molecular psychiatry}, year = {2014}, doi = {10.1038/mp.2014.9}, pmid = {24614494}, url = {https://doi.org/10.1038/mp.2014.9} } @article{yeon2025-40696527, author = {Yeon, Jeon So and Sheng-Min, Wang and Woong, Roh Hyun and You, Kim Keun and Young, Chang Yoon and Eosu, Kim and Jae-Nam, Bae and Seung-Ho, Ryu}, title = {{Practical Guide of the Korean Association for Geriatric Psychiatry to Anti-Amyloid Monoclonal Antibody Therapy for Alzheimer's Disease: Focused on Lecanemab}}, journal = {Journal of Korean medical science}, year = {2025}, doi = {10.3346/jkms.2025.40.e215}, pmid = {40696527}, url = {https://doi.org/10.3346/jkms.2025.40.e215} } @article{baker2003-12611754, author = {Baker, L. D. and Sambamurti, K. and Craft, S. and Cherrier, M. and Raskind, M. A. and Stanczyk, F. Z. and Plymate, SR. and Asthana, S.}, title = {{17beta-estradiol reduces plasma Abeta40 for HRT-naïve postmenopausal women with Alzheimer disease: a preliminary study}}, journal = {The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry}, year = {2003}, doi = {10.1097/00019442-200303000-00015}, pmid = {12611754}, url = {https://doi.org/10.1097/00019442-200303000-00015} } @article{haroon2024-39058809, author = {Haroon, J. and Jordan, K. and Mahdavi, K. and Rindner, E. and Becerra, S. and Surya, JR. and Zielinski, M. and Venkatraman, V. and others}, title = {{A phase 2, open-label study of anti-inflammatory NE3107 in patients with dementias}}, journal = {Medicine}, year = {2024}, doi = {10.1097/md.0000000000039027}, pmid = {39058809}, url = {https://doi.org/10.1097/md.0000000000039027} } @article{orgogozo2003-12847155, author = {Orgogozo, Jean Marc and Gilman, Sid and Dartigues, Jean‐François and Laurent, Bernard and Puel, Michèle and Kirby, Lachlan and Jouanny, P. and Dubois, Bruno and Eisner, L. and Flitman, Stephen S. and Michel, Bernard‐François and Boada, Merçé and Frank, Ana and Hock, C.}, title = {{Subacute meningoencephalitis in a subset of patients with AD after Aβ42 immunization}}, journal = {Neurology}, year = {2003}, doi = {10.1212/01.wnl.0000073623.84147.a8}, pmid = {12847155}, url = {https://doi.org/10.1212/01.wnl.0000073623.84147.a8} } @article{lyketsos2003-12860778, author = {Lyketsos, C. G. and DelCampo, L. and Steinberg, M. and Miles, Q. and Steele, C. D. and Munro, C. and Baker, A. S. and Sheppard, J. M. and others}, title = {{Treating depression in Alzheimer disease: efficacy and safety of sertraline therapy, and the benefits of depression reduction: the DIADS}}, journal = {Archives of general psychiatry}, year = {2003}, doi = {10.1001/archpsyc.60.7.737}, pmid = {12860778}, url = {https://doi.org/10.1001/archpsyc.60.7.737} } @article{seltzer2004-15596605, author = {Seltzer, B. and Zolnouni, P. and Nunez, M. and Goldman, R. and Kumar, D. and Ieni, J. and Richardson, S. and {Donepezil "402" Study Group}}, title = {{Efficacy of donepezil in early-stage Alzheimer disease: a randomized placebo-controlled trial}}, journal = {Archives of neurology}, year = {2004}, doi = {10.1001/archneur.61.12.1852}, pmid = {15596605}, url = {https://doi.org/10.1001/archneur.61.12.1852} } @article{leoutsakos2018-29914028, author = {Leoutsakos, J. S. and Yan, H. and Anderson, W. S. and Asaad, W. F. and Baltuch, G. and Burke, A. and Chakravarty, M. M. and Drake, K. E. and others}, title = {{Deep Brain Stimulation Targeting the Fornix for Mild Alzheimer Dementia (the ADvance Trial): A Two Year Follow-up Including Results of Delayed Activation}}, journal = {Journal of Alzheimer's disease : JAD}, year = {2018}, doi = {10.3233/jad-180121}, pmid = {29914028}, url = {https://doi.org/10.3233/jad-180121} } @article{sparks2002-12474023, author = {Sparks, D. L. and Connor, D. J. and Browne, P. J. and Lopez, J. E. and Sabbagh, M. N.}, title = {{HMG-CoA reductase inhibitors (statins) in the treatment of Alzheimer's disease and why it would be ill-advise to use one that crosses the blood-brain barrier}}, journal = {The journal of nutrition, health \& aging}, year = {2002}, pmid = {12474023} } @article{fleischhacker1986-3517967, author = {Fleischhacker, W. W. and Buchgeher, A. and Schubert, H.}, title = {{Memantine in the treatment of senile dementia of the Alzheimer type}}, journal = {Progress in neuro-psychopharmacology \& biological psychiatry}, year = {1986}, doi = {10.1016/0278-5846(86)90047-3}, pmid = {3517967}, url = {https://doi.org/10.1016/0278-5846(86)90047-3} } @article{burke1993-8227897, author = {Burke, W. J. and Roccaforte, W. H. and Wengel, S. P. and Bayer, B. L. and Ranno, A. E. and Willcockson, N. K.}, title = {{L-deprenyl in the treatment of mild dementia of the Alzheimer type: results of a 15-month trial}}, journal = {Journal of the American Geriatrics Society}, year = {1993}, doi = {10.1111/j.1532-5415.1993.tb07306.x}, pmid = {8227897}, url = {https://doi.org/10.1111/j.1532-5415.1993.tb07306.x} } @article{andrade2022-35339351, author = {Andrade, S. M. and Machado, D. G. D. S. and Silva-Sauerc, L. D. and Regis, C. T. and Mendes, C. K. T. T. and de Araújo, J. S. S. and de Araújo, K. D. T. and Costa, L. P. and others}, title = {{Effects of multisite anodal transcranial direct current stimulation combined with cognitive stimulation in patients with Alzheimer's disease and its neurophysiological correlates: A double-blind randomized clinical trial}}, journal = {Neurophysiologie clinique = Clinical neurophysiology}, year = {2022}, doi = {10.1016/j.neucli.2022.02.003}, pmid = {35339351}, url = {https://doi.org/10.1016/j.neucli.2022.02.003} } @article{haase1996-8974721, author = {Haase, J. and Halama, P. and Hörr, R.}, title = {{[Effectiveness of brief infusions with Ginkgo biloba Special Extract EGb 761 in dementia of the vascular and Alzheimer type]}}, journal = {Zeitschrift fur Gerontologie und Geriatrie}, year = {1996}, pmid = {8974721} } @article{ollat2007-17675917, author = {Ollat, H. and Laurent, B. and Bakchine, S. and Michel, B. F. and Touchon, J. and Dubois, B.}, title = {{[Effects of the association of sulbutiamine with an acetylcholinesterase inhibitor in early stage and moderate Alzheimer disease]}}, journal = {L'Encephale}, year = {2007}, doi = {10.1016/s0013-7006(07)91552-3}, pmid = {17675917}, url = {https://doi.org/10.1016/s0013-7006(07)91552-3} } @article{carlson2002-11882746, author = {Carlson, M. C. and Tschanz, J. T. and Norton, M. C. and Welsh-Bohmer, K. and Martin, B. K. and Breitner, J. C.}, title = {{H2 histamine receptor blockade in the treatment of Alzheimer disease: a randomized, double-blind, placebo-controlled trial of nizatidine}}, journal = {Alzheimer disease and associated disorders}, year = {2002}, doi = {10.1097/00002093-200201000-00004}, pmid = {11882746}, url = {https://doi.org/10.1097/00002093-200201000-00004} } @article{almaraz2009-19590387, author = {Almaraz, A. C. and Driver-Dunckley, E. D. and Woodruff, B. K. and Wellik, K. E. and Caselli, R. J. and Demaerschalk, B. M. and Adler, C. H. and Caviness, J. N. and others}, title = {{Efficacy of rivastigmine for cognitive symptoms in Parkinson disease with dementia}}, journal = {The neurologist}, year = {2009}, doi = {10.1097/nrl.0b013e3181a968df}, pmid = {19590387}, url = {https://doi.org/10.1097/nrl.0b013e3181a968df} } @article{scholz2018-30333067, author = {Scholz, R. and Lemcke, J. and Meier, U. and Stengel, D.}, title = {{Efficacy and safety of programmable compared with fixed anti-siphon devices for treating idiopathic normal-pressure hydrocephalus (iNPH) in adults - SYGRAVA: study protocol for a randomized trial}}, journal = {Trials}, year = {2018}, doi = {10.1186/s13063-018-2951-6}, pmid = {30333067}, url = {https://doi.org/10.1186/s13063-018-2951-6} } @article{benedetti2006-16473462, author = {Benedetti, F. and Arduino, C. and Costa, S. and Vighetti, S. and Tarenzi, L. and Rainero, I. and Asteggiano, G.}, title = {{Loss of expectation-related mechanisms in Alzheimer's disease makes analgesic therapies less effective}}, journal = {Pain}, year = {2006}, doi = {10.1016/j.pain.2005.12.016}, pmid = {16473462}, url = {https://doi.org/10.1016/j.pain.2005.12.016} } @article{silveira2019-30738426, author = {Silveira, C. R. A. and MacKinley, J. and Coleman, K. and Li, Z. and Finger, E. and Bartha, R. and Morrow, S. A. and Wells, J. and others}, title = {{Ambroxol as a novel disease-modifying treatment for Parkinson's disease dementia: protocol for a single-centre, randomized, double-blind, placebo-controlled trial}}, journal = {BMC neurology}, year = {2019}, doi = {10.1186/s12883-019-1252-3}, pmid = {30738426}, url = {https://doi.org/10.1186/s12883-019-1252-3} } @article{vangils2026-41508135, author = {van Gils, Veerle and Waterink, Lisa and Wimmers, S. C. P. M. and Jelsma, J.G.M. and de Vugt, Marjolein Elizabeth and Handels, Ron L. H. and Sikkes, Sietske A.M. and van der Flier, Wiesje M. and others}, title = {{The Lifestyle Intervention in memory clinics of General and academic Hospitals Trial (LIGHT): Rationale and study design of a randomized controlled trial to reduce modifiable dementia risk}}, journal = {Alzheimer s Research \& Therapy}, year = {2026}, doi = {10.1186/s13195-025-01947-9}, pmid = {41508135}, url = {https://doi.org/10.1186/s13195-025-01947-9} } @article{scheuermann2025-40306986, author = {Scheuermann, Julia-Sophia and Scheerbaum, Petra and Liu, Yu and Ding, Yaping and Lu, Jianwen and Zhong, Ming and Su, Jian and Gefeller, Olaf and others}, title = {{SinoMAKS—protocol of a randomised controlled trial to evaluate the Chinese version of the non-pharmacological, multimodal MAKS intervention for people with mild to moderate dementia in Chinese nursing homes}}, journal = {BMJ Open}, year = {2025}, doi = {10.1136/bmjopen-2024-093618}, pmid = {40306986}, url = {https://doi.org/10.1136/bmjopen-2024-093618} } @article{wang2020-32920628, author = {Wang, H. Y. and Pei, Z. and Lee, K. C. and Lopez-Brignoni, E. and Nikolov, B. and Crowley, C. A. and Marsman, M. R. and Barbier, R. and others}, title = {{PTI-125 Reduces Biomarkers of Alzheimer's Disease in Patients}}, journal = {The journal of prevention of Alzheimer's disease}, year = {2020}, doi = {10.14283/jpad.2020.6}, pmid = {32920628}, url = {https://doi.org/10.14283/jpad.2020.6} } @article{rinne2010-20189881, author = {Rinne, Juha O. and Brooks, David James and Rossor, Martin N. and Fox, Nick C. and Bullock, Roger Alan and Klunk, William E. and Mathis, Chester A. and Blennow, Kaj and Barakos, Jerome A. and Okello, Aren and de Liano, Sofia Rodriguez Martinez and Liu, Enchi and Koller, Martin and Gregg, Keith M. and Schenk, Dale and Black, Ronald S. and Grundman, Michael}, title = {{11C-PiB PET assessment of change in fibrillar amyloid-β load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study}}, journal = {The Lancet Neurology}, year = {2010}, doi = {10.1016/s1474-4422(10)70043-0}, pmid = {20189881}, url = {https://doi.org/10.1016/s1474-4422(10)70043-0} } @article{hopkinson2026-42302797, author = {Hopkinson, Olivia K and Chobanov, Jan and Goordeen, Darshna and Man, Kenneth K C and Wong, Ian C K and Reeve, Emily and Bell, J Simon and Wei, Li and others}, title = {{Abrupt discontinuation and tapering of antipsychotics in older adults with dementia: a target trial emulation study}}, journal = {The lancet. Healthy longevity}, year = {2026}, doi = {10.1016/j.lanhl.2026.100852}, pmid = {42302797}, url = {https://doi.org/10.1016/j.lanhl.2026.100852} } @article{albertini2026-41286448, author = {Albertini, G. and Zielonka, M. and Cuypers, M. L. and Snellinx, A. and Xu, C. and Poovathingal, S. and Wojno, M. and Davie, K. and van Lieshout, V. and Craessaerts, K. and Wolfs, L. and Pasciuto, E. and others}, title = {{The Alzheimer's therapeutic Lecanemab attenuates Aβ pathology by inducing an amyloid-clearing program in microglia}}, journal = {Nature Neuroscience}, year = {2026}, doi = {10.1038/s41593-025-02125-8}, pmid = {41286448}, url = {https://doi.org/10.1038/s41593-025-02125-8} } @article{alvarez1999-10669911, author = {Alvarez, X. A. and Mouzo, R. and Pichel, V. and Pérez, P. and Laredo, M. and Fernández-Novoa, L. and Corzo, L. and Zas, R. and others}, title = {{Double-blind placebo-controlled study with citicoline in APOE genotyped Alzheimer's disease patients. Effects on cognitive performance, brain bioelectrical activity and cerebral perfusion}}, journal = {Methods and findings in experimental and clinical pharmacology}, year = {1999}, doi = {10.1358/mf.1999.21.9.795632}, pmid = {10669911}, url = {https://doi.org/10.1358/mf.1999.21.9.795632} } @article{chow2007-19300592, author = {Chow, T. W. and Pollock, B. G. and Milgram, N. W.}, title = {{Potential cognitive enhancing and disease modification effects of SSRIs for Alzheimer's disease}}, journal = {Neuropsychiatric disease and treatment}, year = {2007}, pmid = {19300592} } @article{bergamasco1994-7988944, author = {Bergamasco, B. and Scarzella, L. and La Commare, P.}, title = {{Idebenone, a new drug in the treatment of cognitive impairment in patients with dementia of the Alzheimer type}}, journal = {Functional neurology}, year = {1994}, pmid = {7988944} } @article{mowla2010-20075646, author = {Mowla, A. and Pani, A.}, title = {{Comparison of topiramate and risperidone for the treatment of behavioral disturbances of patients with Alzheimer disease: a double-blind, randomized clinical trial}}, journal = {Journal of clinical psychopharmacology}, year = {2010}, doi = {10.1097/jcp.0b013e3181ca0c59}, pmid = {20075646}, url = {https://doi.org/10.1097/jcp.0b013e3181ca0c59} } @article{miao2012-22500712, author = {Miao, Y. C. and Tian, J. Z. and Shi, J. and Mao, M.}, title = {{Effects of Chinese medicine for tonifying the kidney and resolving phlegm and blood stasis in treating patients with amnestic mild cognitive impairment: a randomized, double-blind and parallel-controlled trial}}, journal = {Zhong xi yi jie he xue bao = Journal of Chinese integrative medicine}, year = {2012}, doi = {10.3736/jcim20120407}, pmid = {22500712}, url = {https://doi.org/10.3736/jcim20120407} } @article{chhugani2018-31370033, author = {Chhugani, K. J. and Metri, K. and Babu, N. and Nagendra, H. R.}, title = {{Effects of Integrated Yoga Intervention on Psychopathologies and Sleep Quality Among Professional Caregivers of Older Adults With Alzheimer's Disease: A Controlled Pilot Study}}, journal = {Advances in mind-body medicine}, year = {2018}, pmid = {31370033} } @article{peters2016-26303700, author = {Peters, M. E. and Vaidya, V. and Drye, L. T. and Devanand, D. P. and Mintzer, J. E. and Pollock, B. G. and Porsteinsson, A. P. and Rosenberg, P. B. and others}, title = {{Citalopram for the Treatment of Agitation in Alzheimer Dementia: Genetic Influences}}, journal = {Journal of geriatric psychiatry and neurology}, year = {2016}, doi = {10.1177/0891988715601735}, pmid = {26303700}, url = {https://doi.org/10.1177/0891988715601735} } @article{luchsinger2025-40434891, author = {Luchsinger, J. A. and Devanand, D. and Goldberg, T. E. and Cammack, S. and Hernández-Santiago, G. and Oishi, K. and Jagust, W. and Baker, S. and others}, title = {{Protocol for a Randomized Phase II/III Double-Blind Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Extended-Release Metformin in Amnestic Mild Cognitive Impairment: Metformin in Alzheimer Dementia Prevention (MAP)}}, journal = {Alzheimer disease and associated disorders}, year = {2025}, doi = {10.1097/wad.0000000000000677}, pmid = {40434891}, url = {https://doi.org/10.1097/wad.0000000000000677} } @article{li2017-29390538, author = {Li, M. and Lyu, J. H. and Zhang, Y. and Gao, M. L. and Li, W. J. and Ma, X.}, title = {{The clinical efficacy of reminiscence therapy in patients with mild-to-moderate Alzheimer disease: Study protocol for a randomized parallel-design controlled trial}}, journal = {Medicine}, year = {2017}, doi = {10.1097/md.0000000000009381}, pmid = {29390538}, url = {https://doi.org/10.1097/md.0000000000009381} } @article{koepsell2007-17984455, author = {Koepsell, T. D. and Chi, Y. Y. and Zhou, X. H. and Lee, W. W. and Ramos, E. M. and Kukull, W. A.}, title = {{An alternative method for estimating efficacy of the AN1792 vaccine for Alzheimer disease}}, journal = {Neurology}, year = {2007}, doi = {10.1212/01.wnl.0000278226.96003.f8}, pmid = {17984455}, url = {https://doi.org/10.1212/01.wnl.0000278226.96003.f8} } @article{ross2022-35344024, author = {Ross, E. L. and Weinberg, M. S. and Arnold, S. E.}, title = {{Cost-effectiveness of Aducanumab and Donanemab for Early Alzheimer Disease in the US}}, journal = {JAMA neurology}, year = {2022}, doi = {10.1001/jamaneurol.2022.0315}, pmid = {35344024}, url = {https://doi.org/10.1001/jamaneurol.2022.0315} } @article{qaseem2018-29507945, author = {Qaseem, A. and Wilt, T. J. and Kansagara, D. and Horwitch, C. and Barry, M. J. and Forciea, M. A. and {Clinical Guidelines Committee of the American College of Physicians} and Fitterman, N. and others}, title = {{Hemoglobin A1c Targets for Glycemic Control With Pharmacologic Therapy for Nonpregnant Adults With Type 2 Diabetes Mellitus: A Guidance Statement Update From the American College of Physicians}}, journal = {Annals of internal medicine}, year = {2018}, doi = {10.7326/m17-0939}, pmid = {29507945}, url = {https://doi.org/10.7326/m17-0939} } @article{bayer2005-15642910, author = {Bayer, A. J. and Bullock, R. and Jones, R. W. and Wilkinson, D. and Paterson, K. R. and Jenkins, L. and Millais, S. B. and Donoghue, S.}, title = {{Evaluation of the safety and immunogenicity of synthetic Abeta42 (AN1792) in patients with AD}}, journal = {Neurology}, year = {2005}, doi = {10.1212/01.wnl.0000148604.77591.67}, pmid = {15642910}, url = {https://doi.org/10.1212/01.wnl.0000148604.77591.67} } @article{fassbender2001-11296263, author = {Fassbender, K. and Simons, M. and Bergmann, C. and Stroick, M. and Lutjohann, D. and Keller, P. and Runz, H. and Kuhl, S. and others}, title = {{Simvastatin strongly reduces levels of Alzheimer's disease beta -amyloid peptides Abeta 42 and Abeta 40 in vitro and in vivo}}, journal = {Proceedings of the National Academy of Sciences of the United States of America}, year = {2001}, doi = {10.1073/pnas.081620098}, pmid = {11296263}, url = {https://doi.org/10.1073/pnas.081620098} } @article{nygaard2015-25874001, author = {Nygaard, H. B. and Wagner, A. F. and Bowen, G. S. and Good, S. P. and MacAvoy, M. G. and Strittmatter, K. A. and Kaufman, A. C. and Rosenberg, B. J. and others}, title = {{A phase Ib multiple ascending dose study of the safety, tolerability, and central nervous system availability of AZD0530 (saracatinib) in Alzheimer's disease}}, journal = {Alzheimer's research \& therapy}, year = {2015}, doi = {10.1186/s13195-015-0119-0}, pmid = {25874001}, url = {https://doi.org/10.1186/s13195-015-0119-0} } @article{deane2012-22406537, author = {Deane, R. and Singh, I. and Sagare, A. P. and Bell, R. D. and Ross, N. T. and LaRue, B. and Love, R. and Perry, S. and others}, title = {{A multimodal RAGE-specific inhibitor reduces amyloid β-mediated brain disorder in a mouse model of Alzheimer disease}}, journal = {The Journal of clinical investigation}, year = {2012}, doi = {10.1172/jci58642}, pmid = {22406537}, url = {https://doi.org/10.1172/jci58642} } @article{rivasi2025-40067602, author = {Rivasi, Giulia and Capacci, Marco and Del Re, Lorenzo Maria and Ambrosino, Ilaria and Ceolin, Ludovica and Liccardo, Alessandra and Bisignano, Maria Francesca and D’Ambrosio, Giuseppe and others}, title = {{Trazodone and Risk of Orthostatic Hypotension, Syncope and Falls in Geriatric Outpatients with Hypertension}}, journal = {Drugs \& Aging}, year = {2025}, doi = {10.1007/s40266-025-01196-3}, pmid = {40067602}, url = {https://doi.org/10.1007/s40266-025-01196-3} } @article{ruthirakuhan2026-42178577, author = {Ruthirakuhan, M. and Mills, M. and Rosenberg, P. and Haughey, N. and Mintzer, J. and Brawman-Mintzer, O. and Craft, S. and Herrmann, N. and others}, title = {{Uncovering lipid biomarkers linked to methylphenidate efficacy in treating apathy in Alzheimer's disease: insights from the ADMET 2 trial}}, journal = {Alzheimer's research \& therapy}, year = {2026}, doi = {10.1186/s13195-026-02055-y}, pmid = {42178577}, url = {https://doi.org/10.1186/s13195-026-02055-y} } @article{ritchie2004-15249273, author = {Ritchie, C. W. and Ames, D. and Clayton, T. and Lai, R.}, title = {{Metaanalysis of randomized trials of the efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alzheimer disease}}, journal = {The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry}, year = {2004}, doi = {10.1176/appi.ajgp.12.4.358}, pmid = {15249273}, url = {https://doi.org/10.1176/appi.ajgp.12.4.358} } @article{gilletteguyonnet2009-19328438, author = {Gillette-Guyonnet, S. and Andrieu, S. and Dantoine, T. and Dartigues, J. F. and Touchon, J. and Vellas, B. and {MAPT Study Group}}, title = {{Commentary on "A roadmap for the prevention of dementia II. Leon Thal Symposium 2008." The Multidomain Alzheimer Preventive Trial (MAPT): a new approach to the prevention of Alzheimer's disease}}, journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association}, year = {2009}, doi = {10.1016/j.jalz.2009.01.008}, pmid = {19328438}, url = {https://doi.org/10.1016/j.jalz.2009.01.008} } @article{rai1990-2178869, author = {Rai, G. and Wright, G. and Scott, L. and Beston, B. and Rest, J. and Exton-Smith, A. N.}, title = {{Double-blind, placebo controlled study of acetyl-l-carnitine in patients with Alzheimer's dementia}}, journal = {Current medical research and opinion}, year = {1990}, doi = {10.1185/03007999009112690}, pmid = {2178869}, url = {https://doi.org/10.1185/03007999009112690} } @article{rubright2010-20808101, author = {Rubright, J. and Sankar, P. and Casarett, D. J. and Gur, R. and Xie, S. X. and Karlawish, J.}, title = {{A memory and organizational aid improves Alzheimer disease research consent capacity: results of a randomized, controlled trial}}, journal = {The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry}, year = {2010}, doi = {10.1097/jgp.0b013e3181dd1c3b}, pmid = {20808101}, url = {https://doi.org/10.1097/jgp.0b013e3181dd1c3b} } @article{monteverde1990-2121360, author = {Monteverde, A. and Gnemmi, P. and Rossi, F. and Finali, G. C.}, title = {{Selegiline in the treatment of mild to moderate Alzheimer-type dementia}}, journal = {Clinical therapeutics}, year = {1990}, pmid = {2121360} } @article{schneider2019-31282954, author = {Schneider, L. S. and Thomas, R. G. and Hendrix, S. and Rissman, R. A. and Brewer, J. B. and Salmon, D. P. and Oltersdorf, T. and Okuda, T. and others}, title = {{Safety and Efficacy of Edonerpic Maleate for Patients With Mild to Moderate Alzheimer Disease: A Phase 2 Randomized Clinical Trial}}, journal = {JAMA neurology}, year = {2019}, doi = {10.1001/jamaneurol.2019.1868}, pmid = {31282954}, url = {https://doi.org/10.1001/jamaneurol.2019.1868} } @article{lee2020-32872063, author = {Lee, J. and Jin, C. and Cho, S. Y. and Park, S. U. and Jung, W. S. and Moon, S. K. and Park, J. M. and Ko, C. N. and others}, title = {{Herbal medicine treatment for Alzheimer disease: A protocol for a systematic review and meta-analysis}}, journal = {Medicine}, year = {2020}, doi = {10.1097/md.0000000000021745}, pmid = {32872063}, url = {https://doi.org/10.1097/md.0000000000021745} } @article{burke1993-8463521, author = {Burke, W. J. and Ranno, A. E. and Roccaforte, W. H. and Wengel, S. P. and Bayer, B. L. and Willcockson, N. K.}, title = {{L-deprenyl in the treatment of mild dementia of the Alzheimer type: preliminary results}}, journal = {Journal of the American Geriatrics Society}, year = {1993}, doi = {10.1111/j.1532-5415.1993.tb06942.x}, pmid = {8463521}, url = {https://doi.org/10.1111/j.1532-5415.1993.tb06942.x} } @article{stryjer2012-22751086, author = {Stryjer, R. and Ophir, D. and Bar, F. and Spivak, B. and Weizman, A. and Strous, R. D.}, title = {{Rivastigmine treatment for the prevention of electroconvulsive therapy-induced memory deficits in patients with schizophrenia}}, journal = {Clinical neuropharmacology}, year = {2012}, doi = {10.1097/wnf.0b013e31825e7945}, pmid = {22751086}, url = {https://doi.org/10.1097/wnf.0b013e31825e7945} } @article{bloniecki2017-28269767, author = {Bloniecki, V. and Aarsland, D. and Blennow, K. and Cummings, J. and Falahati, F. and Winblad, B. and Freund-Levi, Y.}, title = {{Effects of Risperidone and Galantamine Treatment on Alzheimer's Disease Biomarker Levels in Cerebrospinal Fluid}}, journal = {Journal of Alzheimer's disease : JAD}, year = {2017}, doi = {10.3233/jad-160758}, pmid = {28269767}, url = {https://doi.org/10.3233/jad-160758} }